0001385613-20-000083.txt : 20201104 0001385613-20-000083.hdr.sgml : 20201104 20201104161248 ACCESSION NUMBER: 0001385613-20-000083 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 71 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201104 DATE AS OF CHANGE: 20201104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GREENLIGHT CAPITAL RE, LTD. CENTRAL INDEX KEY: 0001385613 STANDARD INDUSTRIAL CLASSIFICATION: FIRE, MARINE & CASUALTY INSURANCE [6331] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33493 FILM NUMBER: 201286830 BUSINESS ADDRESS: STREET 1: 65 MARKET STREET, SUITE 1207, STREET 2: CAMANA BAY, P.O. BOX 31110 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1205 BUSINESS PHONE: 345 943 4573 MAIL ADDRESS: STREET 1: 65 MARKET STREET, SUITE 1207, STREET 2: CAMANA BAY, P.O. BOX 31110 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1205 FORMER COMPANY: FORMER CONFORMED NAME: Greenlight Capital Re, Ltd. DATE OF NAME CHANGE: 20070109 10-Q 1 glre-20200930.htm 10-Q glre-20200930
000138561312/312020Q3falseus-gaap:AccountingStandardsUpdate201613Memberus-gaap:AccountingStandardsUpdate201613MemberP3D000000013856132020-01-012020-09-30xbrli:shares0001385613us-gaap:CommonClassAMember2020-10-300001385613us-gaap:CommonClassBMember2020-10-30iso4217:USD00013856132020-09-3000013856132019-12-31iso4217:USDxbrli:shares0001385613us-gaap:CommonClassAMember2020-09-300001385613us-gaap:CommonClassAMember2019-12-310001385613us-gaap:CommonClassBMember2019-12-310001385613us-gaap:CommonClassBMember2020-09-3000013856132020-07-012020-09-3000013856132019-07-012019-09-3000013856132019-01-012019-09-300001385613us-gaap:CommonStockMember2020-06-300001385613us-gaap:CommonStockMember2019-06-300001385613us-gaap:CommonStockMember2019-12-310001385613us-gaap:CommonStockMember2018-12-310001385613us-gaap:CommonStockMember2020-07-012020-09-300001385613us-gaap:CommonStockMember2019-07-012019-09-300001385613us-gaap:CommonStockMember2020-01-012020-09-300001385613us-gaap:CommonStockMember2019-01-012019-09-300001385613us-gaap:CommonStockMember2020-09-300001385613us-gaap:CommonStockMember2019-09-300001385613us-gaap:AdditionalPaidInCapitalMember2020-06-300001385613us-gaap:AdditionalPaidInCapitalMember2019-06-300001385613us-gaap:AdditionalPaidInCapitalMember2019-12-310001385613us-gaap:AdditionalPaidInCapitalMember2018-12-310001385613us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300001385613us-gaap:AdditionalPaidInCapitalMember2020-01-012020-09-300001385613us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-300001385613us-gaap:AdditionalPaidInCapitalMember2019-01-012019-09-300001385613us-gaap:AdditionalPaidInCapitalMember2020-09-300001385613us-gaap:AdditionalPaidInCapitalMember2019-09-300001385613us-gaap:RetainedEarningsMember2020-06-300001385613us-gaap:RetainedEarningsMember2019-06-300001385613us-gaap:RetainedEarningsMember2019-12-310001385613us-gaap:RetainedEarningsMember2018-12-310001385613us-gaap:RetainedEarningsMembersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember2019-12-310001385613us-gaap:RetainedEarningsMember2020-07-012020-09-300001385613us-gaap:RetainedEarningsMember2019-07-012019-09-300001385613us-gaap:RetainedEarningsMember2020-01-012020-09-300001385613us-gaap:RetainedEarningsMember2019-01-012019-09-300001385613us-gaap:RetainedEarningsMember2020-09-300001385613us-gaap:RetainedEarningsMember2019-09-3000013856132019-09-3000013856132018-12-310001385613srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-09-300001385613srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001385613srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2018-12-310001385613us-gaap:EmployeeStockOptionMember2020-07-012020-09-300001385613us-gaap:EmployeeStockOptionMember2019-07-012019-09-300001385613us-gaap:EmployeeStockOptionMember2020-01-012020-09-300001385613us-gaap:EmployeeStockOptionMember2019-01-012019-09-300001385613us-gaap:RestrictedStockMember2020-07-012020-09-300001385613us-gaap:RestrictedStockMember2019-07-012019-09-300001385613us-gaap:RestrictedStockMember2020-01-012020-09-300001385613us-gaap:RestrictedStockMember2019-01-012019-09-300001385613srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201613Member2019-12-31xbrli:pure0001385613glre:SILPMemberglre:GreenlightCapitalReLimitedPartnersMember2020-08-050001385613glre:SILPMemberglre:GreenlightCapitalReLimitedPartnersMember2020-09-300001385613glre:SILPMemberglre:GreenlightCapitalReLimitedPartnersMember2019-12-310001385613us-gaap:GeneralPartnerMember2020-09-300001385613us-gaap:GeneralPartnerMember2019-12-310001385613glre:LimitedPartnershipAgreementMember2020-01-012020-09-300001385613us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMemberglre:SolasglasInvestmentLPSILPMember2020-09-300001385613us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMemberglre:SolasglasInvestmentLPSILPMember2019-12-310001385613glre:SolasglasInvestmentLPSILPMember2020-07-012020-09-300001385613glre:SolasglasInvestmentLPSILPMember2019-07-012019-09-300001385613glre:SolasglasInvestmentLPSILPMember2020-01-012020-09-300001385613glre:SolasglasInvestmentLPSILPMember2019-01-012019-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2020-09-300001385613us-gaap:EquityMethodInvestmentsMember2020-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2019-12-310001385613us-gaap:EquityMethodInvestmentsMember2019-12-310001385613glre:PrivateAndUnlistedEquitySecuritiesMember2020-07-012020-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2020-01-012020-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2019-07-012019-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2019-01-012019-09-300001385613glre:AccuRiskHoldingsLLCMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2020-09-302020-09-300001385613glre:AccuRiskHoldingsLLCMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2019-12-312019-12-310001385613glre:AccuRiskHoldingsLLCMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2020-01-012020-09-300001385613glre:AccuRiskHoldingsLLCMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2020-07-012020-09-300001385613glre:AccuRiskHoldingsLLCMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2019-07-012019-09-300001385613glre:AccuRiskHoldingsLLCMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2019-01-012019-09-300001385613us-gaap:HealthInsuranceProductLineMember2019-12-310001385613us-gaap:HealthInsuranceProductLineMember2018-12-310001385613us-gaap:HealthInsuranceProductLineMember2020-01-012020-09-300001385613us-gaap:HealthInsuranceProductLineMember2019-01-012019-09-300001385613us-gaap:HealthInsuranceProductLineMember2020-09-300001385613us-gaap:HealthInsuranceProductLineMember2019-09-300001385613us-gaap:CededCreditRiskUnsecuredMemberglre:UnratedMember2020-09-300001385613us-gaap:CededCreditRiskUnsecuredMemberglre:UnratedMember2019-12-310001385613us-gaap:CededCreditRiskSecuredMemberglre:UnratedMember2020-09-300001385613us-gaap:CededCreditRiskSecuredMemberglre:UnratedMember2019-12-310001385613srt:AMBestAMinusRatingMember2020-09-300001385613srt:AMBestAMinusRatingMember2019-12-310001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2018-08-070001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMembersrt:ProFormaMember2020-09-300001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2020-09-300001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2019-12-310001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2020-07-012020-09-300001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2020-01-012020-09-300001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2019-07-012019-09-300001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2019-01-012019-09-300001385613us-gaap:SubsequentEventMemberus-gaap:CommonClassAMember2020-10-292020-10-290001385613us-gaap:SubsequentEventMemberus-gaap:CommonClassAMember2020-10-280001385613us-gaap:SubsequentEventMemberus-gaap:CommonClassAMember2020-10-290001385613us-gaap:CommonClassAMember2020-03-260001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2020-03-260001385613us-gaap:CommonClassAMember2020-01-012020-09-300001385613us-gaap:CommonClassAMember2019-01-012019-09-300001385613us-gaap:CommonClassAMember2018-12-310001385613us-gaap:CommonClassBMember2018-12-310001385613us-gaap:CommonClassBMember2020-01-012020-09-300001385613us-gaap:CommonClassBMember2019-01-012019-09-300001385613us-gaap:CommonClassAMember2019-09-300001385613us-gaap:CommonClassBMember2019-09-300001385613us-gaap:RestrictedStockMemberus-gaap:CommonClassAMember2020-01-012020-09-300001385613us-gaap:RestrictedStockMemberus-gaap:CommonClassAMember2019-01-012019-09-300001385613us-gaap:RestrictedStockMember2020-01-012020-09-300001385613srt:ChiefExecutiveOfficerMemberus-gaap:RestrictedStockMemberus-gaap:CommonClassAMember2020-01-012020-09-300001385613srt:ChiefExecutiveOfficerMemberus-gaap:RestrictedStockMemberus-gaap:CommonClassAMember2019-01-012019-09-300001385613srt:ChiefExecutiveOfficerMemberus-gaap:RestrictedStockMember2020-01-012020-09-300001385613srt:ChiefExecutiveOfficerMemberus-gaap:RestrictedStockMember2019-01-012019-09-300001385613srt:ChiefExecutiveOfficerMemberus-gaap:RestrictedStockMember2020-07-302020-07-300001385613us-gaap:RestrictedStockMember2019-01-012019-09-300001385613us-gaap:RestrictedStockMember2020-09-300001385613us-gaap:RestrictedStockMember2019-12-310001385613us-gaap:RestrictedStockMember2020-09-302020-09-300001385613us-gaap:RestrictedStockMember2019-12-312019-12-310001385613srt:ChiefExecutiveOfficerMemberus-gaap:EmployeeStockOptionMemberus-gaap:CommonClassAMember2020-01-012020-09-300001385613us-gaap:EmployeeStockOptionMember2020-01-012020-09-300001385613us-gaap:EmployeeStockOptionMember2019-01-012019-09-300001385613us-gaap:EmployeeStockOptionMember2020-09-300001385613us-gaap:EmployeeStockOptionMember2019-09-300001385613us-gaap:EmployeeStockOptionMember2019-12-310001385613us-gaap:EmployeeStockOptionMember2020-09-302020-09-300001385613us-gaap:EmployeeStockOptionMember2019-12-312019-12-310001385613us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300001385613us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2020-01-012020-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2019-12-310001385613us-gaap:RestrictedStockUnitsRSUMember2020-09-300001385613us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-09-300001385613us-gaap:GeneralAndAdministrativeExpenseMember2019-01-012019-09-300001385613srt:BoardOfDirectorsChairmanMemberglre:LimitedPartnershipAgreementMember2018-08-312018-08-310001385613srt:BoardOfDirectorsChairmanMemberglre:InvestmentAdvisoryAgreementMember2018-09-012018-09-010001385613glre:GreenBricksPartnersIncGRBKMembersrt:AffiliatedEntityMember2020-09-300001385613srt:BoardOfDirectorsChairmanMemberglre:ServiceAgreementMember2020-01-012020-09-300001385613srt:BoardOfDirectorsChairmanMemberglre:CollateralAssetsInvestementManagementAgreementMember2019-01-012019-01-01glre:facility0001385613us-gaap:FinancialStandbyLetterOfCreditMemberglre:CitibankEuropePlcMember2020-09-300001385613us-gaap:FinancialStandbyLetterOfCreditMemberglre:CitibankEuropePlcMember2020-01-012020-09-3000013856132020-08-2500013856132020-08-26iso4217:EUR0001385613glre:GreenlightReinsuranceIrelandDACMember2020-01-012020-09-300001385613us-gaap:ConvertibleDebtMember2020-09-30glre:segment0001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2020-07-012020-09-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2019-07-012019-09-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2020-01-012020-09-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2019-01-012019-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2020-07-012020-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2019-07-012019-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2020-01-012020-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2019-01-012019-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2020-07-012020-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2019-07-012019-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2020-01-012020-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2019-01-012019-09-300001385613us-gaap:PropertyInsuranceProductLineMember2020-07-012020-09-300001385613us-gaap:PropertyInsuranceProductLineMember2019-07-012019-09-300001385613us-gaap:PropertyInsuranceProductLineMember2020-01-012020-09-300001385613us-gaap:PropertyInsuranceProductLineMember2019-01-012019-09-300001385613us-gaap:GeneralLiabilityMember2020-07-012020-09-300001385613us-gaap:GeneralLiabilityMember2019-07-012019-09-300001385613us-gaap:GeneralLiabilityMember2020-01-012020-09-300001385613us-gaap:GeneralLiabilityMember2019-01-012019-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2020-07-012020-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2019-07-012019-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2020-01-012020-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2019-01-012019-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2020-07-012020-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2019-07-012019-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2020-01-012020-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2019-01-012019-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2020-07-012020-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2019-07-012019-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2020-01-012020-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2019-01-012019-09-300001385613glre:MultilineMember2020-07-012020-09-300001385613glre:MultilineMember2019-07-012019-09-300001385613glre:MultilineMember2020-01-012020-09-300001385613glre:MultilineMember2019-01-012019-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2020-07-012020-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2019-07-012019-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2020-01-012020-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2019-01-012019-09-300001385613us-gaap:HealthInsuranceProductLineMember2020-07-012020-09-300001385613us-gaap:HealthInsuranceProductLineMember2019-07-012019-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2020-07-012020-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2019-07-012019-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2020-01-012020-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2019-01-012019-09-300001385613glre:MarineCasualtyInsuranceMember2020-07-012020-09-300001385613glre:MarineCasualtyInsuranceMember2019-07-012019-09-300001385613glre:MarineCasualtyInsuranceMember2020-01-012020-09-300001385613glre:MarineCasualtyInsuranceMember2019-01-012019-09-300001385613us-gaap:OtherInsuranceProductLineMember2020-07-012020-09-300001385613us-gaap:OtherInsuranceProductLineMember2019-07-012019-09-300001385613us-gaap:OtherInsuranceProductLineMember2020-01-012020-09-300001385613us-gaap:OtherInsuranceProductLineMember2019-01-012019-09-300001385613glre:TotalSpecialtyDomain2020-07-012020-09-300001385613glre:TotalSpecialtyDomain2019-07-012019-09-300001385613glre:TotalSpecialtyDomain2020-01-012020-09-300001385613glre:TotalSpecialtyDomain2019-01-012019-09-300001385613srt:NorthAmericaMember2020-07-012020-09-300001385613srt:NorthAmericaMember2019-07-012019-09-300001385613srt:NorthAmericaMember2020-01-012020-09-300001385613srt:NorthAmericaMember2019-01-012019-09-300001385613glre:WorldwideMember2020-07-012020-09-300001385613glre:WorldwideMember2019-07-012019-09-300001385613glre:WorldwideMember2020-01-012020-09-300001385613glre:WorldwideMember2019-01-012019-09-300001385613srt:EuropeMember2020-07-012020-09-300001385613srt:EuropeMember2019-07-012019-09-300001385613srt:EuropeMember2020-01-012020-09-300001385613srt:EuropeMember2019-01-012019-09-300001385613srt:AsiaMember2020-07-012020-09-300001385613srt:AsiaMember2019-07-012019-09-300001385613srt:AsiaMember2020-01-012020-09-300001385613srt:AsiaMember2019-01-012019-09-300001385613glre:PromissoryNoteMember2020-09-300001385613glre:PromissoryNoteMemberus-gaap:SubsequentEventMember2020-10-012020-11-040001385613glre:PromissoryNoteMembersrt:ScenarioForecastMember2020-10-012020-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
__________________________
FORM 10-Q 
__________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2020

or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 001-33493
____________________________________________________________________________________
GREENLIGHT CAPITAL RE, LTD.
(Exact name of registrant as specified in its charter)
____________________________________________________________________________________
Cayman IslandsN/A
(State or other jurisdiction of incorporation or organization)(I.R.S. employer identification no.)
65 Market Street
Suite 1207, Jasmine Court
P.O. Box 31110
Camana Bay
Grand Cayman
Cayman IslandsKY1-1205
(Address of principal executive offices)(Zip code)

(345) 943-4573
(Registrant’s telephone number, including area code)

Not Applicable
(Former name, former address and former fiscal year, if changed since last report) 

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Ordinary SharesGLRENasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): 
Large accelerated filer ☐          Accelerated filer ☒          Non-accelerated filer ☐          Smaller reporting company ☐          Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) 
Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class A Ordinary Shares, $0.10 par value28,933,957
Class B Ordinary Shares, $0.10 par value6,254,715
(Class)Outstanding as of October 30, 2020


GREENLIGHT CAPITAL RE, LTD.
 
TABLE OF CONTENTS
 
  Page
 Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019 (unaudited)
 Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2020 and 2019 (unaudited)
 Condensed Consolidated Statements of Changes in Shareholders' Equity for the three and nine months ended September 30, 2020 and 2019 (unaudited)
 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2020 and 2019 (unaudited)
 Notes to the Condensed Consolidated Financial Statements (unaudited)


 
2
PART I — FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS 
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED) 

September 30, 2020 and December 31, 2019
(expressed in thousands of U.S. dollars, except per share and share amounts)
 September 30, 2020December 31, 2019
Assets  
Investments  
Investment in related party investment fund$184,956 $240,056 
Other investments22,241 16,384 
Total investments207,197 256,440 
Cash and cash equivalents8,159 25,813 
Restricted cash and cash equivalents723,107 742,093 
Reinsurance balances receivable (net of allowance for expected credit losses of $89)
264,227 230,384 
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47)
19,949 27,531 
Deferred acquisition costs 51,696 49,665 
Unearned premiums ceded— 901 
Notes receivable (net of allowance for expected credit losses of $1,000)
18,461 20,202 
Other assets3,264 2,164 
Total assets$1,296,060 $1,355,193 
Liabilities and equity 
Liabilities 
Loss and loss adjustment expense reserves$481,770 $470,588 
Unearned premium reserves203,855 179,460 
Reinsurance balances payable80,364 122,665 
Funds withheld5,232 4,958 
Other liabilities3,756 6,825 
Convertible senior notes payable94,216 93,514 
Total liabilities869,193 878,010 
Shareholders' equity 
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)
— — 
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 29,113,702 (2019: 30,739,395): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2019: 6,254,715))
3,537 3,699 
Additional paid-in capital492,429 503,547 
Retained earnings (deficit)(69,099)(30,063)
Total shareholders' equity426,867 477,183 
Total liabilities and equity$1,296,060 $1,355,193 
 
  The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements.
3
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
 
For the three and nine months ended September 30, 2020 and 2019
(expressed in thousands of U.S. dollars, except per share and share amounts)
Three months ended September 30Nine months ended September 30
 2020201920202019
Revenues 
Gross premiums written$135,596 $110,607 $362,072 $425,507 
Gross premiums ceded(1,464)(4,035)(2,274)(48,577)
Net premiums written134,132 106,572 359,798 376,930 
Change in net unearned premium reserves(18,613)22,582 (24,844)(1,973)
Net premiums earned115,519 129,154 334,954 374,957 
Income (loss) from investment in related party investment fund [net of related party expenses of $703 and $1,981, (three and nine months ended September 30, 2019: $1,325 and $9,888, respectively)]
6,431 6,609 (34,086)51,770 
Net investment income 466 3,312 11,237 9,265 
Other income (expense), net1,569 (887)2,570 1,299 
Total revenues123,985 138,188 314,675 437,291 
Expenses
Net loss and loss adjustment expenses incurred88,053 92,962 252,944 294,303 
Acquisition costs27,018 30,962 76,660 89,660 
General and administrative expenses5,152 7,725 18,095 22,484 
Interest expense1,579 1,578 4,702 4,684 
Total expenses121,802 133,227 352,401 411,131 
Income (loss) before income tax2,183 4,961 (37,726)26,160 
Income tax (expense) benefit— 179 (424)200 
Net income (loss)$2,183 $5,140 $(38,150)$26,360 
Earnings (loss) per share
Basic$0.06 $0.14 $(1.07)$0.72 
Diluted$0.06 $0.14 $(1.07)$0.72 
Weighted average number of ordinary shares used in the determination of earnings and loss per share
Basic35,677,554 36,841,623 35,569,292 36,646,515 
Diluted35,779,703 36,921,490 35,569,292 36,720,550 
 

 
The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 


 
 
4
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(UNAUDITED)
 
For the three and nine months ended September 30, 2020 and 2019
(expressed in thousands of U.S. dollars)

Three months ended September 30Nine months ended September 30
2020201920202019
Ordinary share capital
Beginning balance$3,627 $3,679 $3,699 $3,638 
Issue of Class A ordinary shares, net of forfeitures(19)20 25 61 
Repurchase of Class A ordinary shares(71)— (187)— 
Ending balance3,537 3,699 3,537 3,699 
Additional paid-in capital
Beginning balance497,559 501,916 503,547 499,726 
Repurchase of Class A ordinary shares(4,828)— (12,484)— 
Share-based compensation expense(302)645 1,366 2,835 
Ending balance492,429 502,561 492,429 502,561 
Retained earnings (deficit)
Beginning balance(71,282)(4,857)(30,063)(26,077)
Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2020
— — (886)— 
Net income (loss)2,183 5,140 (38,150)26,360 
Ending balance(69,099)283 (69,099)283 
Total shareholders' equity$426,867 $506,543 $426,867 $506,543 


The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 


 
5
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
For the nine months ended September 30, 2020 and 2019
(expressed in thousands of U.S. dollars) 
Nine months ended September 30
 20202019
Cash provided by (used in) operating activities 
Net income (loss)$(38,150)$26,360 
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities
Loss (income) from investments in related party investment fund34,086 (51,770)
Loss (income) from investment accounted for under the equity method(870)(267)
Net change in unrealized gains and losses on investments and notes receivable(19,153)(14,362)
Net realized (gains) losses on investments15,000 14,150 
Foreign exchange (gains) losses on investments232 (160)
Current expected credit losses recognized on notes receivable and reinsurance assets 250 — 
Share-based compensation expense1,391 2,896 
Amortization and interest expense, net of change in accruals702 751 
Depreciation expense21 21 
Net change in
Reinsurance balances receivable(33,932)26,981 
Loss and loss adjustment expenses recoverable7,535 2,170 
Deferred acquisition costs(2,031)(678)
Unearned premiums ceded901 17,242 
Other assets, excluding depreciation(1,121)(561)
Loss and loss adjustment expense reserves11,182 (3,227)
Unearned premium reserves24,395 (15,211)
Reinsurance balances payable(42,301)(9,259)
Funds withheld274 (6,465)
Other liabilities(3,069)2,709 
Net cash provided by (used in) operating activities(44,658)(8,680)
Investing activities
Proceeds from redemptions from related party investment fund69,108 107,162 
Contributions to related party investment fund(48,094)(11,306)
Purchases of investments(944)(4,702)
Change in due to related party investment fund— (9,642)
Notes receivable collected (issued)741 (1,016)
Non-controlling interest contribution into (withdrawal from) related party joint venture, net— (1,278)
Net cash provided by (used in) investing activities20,811 79,218 
Financing activities
Repurchase of Class A ordinary shares(12,671)— 
Net cash provided by (used in) financing activities(12,671)— 
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash(122)237 
Net increase (decrease) in cash, cash equivalents and restricted cash(36,640)70,775 
Cash, cash equivalents and restricted cash at beginning of the period (see Note 2)767,906 703,231 
Cash, cash equivalents and restricted cash at end of the period (see Note 2)$731,266 $774,006 
Supplementary information 
Interest paid in cash$4,000 $3,933 
Income tax paid in cash— — 
Non-cash transfer of investments (Note 3)— 36,673 
Non-cash addition of right-of-use asset— 323 

The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 
6
GREENLIGHT CAPITAL RE, LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
 
September 30, 2020
 
 
1. ORGANIZATION AND BASIS OF PRESENTATION
 
Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s principal wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Law, 2010 and underlying regulations thereto (the “Law”) and is subject to regulation by the Cayman Islands Monetary Authority, in terms of the Law. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America.  As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries.

The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE”.

These unaudited condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2019. In the opinion of management, these unaudited condensed consolidated financial statements reflect all of the normal recurring adjustments considered necessary for a fair presentation of the Company’s financial position and results of operations as of the dates and for the periods presented.

The global pandemic related to the novel coronavirus (the “COVID-19 pandemic”) is expected to have a significant adverse impact on the property and casualty insurance and reinsurance industry. The Company has included in the loss and loss adjustment reserves, its best estimate of losses arising from the COVID-19 pandemic. However, there remains considerable uncertainty relating to the ultimate losses, which will depend on the extent and duration of economic contraction, particularly in the United States. Accordingly, significant estimates used in the preparation of the Company’s consolidated financial statements including those associated with premiums, expected credit losses on amounts owed to us and the estimations of loss and loss adjustment expense reserves may be subject to significant adjustments in future periods.

The results for the nine months ended September 30, 2020 are not necessarily indicative of the results expected for the full calendar year.

2. SIGNIFICANT ACCOUNTING POLICIES
 
In the first quarter of 2020, the Company adopted ASU No. 2016-13, Financial Instruments - Credit Losses (“ASU 2016-13”) which requires an entity to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. ASU 2016-13 was effective for public business entities for annual and interim periods beginning after December 15, 2019. The financial assets included in the captions “Reinsurance balances receivable,” “Loss and loss adjustment expenses recoverable” (collectively, “Reinsurance Assets”) and “Notes receivable,” in the Company’s condensed consolidated balance sheets are carried at amortized cost and therefore affected by ASU 2016-13. Other than the changes relating to the adoption of ASU 2016-13, there have been no changes to the Company’s significant accounting policies as described in its Annual Report on Form 10-K for the year ended December 31, 2019.
7

Use of Estimates
 
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of income and expenses during the period. Actual results could differ from these estimates. 

Restricted Cash and Cash Equivalents
 
The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 11). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:

 September 30, 2020December 31, 2019
 ($ in thousands)
Cash and cash equivalents$8,159 $25,813 
Restricted cash and cash equivalents723,107 742,093 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$731,266 $767,906 

Reinsurance Assets

Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model that considers both the Company’s collectibility history on its reinsurance assets as well as representative external loss history. The external loss history that the Company uses includes a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties is also considered as the probability of default is calculated over the contractual length of the reinsurance contracts.

The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The Company manages its credit risk in its reinsurance assets by transacting with insurers and reinsurers that it considers financially sound.

For its retrocessionaire counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts and/or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations or unearned premiums against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of retrocessionaires to honor their respective obligations.

Upon adoption of ASU 2016-13, the Company recorded an allowance for expected credit loss on its Reinsurance Assets of $0.1 million with an offset to retained earnings. At September 30, 2020, the allowance for expected credit losses was $0.1 million.

Notes Receivable
 
Notes receivable represent promissory notes receivable from third parties. These notes are recorded at cost plus accrued interest, if any, net of valuation allowance for expected credit losses. Interest income, changes in the allowance for expected credit losses and unrealized and realized gains or losses on the notes receivable are included in the caption “Net investment income (loss)” in the Company’s condensed consolidated statements of operations.

The allowance for expected credit losses is calculated using a PD / LGD model that takes into account the Company’s experience as well as representative external loss history. The expected loss percentage is calculated as the product of the PD and LGD for each period over the life of a note. The Company evaluates the financial condition of the notes receivable counterparties and monitors its exposure on a regular basis. At September 30, 2020, the Company considers the notes receivable balance to be collectible and has not experienced any default on payments since inception of these notes. The notes receivable originated between 2015 and 2018.
8

At September 30, 2020 and December 31, 2019, $0.1 million and $0.1 million, respectively, of accrued interest was included in the caption “Notes receivable” in the Company’s condensed consolidated balance sheets. When there is uncertainty as to the collection of interest contractually due, the Company places the note on non-accrual status. For notes receivable placed on non-accrual status, the notes are presented excluding any accrued interest amount. The Company resumes the accrual of interest on a note when none of the principal or interest remains past due, and the Company expects to collect the remaining contractual principal and interest. Interest collected on notes that are placed on non-accrual status is recorded as interest income when collected, provided that the recorded value of the note is deemed to be fully collectible. Where doubt exists as to the collectibility of the remaining recorded value of the notes placed on non-accrual status, the Company immediately reverses any previous accrued interest through interest income and any payments received are applied to reduce the recorded value of the notes. The allowance for expected credit losses for notes receivable is calculated on the amortized cost excluding accrued interest and interest written off due to non-accrual status.

Charge offs of notes receivable are recorded when all or a portion of the financial asset is deemed uncollectible. Full or partial charge offs are recorded as reductions to the amortized cost and deducted from the allowance in the period in which the note receivable is deemed uncollectible. In instances where the Company collects cash that it has previously charged off, the recovery will be recognized through earnings or as a reduction of the amortized cost for interest and principal, respectively.

The following table provides a roll-forward of the Company’s allowance for credit losses on notes receivable:
Nine months ended September 30
20202019
($ in thousands)
Balance at beginning of period$15,000 $9,012 
Cumulative effect of adoption of ASU 2016-13 at January 1, 2020750 — 
Charge offs(15,000)— 
Net increase (decrease) in allowance250 — 
Balance at end of period$1,000 $9,012 

Deposit Assets and Liabilities
 
The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, an asset or liability is recognized based on the consideration paid or received. The deposit asset or liability balance is subsequently adjusted using the interest method with a corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company’s deposit assets and liabilities are recorded in the Company’s condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At September 30, 2020, deposit assets and deposit liabilities were $5.3 million and $35.2 million, respectively (December 31, 2019: $5.2 million and $56.9 million, respectively). For the three and nine months ended September 30, 2020 and 2019, the interest income/(expense) on deposit accounted contracts was as follows:
 Three months ended September 30Nine months ended September 30
 2020201920202019
($ in thousands)($ in thousands)
Deposit interest income$560 $1,023 $1,812 $2,493 
Deposit interest expense$— $(656)$— $(135)
Deposit interest income/(expense), net$560 $367 $1,812 $2,358 
9

Other Assets

Other assets consist primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables and deferred tax assets.

Other Liabilities

Other liabilities consist primarily of accruals for legal and other professional fees, employee bonuses and lease liabilities.

Earnings (Loss) Per Share
 
The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:

•Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting;
•additional potential common shares issuable when stock options are exercised, determined using the treasury stock method; and
•those common shares with the potential to be issued by virtue of convertible debt and other such convertible instruments, determined using the treasury stock method.

Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. In the event of a net loss, all RSUs, stock options outstanding, convertible debt and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.

The table below presents the shares outstanding for the purposes of the calculation of earnings (loss) per share for the three and nine months ended September 30, 2020 and 2019:
 Three months ended September 30Nine months ended September 30
 2020201920202019
Weighted average shares outstanding - basic35,677,554 36,841,623 35,569,292 36,646,515 
Effect of dilutive employee and director share-based awards102,149 79,867 — 74,035 
Weighted average shares outstanding - diluted35,779,703 36,921,490 35,569,292 36,720,550 
Anti-dilutive stock options outstanding835,627 875,627 835,627 875,627 
Participating securities excluded from calculation of loss per share — — 878,498 — 

Taxation
 
Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.
 
Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2019: 21%). Verdant’s tax years 2014 and beyond remain open and subject to examination by the IRS.

10
GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income, and 25% on its non-trading income.

The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions that are subject to significant uncertainty that is reasonably likely to have a material impact on the Company. 

Recent Accounting Pronouncements

Recently Issued Accounting Standards Adopted

As discussed above, the Company adopted ASU 2016-13 during the first quarter of 2020 using a modified retrospective transition method. The adoption resulted in a cumulative-effect adjustment to retained earnings of $0.9 million as of January 1, 2020.

Recently Issued Accounting Standards Not Yet Adopted

In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). The amendments in ASU 2020-01 clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815, which could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 is not expected to have a material impact on the Company’s consolidated financial statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity's own equity. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, embedded conversion features would not be presented separately in equity; rather, the contract would be accounted for as a single liability measured at its amortized cost. Subtopic 815-40 simplifies the analysis of whether an embedded conversion feature meets the derivative scope exception for contracts that are indexed to, and classified in, stockholders equity, as well as addresses the computation of earnings per share for convertible debt instruments. ASU 2020-06 requires the application of the if-converted method when calculating diluted earnings per share. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 using either a modified retrospective method of transition or a fully retrospective method of transition. Early adoption is permitted no earlier than for fiscal years beginning after December 15, 2020. The Company is currently evaluating the effect the new standard will have on its consolidated financial statements.

3. INVESTMENT IN RELATED PARTY INVESTMENT FUND

Prior to January 2, 2019, the Company and its reinsurance subsidiaries were party to a joint venture agreement (the “venture agreement”) with DME Advisors, LP (“DME Advisors”) and DME Advisors LLC (“DME”) under which the Company, its reinsurance subsidiaries and DME were participants in a joint venture (the “Joint Venture”) for the purpose of managing certain jointly held assets. DME and DME Advisors are related to the Company and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors.

On September 1, 2018, the Company entered into an amended and restated exempted limited partnership agreement (as amended by that certain letter agreement dated as of August 5, 2020, the “SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re and GRIL, (together the “GLRE Limited Partners”), and the initial limited partner (each, a “Partner”). The SILP LPA, in conjunction with a participation agreement, replaced the venture agreement and assigned and/or transferred Greenlight Re’s and GRIL’s invested assets in the Joint Venture to SILP. The Joint Venture was terminated on January 2, 2019 by which date all assets were transferred to SILP. On September
11
1, 2018, SILP also entered into a SILP investment advisory agreement (“IAA”) with DME Advisors pursuant to which DME Advisors is the investment manager for SILP.

The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:

•DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.

•DME II holds an interest in excess of 10% of SILP’s net assets which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP.

Consequently, the Company has concluded that DME II’s interests, and not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company’s investment in SILP is presented in the Company’s condensed consolidated balance sheets in the caption “Investment in related party investment fund.”

During 2019, SILP’s investment portfolio was de-risked in order to reduce the Company’s investment volatility in the near-term. As a result, a significant proportion of the Company’s investment assets in SILP was held in cash and short-term treasuries as of December 31, 2019. On August 5, 2020, the Company entered into an amended and restated letter agreement with DME Advisors and DME II whereby the deployed Investment Portfolio can not exceed an amount equal to 50% of the Company’s shareholders’ equity, as reported in the Company’s then most recent quarterly U.S. GAAP financial statements, adjusted monthly for investment gains and losses as reported by SILP during any intervening period.

The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. As of September 30, 2020, the net asset value of the GLRE Limited Partners’ investment in SILP was $185.0 million (December 31, 2019: $240.1 million), representing 81.0% (December 31, 2019: 81.0%) of SILP’s total net assets. The remaining 19.0% (December 31, 2019: 19.0%) of SILP’s total net assets was held by DME II. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing three business days’ notice to DME II. As of September 30, 2020, the majority of SILP’s long investments are composed of cash and publicly-traded equity securities, which can be readily liquidated to meet GLRE Limited Partners’ redemption requests.

The Company’s share of the change in the net asset value of SILP for the three and nine months ended September 30, 2020 was $6.4 million and $(34.1) million, respectively, (three and nine months ended September 30, 2019: $6.6 million and $51.8 million, respectively), and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations. The change in the net asset value of SILP for the nine months ended September 30, 2020 was primarily driven by the impact of changes in fair value primarily attributable to the disruptions in global financial markets associated with the COVID–19 pandemic.

The summarized financial statements of SILP are presented below.

12

Summarized Statement of Assets and Liabilities of Solasglas Investments, LP
September 30, 2020December 31, 2019
($ in thousands)
Assets
Investments, at fair value$220,116 $162,928 
Derivative contracts, at fair value3,097 6,324 
Due from brokers130,220 68,060 
Cash and cash equivalents2,202 111,046 
Interest and dividends receivable281 47 
Total assets355,916 348,405 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(116,336)(47,834)
Derivative contracts, at fair value(10,962)(2,054)
Due to brokers— (1,180)
Interest and dividends payable(32)(828)
Other liabilities(233)(101)
Total liabilities(127,563)(51,997)
Net Assets$228,353 $296,408 
GLRE Limited Partners’ share of Net Assets$184,956 $240,056 


13
Summarized Statement of Operations of Solasglas Investments, LP
Three months ended September 30Nine months ended September 30
2020201920202019
($ in thousands)
Investment income
Dividend income (net of withholding taxes)$170 $652 $1,204 $2,334 
Interest income36 279 262 1,869 
Total Investment income206 931 1,466 4,203 
Expenses
Management fee(703)(653)(1,981)(4,235)
Interest(176)(89)(518)(2,308)
Dividends(213)(96)(612)(1,532)
Professional fees and other(432)(204)(764)(1,009)
Total expenses(1,524)(1,042)(3,875)(9,084)
Net investment income (loss)(1,318)(111)(2,409)(4,881)
Realized and change in unrealized gains (losses)
Net realized gain (loss) (1,412)14,760 (44,972)26,989 
Net change in unrealized appreciation (depreciation) 10,832 (5,675)5,811 45,708 
Net gain (loss) on investment transactions9,420 9,085 (39,161)72,697 
Net income (loss)$8,102 $8,974 $(41,570)$67,816 
GLRE Limited Partners’ share of net income (loss) (1)$6,431 $6,609 $(34,086)$51,770 

(1) Net of management fees and accrued performance allocation as follows:

Three months ended September 30Nine months ended September 30
2020201920202019
($ in thousands)
Management fees$703 $652 $1,981 $4,234 
Performance allocation$— $673 $— $5,654 

4. FINANCIAL INSTRUMENTS 
 
Investments
  
Other Investments
 
“Other investments” include unlisted securities and investments accounted for under the equity method.

14
At September 30, 2020, the following securities were included in the caption “Other investments”:
September 30, 2020CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities $11,364 $5,373 $(1,067)$15,670 
Investment accounted for under the equity method — — — 6,571 
Total other investments$22,241 

At December 31, 2019, the following securities were included in the caption “Other investments”: 
December 31, 2019CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities$10,420 $265 $(4)$10,681 
Investment accounted for under the equity method— — — 5,703 
Total other investments$16,384 

Private investments and unlisted equities include securities that do not have readily determinable fair values. The carrying values of these holdings are determined based on their original cost minus impairment, if any, plus or minus changes resulting from observable price changes. At September 30, 2020, the carrying value of private investments and unlisted equities was $15.7 million (December 31, 2019: $10.7 million), and incorporated upward adjustments of $0.0 million and $4.1 million during the three and nine months ended September 30, 2020, respectively (2019: $0.0 million and $0.2 million, respectively), excluding any unrealized gains or losses related to changes in foreign currency exchange rates.

 The Company’s investment accounted for under the equity method represents its investment in AccuRisk Holdings LLC (“AccuRisk”), a Chicago, Illinois-based managing general underwriter focused on employee and health insurance benefits. At September 30, 2020, the Company held a 58% (December 31, 2019: 58%) economic interest in AccuRisk and had provided a $6.0 million credit facility. In addition to providing capital and funding in support of AccuRisk’s expansion plans, the Company also provides reinsurance capacity for business produced by AccuRisk. The Company has determined that AccuRisk is a VIE, of which the Company is not the primary beneficiary. The Company’s carrying value represents its ownership share of AccuRisk’s net assets. The Company’s maximum exposure to loss relating to AccuRisk is limited to the carrying amount of its investment, plus the credit facility extended. For the three and nine months ended September 30, 2020, the Company’s share of AccuRisk’s net income was $0.1 million and $0.9 million, respectively (2019: $(0.2) million and $0.3 million, respectively), which was included in the caption “Net investment income” in the Company’s condensed consolidated statements of operations.

Fair Value Hierarchy

The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

•Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
•Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.
•Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.

As of September 30, 2020 and December 31, 2019, the Company did not carry any investments at fair value that were assigned a Level within the fair value hierarchy. The Company’s investment in the related party investment fund is measured at
15
fair value using the net asset value practical expedient, and is therefore not classified within the fair value hierarchy. (See Note 3 for further details.)

Financial Instruments Disclosed, But Not Carried, at Fair Value

The captions “Notes receivable (net of allowance for expected credit loss)” and “Convertible senior notes payable” represent financial instruments that are carried at amortized cost. The carrying values of the notes receivable (net of allowance for expected credit loss) approximate their fair values, which the Company has determined on the basis of Level 3 inputs. The fair value of the convertible senior notes payable is estimated based on the bid price observed in an inactive market for the identical instrument (Level 2 input) (see Note 7).

5. LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES

At September 30, 2020, the loss and loss adjustment expenses reserves included estimated amounts for several catastrophe events. For significant catastrophe events including, but not limited to, hurricanes, typhoons, floods, wildfires and pandemics, loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. To establish IBNR loss estimates, the Company makes use of, among other things, the following:

•estimates communicated by ceding companies;
•industry data;
•information received from clients, brokers and loss adjusters;
•an understanding of the underlying business written and its exposures to catastrophe event related losses;
•catastrophe scenario modelling software; and
•management’s judgement.

The COVID-19 pandemic is unprecedented. Therefore, the Company does not have previous loss experience on which to base its estimates for loss and loss adjustment expenses related to the COVID-19 pandemic. The determination of the Company's estimate was based on:

•a review of in-force treaties that may provide coverage and incur losses;
•catastrophe and scenario modeling analyses and results shared by cedents;
•preliminary loss estimates received from clients and their analysts and loss adjusters;
•reviews of industry insured loss estimates and market share analyses; and
•management’s judgement.

Significant assumptions on which the Company's estimates of reserves for the COVID-19 pandemic losses and loss adjustment expenses are based include:

•the scope of coverage provided by the underlying policies, particularly those that provide for business interruption coverage;
•the regulatory, legislative or judicial actions and social impact that could influence contract interpretations across the insurance industry;
•the extent of economic contraction caused by the COVID-19 pandemic, particularly in the United States; and
•the ability of the cedents and insured to mitigate some or all of their losses.

While the Company believes its estimate of loss and loss adjustment expense reserves for the COVID-19 pandemic is adequate as of September 30, 2020 based on available information, actual losses may ultimately differ materially from the Company's current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information becomes available and will adjust its estimates accordingly. Such adjustments may be material to the Company's results of operations and financial condition.

There were no significant changes in the actuarial methodology or reserving process related to the Company’s loss and loss adjustment expense reserves for the nine months ended September 30, 2020.

16
At September 30, 2020 and December 31, 2019, loss and loss adjustment expense reserves were composed of the following:
September 30, 2020December 31, 2019
 ($ in thousands)
Case reserves$224,732 $217,834 
IBNR257,038 252,754 
Total$481,770 $470,588 

A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated
for the nine months ended September 30, 2020 and 2019 is as follows: 
Consolidated20202019
 ($ in thousands)
Gross balance at January 1$470,588 $482,662 
Less: Losses recoverable(27,531)(43,705)
Net balance at January 1443,057 438,957 
Incurred losses related to:  
Current year247,559 264,129 
Prior years5,385 30,174 
Total incurred252,944 294,303 
Paid losses related to:  
Current year(72,453)(93,822)
Prior years(161,222)(200,384)
Total paid(233,675)(294,206)
Foreign currency revaluation(505)(1,154)
Net balance at September 30461,821 437,900 
Add: Losses recoverable19,949 41,535 
Gross balance at September 30$481,770 $479,435 
    

17
The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2020 and 2019 are as follows:
Health20202019
 ($ in thousands)
Gross balance at January 1$18,063 $24,502 
Less: Losses recoverable— — 
Net balance at January 118,063 24,502 
Incurred losses related to: 
Current year25,032 26,013 
Prior years1,341 2,196 
Total incurred26,373 28,209 
Paid losses related to: 
Current year(15,115)(14,741)
Prior years(16,327)(23,160)
Total paid(31,442)(37,901)
Foreign currency revaluation— — 
Net balance at September 3012,994 14,810 
Add: Losses recoverable— — 
Gross balance at September 30$12,994 $14,810 

For the nine months ended September 30, 2020, the estimate of net losses incurred relating to prior accident years increased by $5.4 million, primarily in relation to certain general liability, health and multi-line contracts, partially offset by favorable loss development on professional liability contracts. The net financial impact of the prior year unfavorable loss development for the nine months ended September 30, 2020, taking into account earned reinstatement premiums assumed and ceded, adjustments to assumed and ceded acquisition costs and adjustments to deposit accounted contracts, was a loss of $4.8 million.

For the nine months ended September 30, 2019, the estimate of net losses incurred relating to prior accident years increased by $30.2 million that originated primarily from certain private passenger automobile contracts. These unanticipated automobile losses were the result of adverse court rulings that affected a significant number of loss events that occurred in Florida between 2015 and early 2018, including many claims that had previously been considered closed. The net financial impact of the prior year adverse loss development for the nine months ended September 30, 2019 was a loss of $27.7 million.

6. RETROCESSION
 
The Company, from time to time, purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, to reduce its net liability on individual risks, to obtain additional underwriting capacity and to balance its underwriting portfolio. Loss and loss adjustment expenses recoverable from retrocessionaires are recorded as assets.

For the three and nine months ended September 30, 2020, the Company’s earned ceded premiums were $1.7 million and $3.2 million, respectively (2019: $22.0 million and $65.8 million, respectively). For the three and nine months ended September 30, 2020, loss and loss adjustment expenses incurred of $88.1 million and $252.9 million, respectively (2019: $93.0 million and $294.3 million, respectively), reported on the condensed consolidated statements of operations are net of loss and loss expenses recovered and recoverable of $2.5 million and $6.2 million (2019: $13.9 million and $56.2 million).

Retrocession contracts do not relieve the Company from its obligations to the insureds. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At September 30, 2020, the Company’s loss reserves recoverable consisted of (i) $15.0 million (December 31, 2019: $21.2 million) from unrated retrocessionaires, of which $14.5 million (December 31, 2019: $20.0 million) were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $5.0 million (December 31, 2019: $6.4 million) from retrocessionaires rated A- or above by A.M. Best.

The Company regularly evaluates its net credit exposure to assess the ability of the retrocessionaires to honor their respective obligations. At September 30, 2020, the Company had recorded an allowance for expected credit losses of $0.1 million (December 31, 2019: nil).
18

7. SENIOR CONVERTIBLE NOTES

On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”), which mature on August 1, 2023. The Notes bear interest at 4.0% payable semi-annually on February 1 and August 1 of each year beginning on February 1, 2019.

Note holders have the option, under certain conditions, to redeem the Notes prior to maturity.
If the Notes are redeemed by the holder, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. The Company has therefore bifurcated the Notes into liability and equity components.
At September 30, 2020, the Company’s share price was lower than the conversion price of $17.19 per share.
The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%, which equated to an $8.2 million discount. As of September 30, 2020 and December 31, 2019, the unamortized debt discount was $4.7 million and $5.9 million, respectively, and is expected to be amortized through the maturity date. The debt discount also represents the portion of the Note’s principal amount allocated to the equity component.
The Company incurred issuance costs in connection with the issuance of the Notes. As of September 30, 2020, the unamortized portion of these costs attributed to the debt component was $1.8 million (December 31, 2019: $2.3 million), which are expected to be amortized through the maturity date. The portion of these issuance costs attributed to the equity component was netted against the gross proceeds allocated to equity, resulting in $7.9 million being included in the caption “Additional paid-in capital” in the Company’s condensed consolidated balance sheets.

The carrying value of the Notes as of September 30, 2020, including accrued interest of $0.7 million, was $94.2 million (December 31, 2019: $93.5 million). As of September 30, 2020, the fair value of the Notes was estimated to be $80.1 million (December 31, 2019: $94.9 million) (see Note 4 Financial Instruments).
For the three and nine months ended September 30, 2020, the Company recognized interest expense of $1.6 million and $4.7 million (2019: $1.6 million and $4.7 million) in connection with the interest coupon, amortization of issuance costs and amortization of the discount.

The Company was in compliance with all covenants relating to the Notes as of September 30, 2020 and December 31, 2019.

8. SHARE CAPITAL

As of September 30, 2020, 293,939 (December 31, 2019: 555,805) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The stock incentive plan is administered by the Compensation Committee of the Board of Directors. On October 29, 2020, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million.

The Board has adopted a share repurchase plan. The timing of such repurchases and actual number of shares repurchased will depend on a variety of factors including price, market conditions and applicable regulatory and corporate requirements. On March 26, 2020, the Board of Directors extended the share repurchase plan to June 30, 2021 and increased the number of shares authorized to be repurchased to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases or pursuant to one more tender offers. The Company is not required to repurchase any of the Class A ordinary shares or the Notes and the repurchase plans may be modified, suspended or terminated at the election of our Board of Directors at any time without prior notice.

During the nine months ended September 30, 2020, 1.9 million Class A ordinary shares were repurchased by the Company (2019: 0). As of September 30, 2020, 3.1 million Class A ordinary shares and $25.0 million of the Notes, remained available for repurchase under the repurchase plans. All Class A ordinary shares repurchased are canceled immediately upon repurchase.
19

The following table is a summary of voting ordinary shares issued and outstanding:
Nine months ended September 30Nine months ended September 30
 20202019
Class AClass BClass AClass B
Balance – beginning of period30,739,395 6,254,715 30,130,214 6,254,715 
Issue of ordinary shares, net of forfeitures248,726 — 408,233 — 
Repurchase of ordinary shares(1,874,419)— — — 
Balance – end of period29,113,702 6,254,715 30,538,447 6,254,715 

Additional paid-in capital includes the premium per share paid by the subscribing shareholders for Class A and B ordinary shares which have a par value of $0.10 each. It also includes the earned portion of the grant-date fair value of share-based awards that have not yet vested.

9. SHARE-BASED COMPENSATION
 
The Company has a stock incentive plan for directors, employees and consultants that is administered by the Compensation Committee of the Board of Directors.
 
Employee and Director Restricted Shares
 
For the nine months ended September 30, 2020, 306,264 (2019: 235,701) Class A ordinary shares were issued to employees pursuant to the Company’s stock incentive plan. These shares contain certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment and transferability. The restricted shares cliff vest three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company.

For the nine months ended September 30, 2020, 145,089 (2019: 326,240) Class A ordinary shares were issued to the Company’s Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan. These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment and transferability. These restricted shares cliff vest 5 years after the date of issuance, subject to the performance condition being met and the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company. The weighted average grant date fair value of these restricted shares subject to performance conditions was $6.72 (2019: $10.84) per share. On July 30, 2020, the Company accelerated the vesting of a portion of the CEO’s restricted shares resulting in 72,545 shares vesting immediately. The remaining restricted shares are still subject to performance and service conditions. As the performance conditions associated with these restricted shares have not been met, no compensation cost was recognized relating to the unvested shares for the nine months ended September 30, 2020 and 2019.

For the nine months ended September 30, 2020, 210,109 (2019: 27,386) restricted shares were forfeited by employees who left the Company and prior to the expiration of the applicable vesting periods. For the nine months ended September 30, 2020, $0.7 million stock compensation expense (2019: $0.2 million) relating to the forfeited restricted shares was reversed.

The Company recorded $0.6 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the nine months ended September 30, 2020 (2019: $2.0 million). As of September 30, 2020, there was $2.2 million (December 31, 2019: $2.7 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding CEO’s restricted shares with performance conditions) which are expected to be recognized over a weighted average period of 2.4 years (December 31, 2019: 1.6 years). For the nine months ended September 30, 2020, the total fair value of restricted shares vested was $2.8 million (2019: $3.1 million).

20
The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2020:

 Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value
Balance at December 31, 2019873,087 $12.83 
Granted451,353 6.72 
Vested(235,833)13.83 
Forfeited(210,109)10.90 
Balance at September 30, 2020878,498 $9.88 
 
Employee and Director Stock Options

For the nine months ended September 30, 2020, no Class A ordinary share purchase options were granted or exercised by directors or employees, while 40,000 (2019: 60,000) stock options expired and 80,000 (2019: 80,000) stock options vested. When stock options are granted, the Company reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.

The total compensation cost expensed relating to stock options for the nine months ended September 30, 2020 was $0.5 million (2019: $0.7 million). At September 30, 2020, the total compensation cost related to non-vested options not yet recognized was $0.8 million (December 31, 2019: $1.3 million), which will be recognized over a weighted average period of 2.0 years (December 31, 2019: 2.4 years) assuming the grantee completes the service period for vesting of the options.

At September 30, 2020 and December 31, 2019, there were 0.8 million and 0.9 million stock options outstanding, respectively, with a weighted average exercise price of $22.22 and $22.68 per share, respectively and weighted average grant date fair value of $10.25 and $10.25 per share, respectively. The weighted average remaining contractual term of the stock options was 5.3 years and 5.8 years, at September 30, 2020 and December 31, 2019, respectively.

 Employee Restricted Stock Units

The Company issues RSUs to certain employees as part of the stock incentive plan.

These RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability and other matters. Each RSU grant cliff vests three years after the date of issuance, subject to the grantee’s continued service with the Company. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan. For the nine months ended September 30, 2020, 60,622 (2019: 48,535) RSUs were issued to employees pursuant to the Company’s stock incentive plan. For the nine months ended September 30, 2020, no (2019: 24,165) RSUs were forfeited by employees who left the Company prior to the expiration of the applicable vesting periods.

The Company recorded $0.3 million of share-based compensation expense, net of forfeitures, relating to RSUs for the nine months ended September 30, 2020 (2019: $0.1 million).
 
Employee RSU activity during the nine months ended September 30, 2020 was as follows:
 Number of
non-vested
RSUs		Weighted
 average
grant date
fair value
Balance at December 31, 201963,582 $13.76 
Granted60,622 6.72 
Vested(7,482)21.65 
Forfeited— — 
Balance at September 30, 2020116,722 $9.60 
21

For the nine months ended September 30, 2020 and 2019, the combined stock compensation expense (net of forfeitures), which was included in the caption “General and administrative expenses” in the Company’s statements of operations, was $1.4 million and $2.9 million, respectively.

10. RELATED PARTY TRANSACTIONS 
 
Investment Advisory Agreement
 
DME, DME II and DME Advisors are related to the Company and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors.

The Company has entered into the SILP LPA with DME II. DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL include the amount of losses that were to be recouped under the Joint Venture as well as any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry forward provision contained in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss, until all losses are recouped and an additional amount equal to 150% of the loss is earned. On February 26, 2019, effective as of September 1, 2018, the Company entered into Amendment No. 1 to the SILP LPA. The amendment was intended to revise the mechanics for calculating the Carryforward Account and Performance Allocation (as defined in the LPA) to take into account withdrawals from and subsequent recontributions of capital to SILP, consistent with the treatment under the Joint Venture.

In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio” as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023 subject to an automatic extension for successive three-year terms.

The Company has entered into a letter agreement with DME Advisors and DME II whereby during the period from June 1, 2019 to June 30, 2021, cash, cash equivalents and/or U.S government issued securities will not be subject to any management fee or performance allocation. For a detailed breakdown of management fees and performance compensation for the three and nine months ended September 30, 2020 and 2019, refer to Note 3 of the condensed consolidated financial statements.
 
Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II and DME Advisors for reasonable costs and expenses of investigating and/or defending such claims, provided such claims were not caused due to gross negligence, breach of contract or misrepresentation by DME, DME II or DME Advisors. There were no indemnification amounts incurred by the Company during any of the periods presented.

Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly traded company. As of September 30, 2020, SILP, along with certain affiliates of DME Advisors, collectively owned 47.6% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may be limited at times in its ability to trade GRBK shares on behalf of SILP.

Service Agreement
 
The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement is automatically renewed annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. 

22
Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.

11. COMMITMENTS AND CONTINGENCIES 
 
Letters of Credit and Trusts
 
At September 30, 2020, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:
Maximum Facility LimitTermination DateNotice period required for termination
 ($ in thousands)  
Citibank Europe plc$275,000 August 20, 2021
120 days prior to termination date

Effective August 26, 2020, the Company amended the credit facility to reduce the maximum facility limit from $400.0 million to $275.0 million. As of September 30, 2020, an aggregate amount of $133.0 million (December 31, 2019: $204.5 million) in letters of credit were issued under the credit facility. As of September 30, 2020, total cash and cash equivalents with a fair value in the aggregate of $135.6 million (December 31, 2019: $213.4 million) were pledged as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. The credit facility contains customary events of default and restrictive covenants, including but not limited to, limitations on liens on collateral, transactions with affiliates, mergers and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements, and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the covenants of the credit facility as of September 30, 2020 and December 31, 2019.

The Company has also established regulatory trust arrangements for certain cedents. As of September 30, 2020, collateral of $587.5 million (December 31, 2019: $528.7 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets.

Lease Obligations
 
Greenlight Re has entered into lease agreements for office space in the Cayman Islands that expires on December 31, 2020. The Company has determined that the current arrangement qualifies as a short term lease. The short-term lease expense for the three and nine months ended September 30, 2020 was $0.4 million (2019: $0.4 million).

GRIL has entered into a lease agreement for office space in Dublin, Ireland. Under the terms of this lease agreement, GRIL is committed to minimum annual rent payments denominated in Euros approximating €0.1 million until May 2021, and adjusted to the prevailing market rates for the subsequent five-year term. GRIL has the option to terminate the lease agreement in 2021. The Company has determined that this agreement qualifies as an operating lease under GAAP. As of September 30, 2020 the Company has recorded a right-of-use asset and a corresponding lease liability of $0.1 million (December 31, 2019: $0.2 million). The operating lease expense for the three and nine months ended September 30, 2020 and 2019 was insignificant. Included in the “Schedule of Commitments and Contingencies,” below, are the net minimum lease payment obligations relating to this lease as of September 30, 2020.

23
Schedule of Commitments and Contingencies
The following is a schedule of future minimum payments required under the above commitments:  

 20202021202220232024ThereafterTotal
 ($ in thousands)
Operating lease obligations$171 $65 $— $— $— $— $236 
Interest and convertible note payable— 4,000 4,000 102,000 — — 110,000 
 $171 $4,065 $4,000 $102,000 $— $— $110,236 

Litigation
 
From time to time in the normal course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or to collect funds owed to it. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition or operating results.


24
12. SEGMENT REPORTING
 
The Company manages its business on the basis of one operating segment, Property & Casualty Reinsurance. The following tables provide a breakdown of the Company’s gross premiums written by line of business and by geographic area of risks insured for the periods indicated: 

Gross Premiums Written by Line of Business
  Three months ended September 30Nine months ended September 30
2020201920202019
  ($ in thousands)($ in thousands)
Property
Commercial$3,396 2.5 %$5,088 4.6 %$9,426 2.6 %$11,752 2.8 %
Motor10,091 7.4 11,367 10.3 25,136 6.9 50,807 11.9 
Personal3,691 2.7 3,632 3.3 10,326 2.9 9,788 2.3 
Total Property17,178 12.6 20,087 18.2 44,888 12.4 72,347 17.0 
Casualty
General Liability3,224 2.4 913 0.8 3,920 1.1 2,368 0.6 
Motor Liability41,679 30.7 47,021 42.5 96,729 26.7 197,335 46.4 
Professional Liability 76 0.1 11 — 199 0.1 117 — 
Workers' Compensation21,979 16.2 14,077 12.7 60,908 16.8 35,121 8.3 
Multi-line 25,820 19.0 15,082 13.6 67,379 18.6 61,173 14.4 
Total Casualty92,778 68.4 77,104 69.6 229,135 63.3 296,114 69.7 
Other
Accident & Health12,418 9.3 7,527 6.8 40,522 11.2 31,065 7.2 
Financial1,817 1.3 315 0.3 15,704 4.3 15,394 3.6 
Marine127 0.1 (33)— 749 0.2 94 — 
Other Specialty11,278 8.3 5,607 5.1 31,074 8.6 10,493 2.5 
Total Other25,640 19.0 13,416 12.2 88,049 24.3 57,046 13.3 
$135,596 100.0 %$110,607 100.0 %$362,072 100.0 %$425,507 100.0 %

Gross Premiums Written by Geographic Area of Risks Insured
 Three months ended September 30Nine months ended September 30
2020201920202019
 ($ in thousands)($ in thousands)
U.S. and Caribbean$110,798 81.7 %$89,811 81.2 %$291,511 80.5 %$358,099 84.1 %
Worldwide (1) $22,738 16.8 %$18,450 16.7 %$66,150 18.3 %$64,590 15.2 %
Europe$— — %$— — %$— — %$(13)— %
Asia$2,060 1.5 %$2,346 2.1 %$4,411 1.2 %$2,831 0.7 %
$135,596 100.0 %$110,607 100.0 %$362,072 100.0 %$425,507 100.0 %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 

13.    SUBSEQUENT EVENTS

Subsequent to September 30, 2020, the Company agreed to settle a promissory note that had been entered into with a reinsurance counterparty. The Company’s amortized cost associated with the promissory note at September 30, 2020 was $13.3 million, which was included in the caption “Notes receivable (net of allowance for expected credit loss).” In connection with this settlement, the Company received $19.1 million, resulting in a gain of $5.8 million that will be recognized in the fourth quarter of 2020.
25
Item 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
References to “we,” “us,” “our,” “our company,”  or “the Company” refer to Greenlight Capital Re, Ltd. (“GLRE”) and our wholly-owned subsidiaries, Greenlight Reinsurance, Ltd, (“Greenlight Re”), Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”) and Verdant Holding Company, Ltd. (“Verdant”), unless the context dictates otherwise. References to our “Ordinary Shares” refers collectively to our Class A Ordinary Shares and Class B Ordinary Shares.
 
The following is a discussion and analysis of our results of operations for the three and nine months ended September 30, 2020 and 2019 and financial condition as of September 30, 2020 and December 31, 2019. The following discussion should be read in conjunction with the audited consolidated financial statements and accompanying notes, which appear in our annual report on Form 10-K for the fiscal year ended December 31, 2019.
  
Special Note About Forward-Looking Statements
 
Certain statements in Management’s Discussion and Analysis, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” (refer to Part I, Item 1A) contained in our Amendment No. 1 to Form 10-K for the fiscal year ended December 31, 2019, as filed with the Securities and Exchange Commission (the “SEC”) on April 29, 2020. Such risks and uncertainties include, but are not limited to:

•The impact of disruptions to commerce, reduced economic activity and other consequences of a pandemic, including the novel coronavirus (“COVID-19”) is unknown;
•A.M. Best may downgrade or withdraw either of our ratings;
•Our results of operations will likely fluctuate from period to period and may not be indicative of our long-term prospects;
•Under our investment management structure, we have limited control over Solasglas Investments, LP (“SILP”);
•SILP may be concentrated in a few large positions, which could result in large losses;
•Competitors with greater resources may make it difficult for us to effectively market our products or offer our products at a profit;
•If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be significantly and negatively affected;
•We may face risks from future strategic transactions such as acquisitions, dispositions, mergers or joint ventures;
•The effect of emerging claim and coverage issues on our business is uncertain;
•The property and casualty reinsurance market may be affected by cyclical trends;
•The loss of key executives could adversely impact our ability to implement our business strategy; and
•Currency fluctuations could result in exchange rate losses and negatively impact our business.

We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward looking statements which speak only to the dates on which they were made.
 
We intend to communicate certain events that we believe may have a material adverse impact on our operations or financial position, including property and casualty catastrophic events and material losses in our investment portfolio, in a timely manner through a public announcement. Other than as required by the Exchange Act, we do not intend to make public announcements regarding reinsurance or investment events that we do not believe, based on management’s estimates and current information, will have a material adverse impact on our operations or financial position.

26
General
 
We are a global specialty property and casualty reinsurer, headquartered in the Cayman Islands, with a reinsurance and investment strategy that we believe differentiates us from most of our competitors. Our goal is to build long-term shareholder value by providing risk management products and services to the insurance, reinsurance and other risk marketplaces. We focus on delivering risk solutions to clients and brokers who value our expertise, analytics and customer service offerings.
 
We aim to complement our underwriting results with a non-traditional investment approach in order to achieve higher rates of return over the long term than reinsurance companies that exclusively employ more traditional investment strategies. Our investment portfolio is managed according to a value-oriented philosophy, in which our investment advisor takes long positions in perceived undervalued securities and short positions in perceived overvalued securities.

Because our strategy is designed to allow us to capitalize on favorable market conditions and underwriting opportunities, period-to-period comparisons of our underwriting results may not be meaningful. In addition, our historical investment results may not necessarily be indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.

The Company’s subsidiaries hold an A.M. Best Financial Strength Rating of A- (Excellent) with a negative outlook.

Segments
 
We manage our business on the basis of one operating segment, Property & Casualty reinsurance, and we analyze our business based on the following categories:
 ●Property
●Casualty
●Other

Property business covers automobile physical damage, personal lines (including homeowners’ insurance) and commercial lines exposures. Property business includes both catastrophe as well as non-catastrophe coverage. We expect catastrophe business to make up a small proportion of our property business.

Casualty business covers general liability, motor liability, professional liability and workers’ compensation exposures. The Company’s multi-line business relates predominantly to casualty reinsurance and as such all multi-line business is included within the casualty category. Casualty business generally has losses reported and paid over a longer period of time than property business.

Other business covers accident and health, financial lines (including transactional liability, mortgage insurance, surety and trade credit), marine, and to a lesser extent, other specialty business such as aviation, crop, cyber, energy, political and terrorism exposures.

27
Outlook and Trends

Recent loss activity has created an unusually high level of uncertainty in the global reinsurance market. While this uncertainty has caused reserving challenges throughout the industry, it has also led to underwriting opportunities.

COVID-19, which was declared a pandemic in March 2020, has increased loss activity in certain lines we write, including mortgage insurance/reinsurance and multi-line business. Further, while we do not have significant exposure to business interruption claims, the potential exists for elevated losses if the U.S. federal government or other government legislative action is taken to retroactively mandate coverage irrespective of terms, exclusions or other conditions included in our underlying policies that would otherwise preclude coverage. Plaintiffs are continuing to test insurers’ positions on business interruption coverage in court with mixed success. While our estimated loss from the pandemic did not change during the third quarter, this estimate remains subject to significant uncertainty due to the unprecedented nature of this crisis.

We believe that in comparison to other industry participants, our aggregate exposure to the pandemic is small. As a result, the uncertainty that we face is challenging the reinsurance market as a whole on a significantly larger scale. As reinsurers’ reserves must accommodate a wide range of loss estimates, they have less capital to deploy to new underwriting opportunities. Adding to the reduction in capital was the unusually high frequency of small to medium sized natural catastrophes that occurred during the third quarter of 2020. While some new capital has been injected into the industry, our assessment is that this new capital represents a small portion of what has been lost or encumbered.

The resulting imbalance between the demand for reinsurance capacity and the available supply is having a significant effect on market conditions. In recent months, we have seen risk placements in specialty classes with significantly improved terms and have noted that attempts to place risks with only modest pricing improvements are often met with shortfalls in capacity. We continue to diversify the lines of business we write and we have increased our participation in excess-of-loss contracts when the economics support it, thereby replacing some of our lower-performing quota-share contracts with what we anticipate to be higher-margin business. We believe that the benefits of improved market conditions will flow through our underwriting results in future periods.

The technological, analytical, product and delivery mechanism innovations in the insurance and reinsurance industries have accelerated as a result of the COVID-19 pandemic. We expect this dynamic to have a significant impact on the markets in which we operate. We believe that Greenlight Re Innovations unit, our internal effort to develop and implement product and service innovations with insurance applications, is well positioned to facilitate and participate in areas in which the market is growing more efficient.
Compared to most of our competitors, we are small and have low overhead expenses. We believe that our current expense efficiency, agility and existing relationships have provided support to our competitive position and enable us to participate in lines of business that fit within our strategy. However, the size of our current capital base, combined with our A.M. Best rating, may constrain our capacity and our ability to access underwriting business. Our ability to execute our business strategy may be adversely impacted by a prolonged negative outlook from A.M. Best or if A.M. Best revises our subsidiaries’ ratings below A- (Excellent).
In addition to the COVID-19 pandemic impact, there are many global economic, investment and political uncertainties that may impact our business and our investment portfolio, including central bank actions, potential trade disputes and economic inequality. Commencing in 2019 we reduced our investment exposure to such uncertainties and, for the foreseeable future we intend to limit our gross long exposure to 50% of the Company’s total shareholders’ equity.

Critical Accounting Policies and Estimates
 
Our condensed consolidated financial statements contain certain amounts that are inherently subjective in nature and have required management to make assumptions and best estimates to determine reported values. If certain factors, including those described in “Part I. Item IA. — Risk Factors” included in our Amendment No. 1 to Form 10-K for the fiscal year ended December 31, 2019, as filed with the SEC on April 29, 2020, cause actual events or results to differ materially from our underlying assumptions or estimates, there could be a material adverse effect on our results of operations, financial condition or liquidity. “Part II. Item 7. — Management’s Discussion and Analysis of Financial Condition and Results on Operations” included in our annual report on Form 10-K for the fiscal year ended December 31, 2019 describes our critical accounting policies and estimates. The most significant estimates relate to premium revenues and risk transfer, loss and loss adjustment expense reserves, acquisition costs, bonus accruals and share-based payments.

Recently issued and adopted accounting standards and their impact to the Company, if any, are presented under “Recent Accounting Pronouncements” in Note 2 to the condensed consolidated financial statements.
28

Key Financial Measures and Non-GAAP Measures

Management uses certain key financial measures, some of which are not prescribed under U.S. GAAP rules and standards (“non-GAAP financial measures”) to evaluate our financial performance, financial position and the change in shareholder value. Generally, a non-GAAP financial measure, as defined in SEC Regulation G, is a numerical measure of a company’s historical or future financial performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with U.S. GAAP. We believe that these measures, which may be calculated or defined differently by other companies, provide a consistent and comparable measure of performance of our business to help shareholders understand performance trends and allow for a more complete understanding of the Company’s business. Non-GAAP financial measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP. The key non-GAAP financial measures used in this report are:
•Basic book value per share;
•Fully diluted book value per share; and
•Net underwriting income (loss).

These non-GAAP measures are described below.

Basic Book Value Per Share and Fully Diluted Book Value Per Share

We believe that long-term growth in fully diluted book value per share is the most relevant measure of our financial performance because it provides management and investors a yardstick by which to monitor the shareholder value generated. In addition, fully diluted book value per share may assist our investors, shareholders and other interested parties in forming a basis of comparison with other companies within the property and casualty reinsurance industry.

Basic book value per share is calculated on the basis of ending shareholders' equity and aggregate of Class A and Class B Ordinary shares issued and outstanding, as well as all unvested restricted shares. Fully diluted book value per share represents basic book value per share combined with any dilutive impact of in-the-money stock options and RSUs issued and outstanding as of any period end. In addition, fully diluted book value per share includes the dilutive effect, if any, of ordinary shares to be issued upon conversion of the convertible notes. Basic book value per share and fully diluted book value per share should not be viewed as substitutes for the comparable U.S. GAAP measures.

Our primary financial goal is to increase fully diluted book value per share over the long term.

29
The following table presents a reconciliation of the non-GAAP financial measures basic and fully diluted book value per share to the most comparable U.S. GAAP measure.
September 30, 2020June 30, 2020March 31, 2020December 31, 2019September 30, 2019
   ($ in thousands, except per share and share amounts)
Numerator for basic and fully diluted book value per share: 
Total equity (U.S. GAAP) (numerator for basic and fully diluted book value per share)$426,867 $429,904 $436,899 $477,183 $506,543 
Denominator for basic and fully diluted book value per share: (1)
Ordinary shares issued and outstanding (denominator for basic book value per share) 35,368,417 36,272,585 37,434,244 36,994,110 36,994,110 
Add: In-the-money stock options and RSUs issued and outstanding116,722 116,722 116,722 63,582 63,582 
Denominator for fully diluted book value per share 35,485,139 36,389,307 37,550,966 37,057,692 37,057,692 
Basic book value per share$12.07 $11.85 $11.67 $12.90 $13.69 
Increase (decrease) in basic book value per share ($)$0.22 $0.18 $(1.23)$(0.79)$0.08 
Increase (decrease) in basic book value per share (%)1.9 %1.5 %(9.5)%(5.8)%0.6 %
Fully diluted book value per share$12.03 $11.81 $11.63 $12.88 $13.67 
Increase (decrease) in fully diluted book value per share ($)$0.22 $0.18 $(1.25)$(0.79)$0.09 
Increase (decrease) in fully diluted book value per share (%)1.9 %1.5 %(9.7)%(5.9)%0.7 %

(1) All unvested restricted shares, including those with performance conditions, are included in the “basic” and “fully diluted” denominators. As of September 30, 2020, the number of unvested restricted shares with performance conditions was 429,444 (as of June 30, 2020: 501,989, March 31, 2020: 501,989, December, 31, 2019: 356,900, September 30, 2019: 356,900).

Net Underwriting Income (Loss)

One way that we evaluate the Company’s underwriting performance is through the measurement of net underwriting income (loss). We do not use premiums written as a measure of performance. Net underwriting income (loss) is a performance measure used by management as it measures the fundamentals underlying the Company’s underwriting operations. We believe that the use of net underwriting income (loss) enables investors and other users of the Company’s financial information to analyze our performance in a manner similar to how management analyzes performance. Management also believes that this measure follows industry practice and allows the users of financial information to compare the Company’s performance with its those of our industry peer group.

Net underwriting income (loss) is considered a non-GAAP financial measure because it excludes items used in the calculation of net income before taxes under U.S. GAAP. Net underwriting income (loss) is calculated as net premiums earned, plus other income (expense) relating to reinsurance and deposit-accounted contracts, less net loss and loss adjustment expenses, less acquisition costs, and less underwriting expenses. The measure excludes, on a recurring basis: (1) investment income (loss); (2) other income (expense) not related to underwriting, including foreign exchange gains or losses and adjustments to the allowance for expected credit losses; (3) corporate general and administrative expenses; (4) interest expense and (5) income taxes. We exclude total investment income or loss and foreign exchange gains or losses as we believe these items are influenced by market conditions and other factors not related to underwriting decisions. We exclude corporate expenses because these expenses are generally fixed and not incremental to or directly related to our underwriting operations. We believe all of these amounts are largely independent of our underwriting process and including them could hinder the analysis of trends in our underwriting operations. Net underwriting income (loss) should not be viewed as a substitute for U.S. GAAP net income.

30
The reconciliations of net underwriting income (loss) to income (loss) before income taxes (the most directly comparable U.S. GAAP financial measure) on a consolidated basis is shown below:
Three months ended September 30Nine months ended September 30
2020201920202019
($ in thousands)
Income (loss) before income tax$2,183 $4,961 $(37,726)$26,160 
Add (subtract):
Total investment (income) loss(6,897)(9,921)22,849 (61,035)
Other non-underwriting (income) expense(257)1,254 (6)1,059 
Corporate expenses2,972 4,727 9,711 11,418 
Interest expense1,579 1,578 4,702 4,684 
Net underwriting income (loss)$(420)$2,599 $(470)$(17,714)


31
Results of Operations

The table below summarizes our operating results for the three and nine months ended September 30, 2020 and 2019:
Three months ended September 30Nine months ended September 30
2020201920202019
(in thousands, except percentages)
Underwriting revenue
Gross premiums written$135,596 $110,607 $362,072 $425,507 
Gross premiums ceded(1,464)(4,035)(2,274)(48,577)
Net premiums written134,132 106,572 359,798 376,930 
Change in net unearned premium reserves(18,613)22,582 (24,844)(1,973)
Net premiums earned$115,519 $129,154 $334,954 $374,957 
Underwriting related expenses
Loss and LAE incurred, net
Current year$88,334 $92,692 $247,559 $264,129 
Prior year *(281)270 5,385 30,174 
Loss and LAE incurred, net88,053 92,962 252,944 294,303 
Acquisition costs, net27,018 30,962 76,660 89,660 
Underwriting expenses2,180 2,998 8,384 11,066 
Deposit accounting and other reinsurance expense (income)(1,312)(367)(2,564)(2,358)
Underwriting income (loss)$(420)$2,599 $(470)$(17,714)
Income (loss) from investment in related party investment fund$6,431 $6,609 $(34,086)$51,770 
Net investment income (loss)466 3,312 11,237 9,265 
Total investment income (loss)$6,897 $9,921 $(22,849)$61,035 
Net income (loss)$2,183 $5,140 $(38,150)$26,360 
Loss ratio - current year76.5 %71.8 %73.9 %70.5 %
Loss ratio - prior year(0.3)%0.2 %1.6 %8.0 %
Loss ratio76.2 %72.0 %75.5 %78.5 %
Acquisition cost ratio23.4 %24.0 %22.9 %23.9 %
Composite ratio99.6 %96.0 %98.4 %102.4 %
Underwriting expense ratio0.8 %2.0 %1.7 %2.3 %
Combined ratio100.4 %98.0 %100.1 %104.7 %

* The net financial impact associated with changes in the estimate of losses incurred in prior years, which incorporates earned reinstatement premiums assumed and ceded, adjustments to assumed and ceded acquisition costs and adjustments to deposit accounted contracts, was an income of $0.2 million and $0.0 million for the three months ended September 30, 2020 and 2019, respectively, and a loss of $4.8 million and a loss of $27.7 million, for the nine months ended September 30, 2020 and 2019, respectively.

32
Three months ended September 30, 2020 and 2019

For the three months ended September 30, 2020, the fully diluted book value per share increased by $0.22 per share, or 1.9%, to $12.03 per share from $11.81 per share at June 30, 2020. For the three months ended September 30, 2020, the basic book value per share increased by $0.22 per share, or 1.9%, to $12.07 per share from $11.85 per share at June 30, 2020. The increase in basic and fully diluted book value per share for the three months ended September 30, 2020 was due primarily to (i) share repurchases executed, (ii) net income earned and (iii) restricted shares forfeited during the quarter.

For the three months ended September 30, 2020, net income was $2.2 million, compared to a net income of $5.1 million reported for the equivalent 2019 period.

The developments that most significantly affected our financial performance during the three months ended September 30, 2020, compared to the equivalent 2019 period, are summarized below:

•Underwriting: The underwriting loss for the three months ended September 30, 2020 was $0.4 million. By comparison, the equivalent period in 2019 reported an underwriting income of $2.6 million. The decrease in underwriting income was due primarily to natural catastrophe losses from hurricanes Laura, Isaias and Sally, the Midwest derecho storm, and the North American wildfires, which in aggregate contributed $8.1 million to the underwriting loss.

Our overall composite ratio was 99.6% for the three months ended September 30, 2020, compared to 96.0% during the equivalent 2019 period. The composite ratio for three months ended September 30, 2020 included 7.0 points related to natural catastrophe losses compared to 2.4 loss ratio points during the same period in 2019.

•Investments: Our total investment income for the three months ended September 30, 2020 was $6.9 million compared to total investment income of $9.9 million reported for the same period in 2019.

Nine months ended September 30, 2020 and 2019

For the nine months ended September 30, 2020, the fully diluted book value per share decreased by $0.85 per share, or 6.6%, to $12.03 per share from $12.88 per share at December 31, 2019. For the nine months ended September 30, 2020, the basic book value per share decreased by $0.83 per share, or 6.4%, to $12.07 per share from $12.90 per share at December 31, 2019.

For the nine months ended September 30, 2020, net loss was $38.2 million, compared to net income of $26.4 million reported for the equivalent 2019 period.

The developments that most significantly affected our financial performance during the nine months ended September 30, 2020, compared to the equivalent 2019 period, are summarized below:

•Underwriting: The underwriting loss for the nine months ended September 30, 2020 was $0.5 million. By comparison, the underwriting loss for the same period in 2019 was $17.7 million primarily resulting from adverse loss development on our private passenger automobile business.

Our overall composite ratio was 98.4% for the nine months ended September 30, 2020, compared to 102.4% during the same period in 2019.

•Investments: Our total investment loss for the nine months ended September 30, 2020 was $22.8 million compared to total investment income of $61.0 million incurred during the equivalent 2019 period. The investment loss for the nine months ended September 30, 2020 was primarily related to our investment in SILP, which reported an investment loss of $34.1 million, driven primarily by the impact of changes in fair value mainly attributable to the disruptions in global financial markets associated with the COVID–19 pandemic.

33
Underwriting results

Gross Premiums Written
 
Details of gross premiums written are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2020201920202019
($ in thousands)($ in thousands)
Property$17,178 12.7 %$20,087 18.2 %$44,888 12.4 %$72,347 17.0 %
Casualty92,778 68.4 77,104 69.7 229,135 63.3 296,114 69.6 
Other25,640 18.9 13,416 12.1 88,049 24.3 57,046 13.4 
Total$135,596 100.0 %$110,607 100.0 %$362,072 100.0 %$425,507 100.0 %

As a result of our underwriting philosophy, the total premiums we write, as well as the mix of premiums between property, casualty and other business, may vary significantly from period to period depending on the market opportunities that we identify.
For the three months ended September 30, 2020, our gross premiums written increased by $25.0 million, or 22.6%, compared to the equivalent 2019 period. The primary drivers for this change are the following:
Gross Premiums Written
Three months ended September 30, 2020
Increase (decrease)
($ in millions)		% changeExplanation
Property$(2.9)(14.5)%The decrease in property gross premiums written during the three months ended September 30, 2020 over the comparable 2019 period was primarily related to motor contracts that we had elected not to renew in the third quarter of 2019.
Casualty$15.720.3%The increase in casualty gross premiums written during the three months ended September 30, 2020 over the comparable 2019 period related primarily to
an increase in workers’ compensation premiums. This increase in workers’ compensation premiums written was due primarily to an expanded relationship with an existing cedent as well as a restructured and renewed contract that was recorded on a deposit accounting basis during the comparative period in 2019. The increase in casualty premiums written also reflects an increase Lloyds’ syndicate multi-line quota share business.

The increase was partially offset by motor contracts that we elected not to renew, and lower premium volumes on in-force contracts.
Other$12.291.1%The increase in “other” gross premiums written during the three months ended September 30, 2020 over the comparable 2019 period was primarily due to new crop, energy and other specialty business written during 2020 and the latter half of 2019. The increase was also attributed to health premiums resulting from strategic partnerships and our innovation initiatives.
34


For the nine months ended September 30, 2020, our gross premiums written decreased by $63.4 million, or 14.9%, compared to the equivalent 2019 period. The primary drivers of this change are as follows:
Gross Premiums Written
Nine months ended September 30, 2020
Increase (decrease)
($ in millions)		% changeExplanation
Property$(27.5)(38.0)%The decrease in property gross premiums written during the nine months of 2020 over the comparable 2019 period was primarily related to motor contracts that we elected not to renew in the third quarter of 2019.
Casualty$(67.0)(22.6)%The decrease in casualty gross premiums written during the nine months of 2020 over the comparable 2019 period was related primarily to motor contracts that we elected not to renew, and also due to lower premium volumes on in-force contracts.

The decrease was partially offset by an increase in workers’ compensation premiums compared to the same period in 2019. This increase in workers’ compensation premiums written was primarily due to an expanded relationship with an existing cedent as well as a restructured and renewed contract that was recorded on a deposit accounting basis during the comparative period in 2019. In addition, the increase in casualty premiums written also related to Lloyds’ syndicate multi-line quota share contracts.
Other$31.054.3%The increase in “other” gross premiums written during the nine months of 2020 over the comparable 2019 period was primarily attributable to new contracts relating to crop, energy, cyber and other specialty lines. The increase was also attributed to health premiums resulting from strategic partnerships and the innovation initiatives.

The increase was partially offset by decrease in transactional liabilities premiums due to a slow down in M&A activity during 2020 due to the COVID-19 pandemic.

Premiums Ceded
 
For the three and nine months ended September 30, 2020, premiums ceded were $1.5 million and $2.3 million, respectively, compared to $4.0 million and $48.6 million for the three and nine months ended September 30, 2019, respectively. During the comparative period in 2019 we had retroceded a portion of our overall exposure to an inward motor contract. The decrease in premiums ceded for the three and nine months ended September 30, 2020 was primarily related to our decision not to renew the associated inward motor contract. In general, we use retrocessional coverage to manage our net portfolio exposure, to leverage areas of expertise and to improve our strategic position in meeting the needs of clients and brokers.

Net Premiums Written

Details of net premiums written are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2020201920202019
($ in thousands)($ in thousands)
Property$16,845 12.6 %$18,700 17.5 %$44,465 12.4 %$61,183 16.2 %
Casualty91,646 68.3 74,824 70.3 227,453 63.2 259,199 68.8 
Other25,641 19.1 13,048 12.2 87,880 24.4 56,548 15.0 
Total$134,132 100.0 %$106,572 100.0 %$359,798 100.0 %$376,930 100.0 %

For the three and nine months ended September 30, 2020, net premiums written increased by $27.6 million, or 25.9%, and decreased by $17.1 million, or 4.5%, respectively, compared to the three and nine months ended September 30, 2019. The movement in net premiums written resulted from the changes in gross premiums written and ceded during the periods.
35

Net Premiums Earned
 
Details of net premiums earned are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2020201920202019
($ in thousands)($ in thousands)
Property$16,045 13.9 %$22,151 17.2 %$45,111 13.5 %$60,182 16.1 %
Casualty77,731 67.3 85,872 66.4 212,203 63.3 251,766 67.1 
Other21,743 18.8 21,131 16.4 77,640 23.2 63,009 16.8 
Total$115,519 100.0 %$129,154 100.0 %$334,954 100.0 %$374,957 100.0 %

Net premiums earned are primarily a function of the amount and timing of net premiums written during the current and prior periods.

Loss and Loss Adjustment Expenses Incurred, Net
 
Details of net losses incurred are provided in the following table:

 Three months ended September 30Nine months ended September 30
 2020201920202019
($ in thousands)($ in thousands)
Property$14,909 16.9 %$14,079 15.1 %$34,704 13.7 %$39,583 13.4 %
Casualty55,028 62.5 64,172 69.1 151,257 59.8 211,912 72.1 
Other18,116 20.6 14,711 15.8 66,983 26.5 42,808 14.5 
Total$88,053 100.0 %$92,962 100.0 %$252,944 100.0 %$294,303 100.0 %

The below table summarizes the loss ratios for the nine months ended September 30, 2020 and 2019:
 Three months ended September 30Nine months ended September 30
 20202019Increase / (decrease) in loss ratio points20202019Increase / (decrease) in loss ratio points
Property92.9 %63.6 %29.3 76.9 %65.8 %11.1 
Casualty70.8 %74.7 %(3.9)71.3 %84.2 %(12.9)
Other83.3 %69.6 %13.7 86.3 %67.9 %18.4 
Total76.2 %72.0 %4.2 75.5 %78.5 %(3.0)


36
The changes in net losses incurred for the three months ended September 30, 2020 as compared to the equivalent 2019 period were attributable to the following:
Net Losses Incurred
Three months ended September 30, 2020
Increase (decrease)
($ in millions)		Increase / (decrease) in loss ratio pointsExplanation
Property$0.829.3
The increase in property losses incurred during the three months ended September 30, 2020, compared to the equivalent 2019 period, was due to the estimated losses from hurricanes Isaias, Laura and Sally, the Midwest derecho storm, and the North American wildfires. The increase in property losses incurred was partially offset by lower motor losses resulting from the non-renewal of certain motor contracts in Q3 2019.

Despite the small increase in losses incurred during the three months ended September 30, 2020, the property loss ratio increased during that period over the equivalent 2019 period as a result of lower earned premiums on property contracts during the third quarter of 2020.
Casualty$(9.1)(3.9)
The decrease in losses incurred reflects lower motor casualty losses during the three months ended September 30, 2020, compared to the equivalent 2019 period. This reduction was due primarily to the non-renewal of certain motor contracts in Q3 2019.

These decreases in casualty losses were partially offset by increases in losses associated with the growth in our workers’ compensation and catastrophe losses impacting certain multi-line contracts.

The decrease in motor casualty losses offset the impact of the catastrophe losses resulting in a 3.9 percentage point decrease in the casualty loss ratio during the third quarter of 2020 over the equivalent 2019 period.
Other$3.413.7
The increase in “Other” losses incurred during the three months ended September 30, 2020 over the equivalent 2019 period was primarily related to certain health and crop contracts reporting higher than expected losses.

The crop and health contracts contributed to the 13.7 percentage points increase in Other loss ratio during the third quarter of 2020 as compared to the equivalent 2019 period.
37

The changes in net losses incurred for the nine months ended September 30, 2020 were attributable to the following:
Net Losses Incurred
Nine months ended September 30, 2020
Increase (decrease)
($ in millions)		Increase / (decrease) in loss ratio pointsExplanation
Property$(4.9)11.1
The decrease in property losses incurred during the nine months of 2020 as compared to the equivalent 2019 period related primarily to:
•significant adverse loss development recognized during 2019,
•the non-renewal of certain motor contracts, and
•a lower level of losses reported on in-force motor contracts as a result of fewer motorists on the roads at peak traffic times due to the COVID-19 pandemic during 2020.

The decrease in property losses were partially offset by:
•COVID-19 pandemic related business interruption claims incurred on non-motor contracts, and
•catastrophe losses from hurricanes Laura, Isaias, and Sally, the Midwest derecho storm, and the North American wildfires during the nine months ended September 30, 2020.

Despite the reduction in losses incurred during the nine months ended September 30, 2020, the loss ratio increased 11.1 percentage point during that period over the equivalent 2019 period as a result of the COVID-19 pandemic losses and catastrophe losses on a lower level of earned premiums.

Casualty$(60.7)(12.9)
The decrease in casualty losses incurred during the first nine months of 2020 as compared to the equivalent 2019 period related primarily to:
•significant adverse loss development recognized during the first half of 2019,
•favorable loss development on professional liability and motor contracts,
•the non-renewal of certain motor contracts,
•a lower level of losses reported on in-force motor contracts as a result of fewer motorists on the roads at peak traffic times due to the COVID-19 pandemic during 2020.

While the casualty losses incurred and loss ratio decreased for the motor business, the losses incurred and loss ratio for multi-line business increased compared to the same period in 2019. This increase in multi-line losses was due primarily to (i) adverse loss development recognized during the first nine months of 2020 and (ii) and the COVID-19 pandemic related claims incurred on non-motor contracts during the first nine months of 2020.

Overall, the reduced level of adverse prior year loss development recognized during the first nine months of 2020 was the primary driver of the 12.9 percentage point decrease in the casualty loss ratio as compared to the equivalent 2019 period.

Other$24.218.4
The increase in “Other” losses incurred during the nine months ended September 30, 2020 over the comparable 2019 period was primarily related to losses incurred on mortgage contracts resulting from the COVID-19 pandemic. The increases in losses incurred on mortgage business were mostly offset by reductions in the profit commissions we pay to our cedents. To a lesser extent the increase in “Other” losses incurred was due to certain health and crop contracts reporting higher than expected losses.

The mortgage, crop and health contracts contributed to the 18.4 percentage points increase in Other loss ratio during the first nine months of 2020 as compared to the equivalent 2019 period.

38
See Note 5 of the accompanying condensed consolidated financial statements for additional discussion of prior period development of net claims and claim expenses.

Acquisition Costs, Net
 
Details of acquisition costs are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2020201920202019
($ in thousands)($ in thousands)
Property$3,329 12.3 %$4,254 13.7 %$9,191 12.0 %$11,165 12.5 %
Casualty20,418 75.6 20,119 65.0 58,106 75.8 56,825 63.3 
Other3,271 12.1 6,589 21.3 9,363 12.2 21,670 24.2 
Total$27,018 100.0 %$30,962 100.0 %$76,660 100.0 %$89,660 100.0 %

The acquisition cost ratios for the three and nine months ended September 30, 2020 and 2019, were as follows:
 Three months ended September 30Nine months ended September 30
 20202019Increase / (decrease)20202019Increase / (decrease)
Property20.7 %19.2 %1.5 %20.4 %18.6 %1.8 %
Casualty26.3 %23.4 %2.9 %27.4 %22.6 %4.8 %
Other15.0 %31.2 %(16.2)%12.1 %34.4 %(22.3)%
Total23.4 %24.0 %(0.6)%22.9 %23.9 %(1.0)%

The changes in the acquisition cost ratios for the three months ended September 30, 2020, compared to the same period in 2019, were attributable to the following:
Change in Acquisition Cost Ratios
Three months ended September 30, 2020
 Increase / (decrease) in acquisition cost ratio pointsExplanation
Property1.5The increase in the property acquisition cost ratio during the three months ended September 30, 2020 over the comparable 2019 period was due primarily to higher commissions on certain motor contracts.
Casualty2.9The increase in the casualty acquisition cost ratio during the three months ended September 30, 2020 as compared to the equivalent 2019 period was due primarily to the relative increase in the amount of workers’ compensation and multi-line business written during the third quarter of 2020. These lines incorporate relatively high commission rates as compared to other casualty business.
Other(16.2)The decrease in the “other” acquisition cost ratio during the three months ended September 30, 2020 over the comparable 2019 period was due to reversal of profit commissions upon final settlement of a commuted mortgage contract.
39

The changes in the acquisition cost ratios for the nine months ended September 30, 2020, compared to the same period in 2019, were attributable to the following:
Change in Acquisition Cost Ratios
Nine months ended September 30, 2020
 Increase / (decrease) in acquisition cost ratio pointsExplanation
Property1.8The property acquisition cost ratio increased during the nine months ended September 30, 2020 over the comparable 2019 period. The 2019 comparable period benefited from the reversal of sliding scale ceding commissions on private passenger automobile contracts. This reversal was the primary driver of the increase during the first nine months of 2020.
Casualty4.8The casualty acquisition cost ratio increased during the nine months ended September 30, 2020 over the comparable 2019 period. The 2019 comparable period benefited from the reversal of sliding scale ceding commissions on private passenger automobile contracts. This reversal was the primary driver of the increase during the first nine months of 2020. An additional cause of the increase related to a relative increase in the amount of workers’ compensation and multi-line business written during the first nine months of 2020. These lines incorporate relatively high commission rates as compared to other casualty business.
Other(22.3)The decrease in the “other” acquisition cost ratio during the nine months ended September 30, 2020 over the comparable 2019 period was due to profit commission reversals recognized on mortgage contracts, offsetting most of the increase in loss reserves associated with the COVID-19 pandemic.

General and Administrative Expenses

Details of general and administrative expenses are provided in the following table: 
Three months ended September 30Nine months ended September 30
2020201920202019
($ in thousands)($ in thousands)
Underwriting expenses$2,180 $2,998 $8,384 $11,066 
Corporate expenses2,972 4,727 9,711 11,418 
General and administrative expenses$5,152 $7,725 $18,095 $22,484 

General and administrative expenses decreased by $2.6 million, or 33.3%, for the three months ended September 30, 2020, compared to the equivalent 2019 period. The decrease was due primarily to lower corporate expenses including legal and other professional fees compared to the same period in 2019 relating to the strategic review. Additional causes of the decrease in general and administrative expenses were lower stock compensation expense due to share forfeitures and to a lesser extent, lower travel, accommodation and office related expenses due to the COVID-19 pandemic.

For the nine months ended September 30, 2020, general and administrative expenses decreased by $4.4 million, or 19.5%, compared to the equivalent 2019 period. The decrease was due primarily to lower personnel costs including bonus and stock compensation expenses, and to a lesser extent due to lower corporate expenses including legal and other professional fees associated with the strategic review.
For the nine months ended September 30, 2020 and 2019, general and administrative expenses included $1.4 million and $2.9 million, respectively, of expenses related to stock compensation granted to employees and directors.

40
Total Investment Income (Loss)
 
Total investment income (loss) incorporates (i) changes in the net asset value of our investment in SILP managed by DME Advisors, (ii) interest income earned on the restricted cash and cash equivalents pledged as collateral to our clients, and (iii) gains (or losses) and interest on our portfolio of strategic and innovation investments, notes receivable and investments accounted for under the equity method. We expect our total investment income, including any change in the net asset value of our investment in SILP, to fluctuate from period to period.

A summary of our total investment income (loss) is as follows:
Three months ended September 30Nine months ended September 30
 2020201920202019
 ($ in thousands)
Realized gains (losses)$— $— $(15,000)$(14,150)
Change in unrealized gains and losses40 — 18,884 14,350 
Investment related foreign exchange gains (losses)44 (98)(110)(78)
Interest and dividend income, net of withholding taxes1,021 4,415 7,351 13,709 
Interest, dividend and other expenses(719)(822)(757)(4,833)
Income (loss) from equity method investment80 (183)869 267 
Net investment related income (loss)$466 $3,312 $11,237 $9,265 
Income (loss) from investments in related party investment fund$6,431 $6,609 $(34,086)$51,770 
Total investment income (loss)$6,897 $9,921 $(22,849)$61,035 

The investment income from related party investment fund in the above table is net of management fees paid by SILP to DME Advisors as well as performance compensation, if any, allocated from the Company’s investment in SILP to DME II. No performance compensation is allocated in periods of loss reported by SILP. For detailed breakdowns of management fees and performance compensation for the three and nine months ended September 30, 2020 and 2019, please refer to Note 3 of the condensed consolidated financial statements.

For the three months ended September 30, 2020, investment income, net of fees and expenses, resulted in a gain of 1.4%, on the Investment Portfolio managed by DME Advisors, compared to a gain of 1.2% for the three months ended September 30, 2019. SILP’s long portfolio and macro positions gained 3.2% and 0.3%, respectively, while the short portfolio lost 1.9% during the three months ended September 30, 2020. For the three months ended September 30, 2020, the significant contributors to SILP’s investment income were long positions in The Chemours Company (CC), Green Brick Partners (GRBK) and Atlas Air Worldwide Holdings (AAWW). The largest detractors were short positions in Tesla (TSLA), Zillow Group (Z) and a long position in AerCap Holdings (AER).

For the nine months ended September 30, 2020, investment income, net of fees and expenses, resulted in a loss of 6.5% on the Investment Portfolio managed by DME Advisors, compared to a gain of 10.4% for the nine months ended September 30, 2019. The short portfolio lost 7.7%, while the long portfolio and macro positions gained 0.9% and 0.7%, respectively, during the nine months ended September 30, 2020. For the nine months ended September 30, 2020, the largest contributors to SILP’s investment income were a long position in GRBK and short positions in the S&P 500 Index and a group of companies in the life insurance industry that was intended to reduce the exposure to a long position in Brighthouse Financial (BHF). The largest detractors were a long position in BHF and a short position in TSLA and a basket of short positions in companies whose finances are significantly affected by the COVID-19 pandemic.
For the three and nine months ended September 30, 2020, the decrease in interest income compared to the equivalent period in 2019, related to lower interest rates offered by financial institutions on the restricted cash and cash equivalents pledged as collateral to our clients.

During the nine months ended September 30, 2020, we recorded net unrealized gains of $3.3 million relating to our portfolio of innovation investments. During the nine months ended September 30, 2020, we wrote-off a valuation allowance
41
previously recorded on certain other notes receivable. The write-off has been presented in the above table as a realized loss with an offsetting reduction in unrealized loss.

For the three months ended September 30, 2020 and 2019, and for the nine months ended September 30, 2020 and 2019, the gross investment return (loss) on our investments managed by DME Advisors (excluding investment advisor performance allocation) were composed of the following:
Three months ended September 30Nine months ended September 30
2020201920202019
Long portfolio gains (losses)3.2 %2.2 %0.9 %15.6 %
Short portfolio gains (losses)(1.9)(0.8)(7.7)(3.3)
Macro gains (losses)0.3 0.1 0.7 0.6 
Other income and expenses 1
(0.2)(0.1)(0.4)(1.3)
Gross investment return1.4 %1.4 %(6.5)%11.6 %
Net investment return 1
1.4 %1.2 %(6.5)%10.4 %
1 “Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporates both of these amounts.

Our investment returns on investments managed by DME Advisors are posted on our website (www.greenlightre.com) on a monthly basis.
       
Income Taxes
 
We are not obligated to pay taxes in the Cayman Islands on either income or capital gains. We have been granted an exemption by the Governor-In-Cabinet from any income taxes that may be imposed in the Cayman Islands for a period of 20 years, expiring on February 1, 2025.
 
GRIL is incorporated in Ireland and is subject to the Irish corporation tax. GRIL is expected to be taxed at a rate of 12.5% on its taxable trading income, and 25% on its non-trading income, if any.

Verdant is incorporated in Delaware and, therefore, is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the Internal Revenue Service. Verdant’s future taxable income is expected to be taxed at a rate of 21%.

As of September 30, 2020, a gross deferred tax asset of $3.8 million (December 31, 2019: $3.6 million) was included in other assets on the condensed consolidated balance sheets. As of September 30, 2020, this gross deferred tax asset was partially offset by a valuation allowance of $3.3 million (December 31, 2019: $2.6 million). Based on the timing of the reversal of the temporary differences and likelihood of generating sufficient taxable income to realize the future tax benefit, management believes it is more likely than not that the recorded deferred tax asset (net of the valuation allowance) will be fully realized in the future. The Company has not taken any other tax positions that management believes are subject to uncertainty or that are reasonably likely to have a material impact to the Company, GRIL or Verdant.

42
Ratio Analysis
 
The following table provides our underwriting ratios by line of business: 

 Three months ended September 30Three months ended September 30
20202019
 PropertyCasualtyOtherTotalPropertyCasualtyOtherTotal
 
Loss ratio92.9 %70.8 %83.3 %76.2 %63.6 %74.7 %69.6 %72.0 %
Acquisition cost ratio20.7 26.3 15.0 23.4 19.2 23.4 31.2 24.0 
Composite ratio113.6 %97.1 %98.3 %99.6 %82.8 %98.1 %100.8 %96.0 %
Underwriting expense ratio0.8 2.0 
Combined ratio100.4 %98.0 %

 Nine months ended September 30Nine months ended September 30
20202019
 PropertyCasualtyOtherTotalPropertyCasualtyOtherTotal
 
Loss ratio76.9 %71.3 %86.3 %75.5 %65.8 %84.2 %67.9 %78.5 %
Acquisition cost ratio20.4 27.4 12.1 22.9 18.6 22.6 34.4 23.9 
Composite ratio97.3 %98.7 %98.4 %98.4 %84.4 %106.8 %102.3 %102.4 %
Underwriting expense ratio1.7 2.3 
Combined ratio100.1 %104.7 %
              

Financial Condition
 
Total investments
 
The total investments reported in the condensed consolidated balance sheets as of September 30, 2020, was $207.2 million, compared to $256.4 million as of December 31, 2019, a decrease of $49.2 million, or 19.2%. The decrease was primarily related to investment losses from our investment in SILP driven by the significant volatility in the equity markets arising from economic uncertainty relating to the COVID-19 pandemic, and to a lesser extent due to withdrawals for claim payments.

As of September 30, 2020, 91.1% of SILP’s investments were valued based on quoted prices in actively traded markets (Level 1), 4.7% was composed of instruments valued based on observable inputs other than quoted prices (Level 2) and 1.0% was composed of instruments valued based on non-observable inputs (Level 3). As of September 30, 2020, 3.2% of SILP’s investments were in private equity funds valued using the funds’ net asset values as a practical expedient.

Restricted cash and cash equivalents

The Company’s restricted cash and cash equivalents are used for funding trusts and letters of credits issued to our ceding insurers. Our restricted cash decreased by $19.0 million, or 2.6%, from $742.1 million at December 31, 2019 to $723.1 million, as of September 30, 2020, primarily due to reduction in collateral held by our ceding insurers.

43
Loss and loss adjustment expense reserves; Loss and loss adjustment expenses recoverable
 
The COVID-19 pandemic is unprecedented and we do not have previous loss experience on which to base estimates for loss and loss adjustment expense reserves related to this pandemic. See Note 5 of the accompanying condensed consolidated financial statements for assumptions used in our loss estimates relating to the COVID-19 pandemic. Losses in respect of the COVID-19 pandemic subsequent to September 30, 2020 will be reflected in the periods in which those losses are incurred.

Reserves for loss and loss adjustment expenses were composed of the following: 
 September 30, 2020December 31, 2019
 Case
Reserves		IBNRTotalCase
Reserves		IBNRTotal
 ($ in thousands)
Property$56,353 $20,425 $76,778 $48,350 $27,126 $75,476 
Casualty143,443 195,726 339,169 152,049 204,574 356,623 
Other24,936 40,887 65,823 17,435 21,054 38,489 
Total$224,732 $257,038 $481,770 $217,834 $252,754 $470,588 
 
During the nine months ended September 30, 2020, the total gross loss and loss adjustment expense reserves increased by $11.2 million, or 2.4% to $481.8 million from $470.6 million as of December 31, 2019. See Note 5 of the accompanying condensed consolidated financial statements for a summary of changes in outstanding loss and loss adjustment expense reserves and for a description of prior period loss developments.

During the nine months ended September 30, 2020, the total loss and loss adjustment expenses recoverable decreased by $7.6 million, or 27.5%, to $19.9 million from $27.5 million as of December 31, 2019. The decrease primarily related to losses recovered relating to retroceded private passenger automobile contracts that were not renewed during 2019. See Note 6 of the accompanying condensed consolidated financial statements for a description of the credit risk associated with our retrocessionaires.

For most of the contracts we write, our risk exposure is limited by defined limits of liability. Once the loss limit has been reached, we have no further exposure to additional losses from that contract outside of contract failure. However, certain contracts, particularly quota share contracts that relate to first-dollar exposure, may not contain aggregate limits.

Our property business, and to a lesser extent our casualty and other business, incorporate contracts that contain natural peril loss exposure. We estimate catastrophe loss exposure in terms of the probable maximum loss (“PML”). We define PML as the anticipated loss, taking into account contract terms and limits, caused by a catastrophe affecting a broad geographic area, such as that caused by an earthquake or hurricane. We anticipate that the PML will vary from period to period depending upon the modeled simulated losses and the composition of the in-force book of business. The projected severity levels are described in terms of a 1-in-250 year return period. The 1-in-250 year return period PML means that we believe there is a 0.4% chance in any given year that an occurrence of a natural catastrophe will lead to losses exceeding the stated estimate. In other words, it corresponds to a 99.6% probability that the loss from an event will fall below the indicated PML.

PMLs are estimates and as a result, we cannot provide any assurance that any actual event will align with the modeled event or that actual losses from events similar to the modeled events will not vary materially from the modeled event PML. The PML estimate incorporates all significant exposure from our reinsurance operations, including coverage for property, marine and energy, motor and catastrophe workers’ compensation.
44
As of October 1, 2020, our estimated PML exposure (net of retrocession and reinstatement premiums) at a 1-in-250 year return period for a single event and in aggregate was $89.7 million and $108.1 million, respectively. The following table provides the PML for single event loss exposure and aggregate loss exposure to natural peril losses for each of the peak zones as of October 1, 2020:
October 1, 2020
1-in-250 year return period
ZoneSingle Event LossAggregate Loss
($ in thousands)
United States, Canada and the Caribbean$89,686 $98,248 
Europe43,279 46,869 
Japan33,256 35,459 
Rest of the world32,067 35,629 
Maximum89,686 108,073 
Total shareholders’ equity
 
Total equity reported on the condensed consolidated balance sheet decreased by $50.3 million to $426.9 million as of September 30, 2020, compared to $477.2 million as of December 31, 2019. Retained earnings decreased primarily due to a net loss of $38.2 million reported for the nine months ended September 30, 2020. Additionally, the Company repurchased 1.9 million Class A ordinary shares during the nine months ended September 30, 2020 resulting in a $12.7 million decrease in shareholders’ equity. For details of other movements in shareholders’ equity see Part I, Item 1. “Condensed Consolidated Statements of Shareholders’ Equity.”

Liquidity and Capital Resources
 
General

Greenlight Capital Re is organized as a holding company with no operations of its own. As a holding company, Greenlight Capital Re has minimal continuing cash needs, most of which are related to the payment of administrative expenses and interest expense. All of our underwriting operations are conducted through our wholly-owned reinsurance subsidiaries, Greenlight Re and GRIL, which underwrite property and casualty reinsurance. There are restrictions on each of Greenlight Re’s and GRIL’s ability to pay dividends, which are described in more detail below. It is our current policy to retain earnings to support the growth of our business. We currently do not expect to pay dividends on our ordinary shares.

As of September 30, 2020, Greenlight Re and GRIL were each rated “A- (Excellent)” with a negative outlook, by A.M. Best. On July 22, 2020, A.M. Best affirmed the “A- (Excellent)” ratings. The ratings reflect A.M. Best’s opinion of our reinsurance subsidiaries’ financial strength, operating performance and ability to meet obligations and it is not an evaluation directed toward the protection of investors or a recommendation to buy, sell or hold our Class A ordinary shares. If A.M. Best downgrades our ratings below “A- (Excellent)” or withdraws our rating, we could be severely limited or prevented from writing any new reinsurance contracts, which would significantly and negatively affect our business. Our A.M. Best ratings may be revised or revoked at the sole discretion of the rating agency. 

Sources and Uses of Funds
 
Our sources of funds consist primarily of premium receipts (net of brokerage and ceding commissions), investment income and other income. We use cash from our operations to pay losses and loss adjustment expenses, profit commissions, interest and general and administrative expenses. As of September 30, 2020, all of our investable assets, excluding strategic investments and funds required for business operations and for capital risk management, are invested by DME Advisors in SILP, subject to our investment guidelines. We have the ability to redeem funds from SILP at any time for operational purposes by providing three days’ notice to the general partner. As of September 30, 2020, the majority of SILP’s long investments were composed of cash and cash equivalents, and publicly-traded equity securities, which can be readily liquidated to meet our redemption requests. We record all investment income (loss), including any changes in the net asset value of SILP, and any unrealized gains and losses, in our condensed consolidated statements of operations for each reporting period.    
   
45
For the nine months ended September 30, 2020 and 2019, the net cash used in operating activities was $44.7 million and $8.7 million, respectively. The net cash used in our underwriting activities and for payment of corporate expenses was $51.3 million and $17.6 million for the nine months ended September 30, 2020 and 2019, respectively. Generally, if the premiums collected exceed claim payments within a given period, we generate cash from our underwriting activities. Our underwriting activities represented a net use of cash for the nine months ended September 30, 2020 and 2019, as the losses we paid exceeded the premiums we collected. The cash used in, and generated from, underwriting activities may vary significantly from period to period depending on the underwriting opportunities available and claims submitted to us by our cedents.

For the nine months ended September 30, 2020, our net withdrawals from SILP provided cash of $21.0 million which was primarily used to pay losses and to fund collateral required by our ceding insurers. By comparison, for the same period in 2019 our investing activities provided cash of $79.2 million.
  
As of September 30, 2020, we believe we have sufficient cash flow from operating and investing activities to meet our foreseeable liquidity requirements. We expect that our operational needs for liquidity will not be materially impacted by the COVID-19 pandemic and will be met by cash, funds generated from underwriting activities and investment income, including withdrawals from SILP, if necessary. As of September 30, 2020, we expect to fund our operations for the next twelve months from operating and investing cash flow. However, we may explore various financing alternatives, including capital raising alternatives, to fund our business strategy, improve our capital structure, increase surplus, pay claims or make acquisitions. We can provide no assurances that any such transactions will occur or, if so, as to the terms of such transactions.
 
Although GLRE is not subject to any significant legal prohibitions on the payment of dividends, Greenlight Re and GRIL are each subject to regulatory minimum capital requirements and regulatory constraints that affect their ability to pay dividends to us. In addition, any dividend payment would have to be approved by the relevant regulatory authorities prior to payment. During the nine months ended September 30, 2020, we received regulatory approval for a return of up to $15.0 million of Greenlight Re’s share premium to GLRE to facilitate the share repurchases. In October 2020, we received regulatory approval for return of up to $25.0 million of Greenlight Re’s share premium to GLRE in order to provide additional capital to GRIL. For the nine months ended September 30, 2020, we used $12.7 million to repurchase 1.9 million Class A ordinary shares. As of September 30, 2020, Greenlight Re and GRIL both exceeded the regulatory minimum capital requirements. 

Letters of Credit and Trust Arrangements
 
As of September 30, 2020, neither Greenlight Re nor GRIL was licensed or admitted as a reinsurer in any jurisdiction other than the Cayman Islands and the European Economic Area, respectively. Because many jurisdictions do not permit domestic insurance companies to take credit on their statutory financial statements for loss recoveries or ceded unearned premiums unless appropriate measures are in place for reinsurance obtained from unlicensed or non-admitted insurers, we anticipate that all of our U.S. clients and some of our non-U.S. clients will require us to provide collateral through funds withheld, trust arrangements, letters of credit or a combination thereof.

As of September 30, 2020, we had one letter of credit facility available with an aggregate capacity of $275.0 million (December 31, 2019: $400.0 million). See Note 11 of the accompanying condensed consolidated financial statements for details on the letter of credit facility. We provide collateral to cedents in the form of letters of credit and trust arrangements. As of September 30, 2020, the aggregate amount of collateral provided to cedents under such arrangements was $720.6 million (December 31, 2019: $733.2 million). As of September 30, 2020, the letters of credit and trust accounts were secured by restricted cash and cash equivalents with a total fair value of $723.1 million (December 31, 2019: $742.1 million).

The letter of credit facility contains customary events of default and restrictive covenants, including but not limited to, limitations on liens on collateral, transactions with affiliates, mergers and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements, and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re would be prohibited from paying dividends to its parent company. The Company was in compliance with all the covenants of this facility as of September 30, 2020.

46
Capital
 
Our capital structure currently consists of senior convertible notes and equity issued in two classes of ordinary shares. We expect that the existing capital base and internally generated funds will be sufficient to implement our business strategy for the foreseeable future. Consequently, we do not presently anticipate that we will incur any additional material indebtedness in the ordinary course of our business. However, in order to provide us with flexibility and timely access to public capital markets should we require additional capital for working capital, capital expenditures, acquisitions or other general corporate purposes, we have filed a Form S-3 registration statement, which expires in July 2021. In addition, as noted above, we may explore various financing alternatives, although there can be no assurance that additional financing will be available on acceptable terms when needed or desired. We did not make any significant commitments for capital expenditures during the nine months ended September 30, 2020.

On March 26, 2020, the Board of Directors extended the share repurchase plan to June 30, 2021 and increased the number of shares authorized to be repurchased to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases or pursuant to one more tender offers. The Company is not required to repurchase any of the Class A ordinary shares or the Notes and the repurchase plans may be modified, suspended or terminated at the election of our Board of Directors at any time without prior notice. During the nine months ended September 30, 2020, 1.9 million Class A ordinary shares were repurchased by the Company. As of September 30, 2020, 3.1 million Class A ordinary shares and $25.0 million of the Notes, remained available for repurchase under the repurchase plans.
As of September 30, 2020, there were 293,939 Class A ordinary shares available for future issuance under the Company’s stock incentive plan. The stock incentive plan is administered by the Compensation Committee of the Board of Directors. On October 29, 2020, our shareholders approved an amendment to our stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million shares.
 
Contractual Obligations and Commitments
 
The following table shows our aggregate contractual obligations as of September 30, 2020 by time period remaining: 
Less than
 1 year		1-3 years3-5 yearsMore than
 5 years		Total
   ($ in thousands)
Operating lease obligations (1)$236 $— $— $— $236 
Interest and convertible note payable (2)4,000 106,000 — — 110,000 
Loss and loss adjustment expense reserves (3)248,593 128,151 49,141 55,885 481,770 
$252,829 $234,151 $49,141 $55,885 $592,006 
(1)Reflects our minimum contractual obligations pursuant to the lease agreements as described below.  
(2)Includes interest payments due on $100.0 million of senior convertible note payable at 4.0% per annum, as well as the payment of principal upon maturity on August 1, 2023.
(3)      Due to the nature of our reinsurance operations, the amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain.

Greenlight Re had entered into lease agreements for office space in the Cayman Islands. The leases expired on June 30, 2018 and the Company is currently in negotiations with the lessor for renewal of the leases and meanwhile both parties have agreed to extend the lease until December 31, 2020. The remaining obligations relating to the monthly lease are included in the above table in the caption “Operating lease obligation.”
 
GRIL has entered into a lease agreement for office space in Dublin, Ireland. Under the terms of this lease agreement, GRIL is committed to minimum annual rent payments denominated in Euros approximating €0.1 million until May 2021, and adjusted to the prevailing market rates for the subsequent ten-year term. GRIL has the option to terminate the lease agreement in 2021. The minimum lease payment obligations are included in the above table under operating lease obligations and in Note 11 to the accompanying condensed consolidated financial statements.
 
47
Pursuant to the IAA between SILP and DME Advisors, DME Advisors is entitled to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio, as provided in the SILP LPA. The IAA has an initial term ending on August 31, 2023 subject to automatic extension for successive three-year terms. For the three and nine months ended September 30, 2020, management fees paid by SILP to DME Advisors were $0.7 million and $2.0 million, respectively (2019: $0.7 million and $4.2 million, respectively). Pursuant to the SILP LPA, DME II is entitled to a performance allocation equal to 20% of the net profit, calculated per annum, of each limited partner’s share of the capital account managed by DME Advisors, subject to a loss carry forward provision. DME II is not entitled to earn a performance allocation in a year in which SILP incurs a loss. The loss carry forward provision contained in the SILP LPA allows DME II to earn reduced performance allocation of 10% of net profits in years subsequent to the year in which the capital accounts of the limited partners incur a loss, until all losses are recouped and an additional amount equal to 150% of the loss is earned. Due to the investment loss for the nine months ended September 30, 2020, no performance allocation was earned by DME II. For the three and nine months ended September 30, 2019, $0.7 million and $5.7 million, respectively, of performance allocation was netted against income in the caption “Investment in related party investment fund” in the Company’s condensed consolidated statement of operations.

On February 26, 2019, effective as of September 1, 2018, the Company entered into Amendment No. 1 to the SILP LPA. The amendment was intended to revise the mechanics for calculating the Carryforward Account and Performance Allocation (as defined in the LPA) to take into account withdrawals from and subsequent recontributions of capital to SILP, consistent with the treatment under the Joint Venture. The Company has also entered into a letter agreement with DME Advisors and DME II whereby during the period from June 1, 2019 to June 30, 2021, cash, cash equivalents and/or U.S. government issued securities will not be subject to any management fee or performance allocation.

The Company has entered into a service agreement with DME Advisors pursuant to which DME Advisors will provide investor relations services to us for compensation of $5,000 per month plus expenses. The service agreement had an initial term of one year, and continues for sequential one-year periods until terminated by us or DME Advisors. Either party may terminate the service agreement for any reason with 30 days prior written notice to the other party.

Our related party transactions are presented in Note 10 to the accompanying condensed consolidated financial statements.

Off-Balance Sheet Financing Arrangements
 
We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements. Other than our investments in SILP and AccuRisk Holdings LLC (see Notes 3 and 4 of the accompanying condensed consolidated financial statements), we have not participated in transactions that created relationships with unconsolidated entities or financial partnerships, including VIEs, established for the purpose of facilitating off-balance sheet arrangements. 

Effects of Inflation
 
Inflation generally affects the cost of claims and claim expenses, as well as asset values in our investment portfolio. The anticipated effects of inflation on our claim costs are considered in our pricing and reserving models. However, the actual effect of increases in claim costs due to inflation cannot be accurately known until claims are ultimately settled, and may differ significantly from our estimate. In addition, the onset, duration and severity of an inflationary period cannot be predicted or estimated with precision.

Item 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
We believe we are principally exposed to the following types of market risk: 
•equity price risk;
•commodity price risk;
•foreign currency risk;
•interest rate risk;
•credit risk; and
•political risk.
 
48
Equity Price Risk
As of September 30, 2020, our investments consisted primarily of an investment in SILP. Among SILP’s holdings are equity securities, the carrying values of which are based primarily on quoted market prices. Generally, market prices of common equity securities are subject to fluctuation, which could cause the amount to be realized upon the closing of a position to differ significantly from its current reported value. This risk is partly mitigated by the presence of both long and short equity securities as part of our investment strategy. As of September 30, 2020, a 10% decline in the price of each of the underlying listed equity securities and equity-based derivative instruments would result in a loss of $6.4 million, or 1.4%, of our Investment Portfolio.
 
Computations of the prospective effects of hypothetical equity price changes are based on numerous assumptions, including the maintenance of the existing level and composition of investment securities and should not be relied on as indicative of future results.

Commodity Price Risk
Generally, market prices of commodities are subject to fluctuation. SILP’s investments periodically include long or short investments in commodities or in derivatives directly impacted by fluctuations in the prices of commodities. As of September 30, 2020, SILP’s investments included unhedged exposure to changes in gold prices, through physical gold holdings and derivative instruments with underlying exposure to changes in the price of natural gas.
The following table summarizes the net impact that a 10% increase and decrease in commodity prices would have on the value of our Investment Portfolio as of September 30, 2020. The below table excludes the indirect effect that changes in commodity prices might have on equity securities in our Investment Portfolio. 
10% increase in commodity prices10% decrease in commodity prices
CommodityChange in
fair value		Change in
fair value
  ($ in millions)
Gold$1.9 $(1.9)
Natural Gas0.5 (0.5)
Total$2.4 $(2.4)

Foreign Currency Risk
Certain of our reinsurance contracts are denominated in foreign currencies whereby premiums are receivable and losses are payable in foreign currencies. Foreign currency exchange rate risk exists to the extent that our foreign currency reinsurance balances are in excess of (or less than) the corresponding foreign currency cash balances and there is an increase (or decrease) in the exchange rate of that foreign currency.  

While we do not seek to precisely match our liabilities under reinsurance policies that are payable in foreign currencies with investments denominated in such currencies, we continually monitor our exposure to potential foreign currency losses and may use foreign currency cash and cash equivalents or forward foreign currency exchange contracts in an effort to mitigate against adverse foreign currency movements. As of September 30, 2020, our net exposure to GBP denominated balances was £7.7 million. As of September 30, 2020, a 10% decrease in the U.S. dollar against the GBP (all else constant) would result in an estimated $1.0 million foreign exchange gain. Alternatively, a 10% increase in the U.S dollar against the GBP, would result in an estimated $1.0 million foreign exchange loss.

We may also be exposed to foreign currency risk through SILP’s underlying cash, forwards, options and investments in securities denominated in foreign currencies. As of September 30, 2020, some of our currency exposure resulting from foreign denominated securities (longs and shorts) was reduced by offsetting cash balances denominated in the corresponding foreign currencies.

As of September 30, 2020, a 10% increase or decrease in the value of the U.S. dollar against foreign currencies would have no meaningful impact on the value of our Investment Portfolio. 
 
49
Interest Rate Risk
Our investment in SILP includes interest rate sensitive securities, such as corporate and sovereign debt instruments and interest rate swaps. The primary market risk exposure for any debt instrument is interest rate risk. As interest rates rise, the fair value of a long fixed-income portfolio generally falls. Similarly, falling interest rates generally lead to increases in the fair value of fixed-income securities. Additionally, some of the derivative investments may also be sensitive to interest rates and their value may indirectly fluctuate with changes in interest rates. 

As of September 30, 2020, a 100 basis points increase or decrease in interest rates would have no meaningful impact on the value of our Investment Portfolio. 
 
We, along with DME Advisors, monitor the net exposure to interest rate risk and generally do not expect changes in interest rates to have a materially adverse impact on our operations.
 
Credit Risk

Credit risk relates to the uncertainty of a counterparty’s ability to make timely payments in accordance with contractual terms of the instrument or contract. Our maximum exposure to credit risk is the carrying value of our financial assets. We evaluate the financial condition of our notes receivable counterparties and monitor our exposure to them on a regular basis. We are also exposed to credit risk from our business partners and clients relating to balances receivable under our reinsurance contracts, including premiums receivable, losses recoverable and commission adjustments recoverable. We obtain collateral in the form of funds withheld, trusts and letters of credit from our counterparties to mitigate this credit risk. We monitor our net exposure to each counterparty relative to the financial strength of our counterparties and assess the collectibility of these balances on a regular basis. See Note 2 of the accompanying condensed consolidated financial statements for further details on allowance for credit loss on reinsurance assets and notes receivable.

In addition, the securities, commodities, and cash in SILP’s investment portfolio are held with several prime brokers and derivative counterparties, subjecting SILP, and indirectly us, to significant concentration of credit risk. While we have no direct control over SILP, DME Advisors regularly monitors the concentration of credit risk with each counterparty and, if appropriate, transfers cash or securities between counterparties or requests collateral to diversify and mitigate this credit risk. 

Political Risk

Through our assumed reinsurance contracts, we currently provide a limited amount of political risk insurance coverage which is not expected to have a materially adverse impact on our underwriting results.

We are exposed to political risk to the extent that we underwrite business from entities located in foreign markets and to the extent that DME Advisors, on behalf of SILP and subject to our investment guidelines, trades securities that are listed on various U.S. and foreign exchanges and markets. The governments in any of these jurisdictions could impose restrictions, regulations or other measures, which may have a material adverse impact on our underwriting operations and investment strategy. See “Item 1A. Risk Factors - We could face unanticipated losses from political instability which could have a material adverse effect on our financial condition and results of operations.” included in our Amendment No. 1 to Form 10-K for the fiscal year ended December 31, 2019.

 
Item 4. CONTROLS AND PROCEDURES
 
Disclosure Controls and Procedures
 
As required by Rules 13a-15 and 15d-15 of the Exchange Act, the Company has evaluated, with the participation of management, including the Chief Executive Officer and the Chief Financial Officer, the effectiveness of its disclosure controls and procedures (as defined in such rules) as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports prepared in accordance with the rules and regulations of the SEC is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
50
 
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s disclosure controls and procedures will prevent all errors and all frauds. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.
 
Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.  
  
Changes in Internal Control Over Financial Reporting
 
There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company continues to review its disclosure controls and procedures, including its internal controls over financial reporting, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Company’s systems evolve with its business.


51
PART II — OTHER INFORMATION
 
Item 1.    LEGAL PROCEEDINGS
 
From time to time, in the normal course of business, we may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine our rights and obligations under our reinsurance contracts and other contractual agreements. In some disputes, we may seek to enforce our rights under an agreement or to collect funds owing to us. In other matters, we may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, we do not believe that any of our existing contractual disputes, when finally resolved, will have a material adverse effect on our business, financial condition or operating results.
 
Item 1A. RISK FACTORS
 
Factors that could cause our actual results to differ materially from those in this report are any of the risks described in “Part I. Item 1A. Risk Factors” included in our Amendment No. 1 to Form 10-K for the fiscal year ended December 31, 2019, as filed with the "Securities and Exchange Commission ("SEC") on April 29, 2020 (the “ Form 10-K/A”). Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
As of the date of this report, there have been no other material changes to the risk factors as disclosed in the Form 10-K/A. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Item 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 
 
The Board has adopted a share and notes repurchase plan. On March 26, 2020, the Board of Directors extended the share repurchase plan to June 30, 2021 and increased the number of shares authorized to be repurchased to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases or pursuant to one more tender offers.

The Company is not required to repurchase any of the Class A ordinary shares or Notes and the repurchase plans may be modified, suspended or terminated at the election of our Board of Directors at any time without prior notice. There were no repurchases of the Notes during the three months ended September 30, 2020.

The table below details the share repurchases that were made under the plan during the three months ended September 30, 2020:
Issuer Purchases of Equity Securities
PeriodTotal Number of Shares Purchased (1)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (1)
July 1 - 31, 2020272,416 $6.65 272,416 3,565,925 
August 1 - 31, 2020234,336 $7.15 234,336 3,331,589 
September 1 - 30, 2020206,008 $6.86 206,008 3,125,581 
Total712,760 $6.87 712,760 3,125,581 
(1) Class A ordinary shares.


Item 3.    DEFAULTS UPON SENIOR SECURITIES 
 
None.
 
52
Item 4.    MINE SAFETY DISCLOSURES

Not applicable
 
Item 5.    OTHER INFORMATION

Disclosure of Certain Activities Under Section 13(r) of the Securities Exchange Act of 1934

Section 13(r) of the Securities Exchange Act of 1934, as amended, requires an issuer to disclose in its annual or quarterly reports whether it or an affiliate knowingly engaged in certain activities described in that section, including certain activities related to Iran during the period covered by the report. During 2016, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”) adopted General License H, which authorizes non-U.S. entities that are owned or controlled by a U.S. person to engage in certain activities with Iran so long as they comply with certain specific requirements set forth therein. During 2018, OFAC reimposed certain sanctions on Iran related activities including providing insurance, reinsurance and underwriting services and required such activities to be wound-down by November 4, 2018.

As and when allowed by the applicable law and regulations, our non-U.S. subsidiaries provide treaty reinsurance coverage to non-U.S. insurers on a worldwide basis, including insurers of liability, marine, aviation and energy risks, and as a result, these underlying reinsurance portfolios may have some exposure to Iran. In addition, we may underwrite facultative reinsurance on a global basis to non-U.S. insurers, including for liability, marine, aviation and energy risks. Coverage provided to non-Iranian business may indirectly cover an exposure in Iran. For example, certain of our reinsurance contracts cover global marine hull and cargo policies that provide coverage for vessels navigating into and out of ports worldwide, including Iran.

For the quarter ended September 30, 2020, we are not aware of any premiums with respect to underwriting reinsurance activities reportable under Section 13(r). Should any such risks have entered into the stream of commerce covered by these reinsurance activities, we believe that the premiums associated with such business would be immaterial.
 
Item 6.    EXHIBITS

10.1
10.2
10.3
31.1
31.2
32.1
32.2
101The following materials from the Company’s Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2020 formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Changes in Shareholders’ Equity; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) the Notes to Condensed Consolidated Financial Statements.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 
 
53


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 GREENLIGHT CAPITAL RE, LTD.
 (Registrant)
 By:/s/ SIMON BURTON                     
 Simon Burton
Director and Chief Executive Officer
(principal executive officer)
 November 4, 2020
 By:/s/ NEIL GREENSPAN                           
 Neil Greenspan
Chief Financial Officer
(principal financial and accounting officer)
 November 4, 2020
54
 EX-31.1 2 glre-20200930exhibit311.htm EX-31.1 Document

EXHIBIT 31.1  

CERTIFICATION OF
CHIEF EXECUTIVE OFFICER OF
GREENLIGHT CAPITAL RE, LTD.

I, Simon Burton, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Greenlight Capital Re, Ltd.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.   

Dated:November 4, 2020/s/ SIMON BURTON                     
  Simon Burton
Chief Executive Officer
(principal executive officer)
  

 EX-31.2 3 glre-20200930exhibit312.htm EX-31.2 Document

 EXHIBIT 31.2 

CERTIFICATION OF
CHIEF FINANCIAL OFFICER OF
GREENLIGHT CAPITAL RE, LTD.

I, Neil Greenspan, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Greenlight Capital Re, Ltd.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.   


Dated:November 4, 2020/s/ NEIL GREENSPAN  
  Neil Greenspan
  Chief Financial Officer
(principal financial officer)

 EX-32.1 4 glre-20200930exhibit321.htm EX-32.1 Document

EXHIBIT 32.1   
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER OF
GREENLIGHT CAPITAL RE, LTD.  


This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the ‘‘Form 10-Q’’) for the quarter ended September 30, 2020 of Greenlight Capital Re, Ltd. (the ‘‘Issuer’’). 

I, Simon Burton, the Principal Executive Officer of the Issuer, certify that to the best of my knowledge: 

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and 

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer. 


Dated:November 4, 2020/s/ SIMON BURTON                     
  Simon Burton
Chief Executive Officer
(principal executive officer)
 


 EX-32.2 5 glre-20200930exhibit322.htm EX-32.2 Document

EXHIBIT 32.2  
CERTIFICATION OF
CHIEF FINANCIAL OFFICER OF
GREENLIGHT CAPITAL RE, LTD.  


This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the ‘‘Form 10-Q’’) for the quarter ended September 30, 2020 of Greenlight Capital Re, Ltd. (the ‘‘Issuer’’). 

I, Neil Greenspan, the Principal Financial Officer of the Issuer, certify that to the best of my knowledge: 

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and 

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.  


Dated:November 4, 2020/s/ NEIL GREENSPAN
  Neil Greenspan
Chief Financial Officer
(principal financial officer)
 


 EX-101.SCH 6 glre-20200930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 2102102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Cash Flow, Supplemental Cash Equivalents Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Schedule of Allowance For Credit Losses on Notes Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Interest Income and Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 2110103 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND link:presentationLink link:calculationLink link:definitionLink 2311302 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413407 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details) link:presentationLink link:calculationLink link:definitionLink 2414408 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Income Statements of SILP (Details) link:presentationLink link:calculationLink link:definitionLink 2115104 - Disclosure - FINANCIAL INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 2316303 - Disclosure - FINANCIAL INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2417409 - Disclosure - FINANCIAL INSTRUMENTS Schedule of Other Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2418410 - Disclosure - FINANCIAL INSTRUMENTS Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2119105 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES link:presentationLink link:calculationLink link:definitionLink 2320304 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables) link:presentationLink link:calculationLink link:definitionLink 2421411 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Change in Outstanding Loss and Loss Adjustment Expense Reserve For Health Claims (Details) link:presentationLink link:calculationLink link:definitionLink 2122106 - Disclosure - RETROCESSION link:presentationLink link:calculationLink link:definitionLink 2423412 - Disclosure - RETROCESSION (Details) link:presentationLink link:calculationLink link:definitionLink 2124107 - Disclosure - SENIOR CONVERTIBLE NOTES link:presentationLink link:calculationLink link:definitionLink 2425413 - Disclosure - SENIOR CONVERTIBLE NOTES (Details) link:presentationLink link:calculationLink link:definitionLink 2126108 - Disclosure - SHARE CAPITAL link:presentationLink link:calculationLink link:definitionLink 2327305 - Disclosure - SHARE CAPITAL (Tables) link:presentationLink link:calculationLink link:definitionLink 2428414 - Disclosure - SHARE CAPITAL Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2429415 - Disclosure - SHARE CAPITAL Schedule of Voting Ordinary Shares Issued And Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 2130109 - Disclosure - SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 2331306 - Disclosure - SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2432416 - Disclosure - SHARE-BASED COMPENSATION Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2433417 - Disclosure - SHARE-BASED COMPENSATION Restricted Shares (Details) link:presentationLink link:calculationLink link:definitionLink 2434418 - Disclosure - SHARE-BASED COMPENSATION Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2135110 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 2436419 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 2137111 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2338307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2439420 - Disclosure - COMMITMENTS AND CONTINGENCIES Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2440421 - Disclosure - COMMITMENTS AND CONTINGENCIES Schedule of Letters of Credit (Details) link:presentationLink link:calculationLink link:definitionLink 2441422 - Disclosure - COMMITMENTS AND CONTINGENCIES Schedule of Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2441422 - Disclosure - COMMITMENTS AND CONTINGENCIES Schedule of Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2142112 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 2343308 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 2444423 - Disclosure - SEGMENT REPORTING Gross Premiums Written by Line of Business (Details) link:presentationLink link:calculationLink link:definitionLink 2445424 - Disclosure - SEGMENT REPORTING Geographic Information (Details) link:presentationLink link:calculationLink link:definitionLink 2146113 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 2447425 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 glre-20200930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 glre-20200930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 glre-20200930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Number of RSUs issued to employees (in shares) Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Revision of Prior Period [Axis] Revision of Prior Period [Axis] Document Type Document Type COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Number of options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Related Party [Axis] Related Party [Axis] Total Gross balance at January 1 Gross balance at September 30 Liability for Claims and Claims Adjustment Expense Performance allocation Incentive Fee Expense AccuRisk Holdings LLC AccuRisk Holdings LLC [Member] AccuRisk Holdings LLC [Member] Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Number of shares with accelerated vesting Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number Liability for Claims and Claims Adjustment Expense [Table] Liability for Claims and Claims Adjustment Expense [Table] Total Contractual Obligation Investor relations monthly fee Related Party Transaction, Expenses from Transactions with Related Party Derivative contracts, at fair value Derivative Asset Liabilities and equity Liabilities and Equity [Abstract] Investment management fee rate - monthly Related Party Transaction, Monthly Management Fee Percentage The monthly rate charged by investment advisor calculated as a percentage of assets under management Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Security Exchange Name Security Exchange Name Unrealized losses Other Investments, Accumulated Gross Unrealized Holding Loss Other Investments, Accumulated Gross Unrealized Holding Loss Ceded Credit Risk, Collateralization [Domain] Ceded Credit Risk, Collateralization [Domain] Reinsurance balances payable Reinsurance Payable Reinsurance Disclosures [Abstract] Reinsurance Disclosures [Abstract] Management fees Equity Method Investment, Summarized Financial Information, Management Fee Expense Equity Method Investment, Summarized Financial Information, Management Fee Expense Deposit Assets and Liabilities Deposit Contracts, Policy [Policy Text Block] Balance at December 31, 2019 (in dollars per share) Balance at September 30, 2020 (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Investments by Consolidated and Nonconsolidated Entities [Axis] Investments by Consolidated and Nonconsolidated Entities [Axis] Net Assets Net Assets, Fair Value Disclosure Net Assets, Fair Value Disclosure Other investments Other Investments Gains on restructuring of debt Gains (Losses) on Restructuring of Debt Repurchase of Class A ordinary shares Payments for Repurchase of Common Stock Assets Assets [Abstract] Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Accounting Policies [Abstract] Accounting Policies [Abstract] Restricted Cash and Cash Equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Issue of Class A ordinary shares, net of forfeitures Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Reinsurance Assets Reinsurance Accounting Policy [Policy Text Block] 2023 Long-Term Debt, Maturity, Year Three Service Agreement Service Agreement [Member] Service Agreement [Member] Retained earnings (deficit) Retained Earnings (Accumulated Deficit) Operating lease, ROU asset Operating Lease, Right-of-Use Asset Reinsurance balances receivable, allowance Provision for uncollectible losses recoverable Reinsurance Recoverable, Allowance for Credit Loss Entity Address, Country Entity Address, Country Unamortized discount Debt Instrument, Unamortized Discount 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Non-controlling interest contribution into (withdrawal from) related party joint venture, net Payments to Acquire Interest in Joint Venture Common Class B Common Class B [Member] Options outstanding (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Deferred acquisition costs Increase (Decrease) in Deferred Policy Acquisition Costs New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Preferred share capital (par value $0.10; authorized, 50,000,000; none issued) Preferred Stock, Value, Issued Taxation Income Tax, Policy [Policy Text Block] Contributions to related party investment fund Payments to Acquire Equity Method Investments Ordinary share capital, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Non-cash transfer of investments (Note 3) Transfer From Assets Transfer From Assets Unearned premium reserves Unearned Premiums Investment management fee rate - annual Related Party Transaction, Annual Management Fee Percentage The annual rate charged by investment advisor calculated as a percentage of assets under management Effect of dilutive employee and director share-based awards (in shares) Incremental Common Shares Attributable To Dilutive Effect Of Share-based Payment Arrangements, Employees And Directors Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements, Employees and Directors Share-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Document Information [Table] Document Information [Table] Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents U.S. and Caribbean North America [Member] Net investment income Investment Income The net income earned from investments in securities and other investments including derivatives. It includes dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It also includes realized and unrealized gains and losses on all investments. Lender Name [Axis] Lender Name [Axis] Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Geographical [Domain] Geographical [Domain] Board of Directors Chairman Board of Directors Chairman [Member] Performance compensation full rate Related Party Transaction, Performance Compensation Full Rate As Percentage Of Investment Income The full rate of performance compensation as a percent of investment income charged by a related party. Statement [Line Items] Statement [Line Items] Equity method investments, fair value Equity Method Investments, Fair Value Disclosure Forecast Forecast [Member] Class of Stock [Domain] Class of Stock [Domain] Net change in unrealized appreciation (depreciation) Unrealized Gain (Loss) on Investments Reinsurance balances receivable (net of allowance for expected credit losses of $89) Premiums and Other Receivables, Net Accrued interest Interest Payable, Current Vested number of shares (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Statement [Table] Statement [Table] RETROCESSION Reinsurance [Text Block] Credit Facility [Axis] Credit Facility [Axis] Worldwide Worldwide [Member] Worldwide Fair value of debt Debt Instrument, Fair Value Disclosure Preferred share capital, issued (in shares) Preferred Stock, Shares Issued Schedule of Weighted Average Number of Shares Schedule of Weighted Average Number of Shares [Table Text Block] Net realized (gains) losses on investments Realized Gains Losses On Sale Of Investments And Derivatives The net realized gains (losses) on investments and derivatives sold during the period. Net balance at January 1 Net balance at September 30 Liability for Unpaid Claims and Claims Adjustment Expense, Net Entity Small Business Entity Small Business Other income (expense), net Other Operating Income (Expense), Net Health Accident & Health Health Insurance Product Line [Member] Operating lease obligations Lessee, Operating Lease, Liability, Payment, Due [Abstract] Investment accounted for under the equity method Equity Method Investments [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Interest and dividends receivable Interest And Dividends Receivable, Fair Value Disclosure Interest And Dividends Receivable, Fair Value Disclosure Unamortized debt issuance expense Unamortized Debt Issuance Expense SENIOR CONVERTIBLE NOTES Debt Disclosure [Text Block] Total Investment income Interest and Dividend Income, Operating Amendment Flag Amendment Flag Weighted average number of ordinary shares used in the determination of earnings and loss per share Weighted Average Number of Shares Outstanding, Diluted [Abstract] Number of shares authorized for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Thereafter Lessee Operating Lease Liability Payments Due After Year Four Lessee Operating Lease Liability Payments Due After Year Four Realized and change in unrealized gains (losses) Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment [Abstract] Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment Number of shares available for grant (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Due to brokers Payables To Broker-Dealers, Fair Value Disclosure Payables To Broker-Dealers, Fair Value Disclosure Summarized Financial Information of Investment Equity Method Investments [Table Text Block] Number of restricted shares forfeited (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Prior years Prior years adjustment increase (decrease) Prior Year Claims and Claims Adjustment Expense Entity Central Index Key Entity Central Index Key Related Party [Domain] Related Party [Domain] Related Party Transaction [Line Items] Related Party Transaction [Line Items] General Liability General Liability [Member] Senior Notes Senior Notes [Member] Total expenses Benefits, Losses and Expenses Geographical [Axis] Geographical [Axis] SUBSEQUENT EVENTS Subsequent Events [Text Block] Thereafter Long Term Debt Maturity After Year Four Long Term Debt Maturity After Year Four Cost not yet recognized Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] 2023 Contractual Obligation, to be Paid, Year Three Ceded Credit Risk [Line Items] Ceded Credit Risk [Line Items] 2024 Long-Term Debt, Maturity, Year Four Income (loss) before income tax Income (Loss) Attributable to Parent, before Tax Letters of Credit Facilities Schedule of Line of Credit Facilities [Table Text Block] Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Income Statement Location [Axis] Income Statement Location [Axis] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Income Statement Location [Domain] Income Statement Location [Domain] 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Line of Credit Facility [Table] Line of Credit Facility [Table] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three Workers' Compensation Workers' Compensation Insurance Product Line [Member] Workers' compensation line of business of insurance coverage INVESTMENT IN RELATED PARTY INVESTMENT FUND Equity Method Investments and Joint Ventures Disclosure [Text Block] Loss and loss adjustment expense reserves Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve Other liabilities Other Liabilities SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Total assets Assets RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Gross premiums by geographical area as a percentage of total gross premiums Gross premiums by geographical area as a percentage of total gross premiums Gross written premiums by geographical area as a percentage of total gross written premiums Scenario [Axis] Scenario [Axis] Balance at December 31, 2019 (in shares) Balance at September 30, 2020 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Title of 12(b) Security Title of 12(b) Security LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] Collateral held in trust Collateral Held In Trust Cash and securities posted as collateral by the retrocessionaire in a trust account for the benefit of the ceding reinsurer. Weighted average grant date fair value, granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Citibank Europe plc Citibank Europe plc [Member] Citibank Europe plc Depreciation expense Depreciation, Nonproduction Subsequent Event Type [Axis] Subsequent Event Type [Axis] Convertible senior notes payable Convertible Notes Payable Antidilutive Securities [Axis] Antidilutive Securities [Axis] Chief Executive Officer Chief Executive Officer [Member] Unrated Unrated [Member] No rating assigned by any external rating agencies. Less: Losses recoverable Loss and loss adjustment expenses recoverable Reinsurance Recoverables, Including Reinsurance Premium Paid 2021 Contractual Obligation, to be Paid, Year One Interest expense Interest Interest Expense Schedule of Commitments and Contingencies, Fiscal Year Maturity Schedule Contractual Obligation, Fiscal Year Maturity [Table Text Block] Product and Service [Axis] Insurance Product Line [Axis] Product and Service [Axis] Total liabilities Liabilities Contract termination prior notice period Related Party Transactions, Contract Termination Prior Notice Period Related Party Transactions, Contract Termination Prior Notice Period Investment Type [Axis] Investment Type [Axis] Period of recognition Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 2022 Long-Term Debt, Maturity, Year Two Dividend income (net of withholding taxes) Dividend Income, Operating Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Stock by Class Schedule of Stock by Class [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Financing Receivable, Allowance for Credit Loss [Roll Forward] Financing Receivable, Allowance for Credit Loss [Roll Forward] Receivable collection amount Proceeds from Collection of Loans Receivable Number of non-vested restricted  shares Number of non-vested RSUs Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Notes receivable, allowance Balance at beginning of period Balance at end of period Financing Receivable, Allowance for Credit Loss Debt Instrument [Axis] Debt Instrument [Axis] Deposit interest income/(expense), net Interest Income (Expense), Net Additional paid-in capital Additional Paid-in Capital [Member] Other assets Other Assets Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Class of Stock [Line Items] Class of Stock [Line Items] Reinsurance balances payable Increase (Decrease) in Reinsurance Payables Derivative contracts, at fair value Derivative Liability Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Ordinary share capital, outstanding (in shares) Balance – beginning of period (in shares) Balance – end of period (in shares) Common Stock, Shares, Outstanding Total paid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Other Specialty Insurance, Other [Member] Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member] Subsequent Event Subsequent Event [Member] Deposit contracts, assets Deposit Contracts, Assets Exercise price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Amount of letters of credit issued Letters of Credit Outstanding, Amount Ordinary share capital, authorized (in shares) Common Stock, Shares Authorized Reinsurance balances receivable Increase (Decrease) in Premiums Receivable Gross Premiums Written by Geographic Area of Risks Insured Revenue from External Customers by Geographic Areas [Table Text Block] Professional fees and other Professional Fees And Other Noninterest Expense Professional Fees And Other Noninterest Expense Number of credit facilities Number Of Credit Facilities Number Of Credit Facilities Debt instrument, amount authorized for repurchase (up to) Debt Instrument, Amount Authorized For Repurchase Debt Instrument, Amount Authorized For Repurchase Gross Premiums Written by Line of Business Schedule of Segment Reporting Information, by Segment [Table Text Block] Other investments, adjustment Other Investments, Adjustment Other Investments, Adjustment Other Investments Investment Holdings, Other than Securities [Table Text Block] Interest income Interest Income, Operating Change in due to related party investment fund Increase (Decrease) in Due to Related Parties Gross premiums written, percent Premiums Written, Gross As Percentage Of Total Gross Premiums Written Gross written premiums by line of business as a percentage of total gross written premiums Income Statement [Abstract] Income Statement [Abstract] Total Property Property Insurance [Member] Loss and loss expenses recovered and recoverable Policyholder Benefits and Claims Incurred, Assumed and Ceded Secured Ceded Credit Risk, Secured [Member] Accrued interest Interest Receivable Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Use of Estimates Use of Estimates, Policy [Policy Text Block] Total incurred Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Loss and loss adjustment expense reserves Liability for Claims and Claims Adjustment Expense, Property Casualty Liability Line of credit facility increase accrued interest Line of Credit Facility, Increase, Accrued Interest Investments, at fair value Investments, Fair Value Disclosure Dividends Dividends Professional Liability Professional Malpractice Liability Insurance [Member] Notes receivable collected (issued) Increase (Decrease) in Notes Receivables Preferred share capital, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share 2021 Long-Term Debt, Maturity, Year One Personal Property and Casualty, Personal Insurance [Member] Net realized gain (loss) Realized Investment Gains (Losses) Scenario [Domain] Scenario [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Legal Entity [Axis] Legal Entity [Axis] City Area Code City Area Code Document Period End Date Document Period End Date Credit Rating Source [Domain] Credit Rating, AM Best [Domain] Loss (income) from investment accounted for under the equity method Income (loss) from equity method investments Income (Loss) from Equity Method Investments Acquisition costs Deferred Policy Acquisition Costs, Amortization Expense Commercial Property and Casualty, Commercial Insurance [Member] Term of contract Lessee, Operating Lease, Term of Contract Total Other Total Specialty [Domain] Total of all Specialty lines insurance products types [Domain] Deposit interest income Deposit Contract Liabilities Net Investment Income Allocation Accrued Deposit Contract Liabilities Net Investment Income Allocation Accrued Amortization and interest expense, net of change in accruals Amortization And Interest Expense Net Amortization And Interest Expense Net Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Share-based compensation expense Share-based Payment Arrangement, Noncash Expense Repurchase of Class A ordinary shares Stock Repurchased During Period, Value 2020 Long-Term Debt, Maturity, Remainder of Fiscal Year Entity [Domain] Entity [Domain] Incurred losses related to: Incurred Losses Related To [Abstract] Incurred Losses Related To [Abstract] Shares issued (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Cover [Abstract] Cover [Abstract] Shares forfeited Shares Granted, Value, Share-based Payment Arrangement, Forfeited Collateral Assets Investment Management Agreement Collateral Assets Investement Management Agreement [Member] Collateral Assets Investement Management Agreement [Member] Repurchase of ordinary shares (in shares) Repurchase of ordinary shares (in shares) Stock Repurchased and Retired During Period, Shares Case reserves Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Stock repurchase program, remaining number of shares to be repurchased (in shares) Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased Total Long-term Debt Affiliated Entity Affiliated Entity [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Total investments Investments SILP Limited Partnership Agreement [Member] Limited Partnership Agreement between SILP and its partners Total Casualty Liability and Casualty Insurance Product Line [Member] Total casualty line of business for insurance operations Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Investment portfolio percent of shareholders equity maximum Related Party Transactions, Investment Portfolio Percent Of Shareholders Equity Maximum Related Party Transactions, Investment Portfolio Percent Of Shareholders Equity Maximum Equity Components [Axis] Equity Components [Axis] Thereafter Contractual Obligation Due After Year Four Contractual Obligation Due After Year Four Ceded Credit Risk, Collateralization [Axis] Ceded Credit Risk, Collateralization [Axis] Participating securities excluded from calculation of loss per share  Employee and Director Restricted Shares Restricted Stock [Member] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Net premiums written Premiums Written, Net Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Unrecognized cost Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Europe Europe [Member] Funds withheld Funds Held under Reinsurance Agreements, Liability Ceded premiums earned Ceded Premiums Earned Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Class of Financing Receivable [Domain] Class of Financing Receivable [Domain] Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Entity Interactive Data Current Entity Interactive Data Current Restrictions on Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Revenues Revenues [Abstract] Cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] SHARE CAPITAL Stockholders' Equity Note Disclosure [Text Block] Liability for Claims and Claims Adjustment Expense [Line Items] Liability for Claims and Claims Adjustment Expense [Line Items] Current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Net change in unrealized gains and losses on investments and notes receivable Change In Unrealized Gains Losses On Investments And Derivatives The net increase (decrease) in fair value of unsold investments and derivatives not held for hedging whose gains and losses are included in net income. Equity method investment, ownership percentage Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Cumulative Effect Period Of Adoption Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Entity Registrant Name Entity Registrant Name Subsequent Event Type [Domain] Subsequent Event Type [Domain] Notes Receivable Loans and Leases Receivable, Nonaccrual Loan and Lease Status, Policy [Policy Text Block] Greenlight Capital Re Limited Partners Greenlight Capital Re Limited Partners [Member] Greenlight Capital Re Limited Partners [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Assets Assets, Fair Value Disclosure [Abstract] Other liabilities Increase (Decrease) in Other Operating Liabilities Management fee Management fee Management Fee Expense Net investment income (loss) Net Investment Income Performance compensation reduced rate Related Party Transaction, Performance Compensation Reduced Rate As Percentage of Investment Income The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision. Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Investments Investments [Abstract] Total Lessee, Operating Lease, Liability, to be Paid AM Best, A- Rating AM Best, A- Rating [Member] SILP SILP [Member] SILP [Member] Solasglas Investments, LP Deferred acquisition costs Deferred Policy Acquisition Cost Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Purchases of investments Payments to Acquire Trading Securities Held-for-investment Entity Address, Postal Zip Code Entity Address, Postal Zip Code Other Liabilities Other Liabilities [Policy Text Block] Description of items aggregated and included under Other Liabilities on the balance sheet. Document Transition Report Document Transition Report Title of Individual [Axis] Title of Individual [Axis] General Partner General Partner [Member] Convertible debt, amount Debt Instrument, Face Amount Funds withheld Increase (Decrease) in Funds Held under Reinsurance Agreements Prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years Document Quarterly Report Document Quarterly Report Liabilities Liabilities, Fair Value Disclosure [Abstract] Investment income Interest and Dividend Income, Operating [Abstract] General and Administrative Expense General and Administrative Expense [Member] Equity [Abstract] Total assets Assets, Fair Value Disclosure Notice period required for termination Line Of Credit Facility, Termination Notice Period Termination notice period for LOC facilities Accounting Standards Update 2016-13 Accounting Standards Update 2016-13 [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Charge offs Provision for Loan, Lease, and Other Losses Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible List] Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2020 Revision of Prior Period, Accounting Standards Update, Adjustment [Member] Cumulative Effect, Period Of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] 2020 Contractual Obligation, to be Paid, Remainder of Fiscal Year Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47) Add: Losses recoverable Reinsurance Recoverable for Unpaid Claims and Claims Adjustments Credit Facility [Domain] Credit Facility [Domain] Debt conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Diluted (in shares) Weighted average shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Basic (in dollars per share) Earnings Per Share, Basic Number of operating segments Number of Operating Segments Entity File Number Entity File Number Shares forfeited (in shares) Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Disclosure [Abstract] Debt Disclosure [Abstract] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Net loss and loss adjustment expenses incurred Policyholder Benefits and Claims Incurred, Net Stock based compensation expense Share-based Payment Arrangement, Expense Multi-line Multi-line [Member] Multi-line [Member] Number of shares authorized for issuance period increase (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized, Period Increase (Decrease) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized, Period Increase (Decrease) Investments by Consolidated and Nonconsolidated Entities [Domain] Investments by Consolidated and Nonconsolidated Entities [Domain] Counterparty Name [Axis] Counterparty Name [Axis] Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 29,113,702 (2019: 30,739,395): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2019: 6,254,715)) Common Stock, Value, Issued Credit Rating Source [Axis] Credit Rating, AM Best [Axis] Document Fiscal Year Focus Document Fiscal Year Focus Gross premiums ceded Ceded Premiums Written Loss and loss adjustment expenses recoverable Increase (Decrease) in Reinsurance Recoverable Entity Current Reporting Status Entity Current Reporting Status Related Party Transaction [Axis] Related Party Transaction [Axis] Subsequent Event [Table] Subsequent Event [Table] Earnings (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Fair value (in dollars per share) Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Method Investment, Nonconsolidated Investee [Domain] Equity Method Investment, Nonconsolidated Investee [Domain] Cost Other Investments, Cost Other Investments, Cost Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Ordinary share capital, issued (in shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Gross Premiums Written by Geographic Area of Risks Insured [Table] Revenue from External Customers by Products and Services [Table] Private investments and unlisted equities Private and unlisted equity securities [Member] Private equities and unlisted equity securities Operating lease, liability Operating Lease, Liability Segment Reporting [Abstract] Segment Reporting [Abstract] 2024 Contractual Obligation, to be Paid, Year Four GRIL Greenlight Reinsurance Ireland, DAC [Member] Greenlight Reinsurance Ireland, DAC Due from brokers Due From Brokers, Fair Value Disclosure Due From Brokers, Fair Value Disclosure Asia Asia [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Total shareholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Deposit contracts, liabilities Deposit Contracts, Liabilities Total liabilities and equity Liabilities and Equity Entity Address, City or Town Entity Address, City or Town Net increase (decrease) in allowance Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease) RSUs Restricted Stock Units (RSUs) [Member] Operating lease expense Operating Lease, Cost General and administrative expenses General and Administrative Expense Notes receivable (net of allowance for expected credit losses of $1,000) Note Financing Receivable, after Allowance for Credit Loss Other Assets Other Assets [Policy Text Block] Description of immaterial items aggregated and included under the Other Assets line item on the balance sheet. Type of Adoption [Domain] Accounting Standards Update [Domain] Fair value / carrying value Other Investments, Fair Value Disclosure Other Investments, Fair Value Disclosure Anti-dilutive stock options outstanding (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Short term lease cost Short-term Lease, Cost Solasglas Investment LP (SILP) Solasglas Investment LP (SILP) [Member] Solasglas Investment LP (SILP) [Member] Equity Component [Domain] Equity Component [Domain] Insurance Loss Reserves [Abstract] Insurance Loss Reserves [Abstract] Equity Method Investment, Nonconsolidated Investee [Axis] Equity Method Investment, Nonconsolidated Investee [Axis] Unearned premiums ceded Increase (Decrease) in Prepaid Reinsurance Premiums Liabilities Liabilities [Abstract] Automatic agreement extension, term Related Party Transactions, Automatic Agreement Extension, Term Related Party Transactions, Automatic Agreement Extension, Term Ceded Credit Risk [Table] Ceded Credit Risk [Table] Conversion ratio (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio Liabilities and partners’ capital Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract] Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract] SHARE-BASED COMPENSATION Share-based Payment Arrangement [Text Block] Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Net change in Increase (Decrease) in Operating Capital [Abstract] 2020 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Convertible debt, carrying amount of equity component Debt Instrument, Convertible, Carrying Amount of Equity Component Total future obligations by year Contractual Obligation, Fiscal Year Maturity [Abstract] Pro Forma Pro Forma [Member] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Expenses Benefits, Losses and Expenses [Abstract] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Expenses Operating Expenses [Abstract] Earnings (loss) per share Earnings Per Share [Abstract] Shareholders' equity Stockholders' Equity Attributable to Parent [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Interest and dividends payable Interest And Dividends Payable, Fair Value Disclosure Interest And Dividends Payable, Fair Value Disclosure Total equity securities, restricted cash, and cash and cash equivalents fair value pledged as security against the letters of credit Pledged Financial Instruments, Not Separately Reported, Securities for Letter of Credit Facilities Paid losses related to: Paid Losses Related To [Abstract] Paid Losses Related To [Abstract] Equity Method Investment, Nonconsolidated Investee or Group of Investees Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member] Supplementary information Supplemental Cash Flow Information [Abstract] Facility Financial Standby Letter of Credit [Member] Entity Filer Category Entity Filer Category Ordinary share capital Common Stock [Member] Insurance Product Line [Domain] Product and Service [Domain] Investment Advisory Agreement Investment Advisory Agreement [Member] Investment Advisory Agreement [Member] Proceeds from redemptions from related party investment fund Proceeds from Equity Method Investment, Distribution, Return of Capital Convertible Debt Convertible Debt [Member] Issue of ordinary shares, net of forfeitures (in shares) Stock Issued During Period, Shares, New Issues Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Ownership percentage Related Party Transaction, Investment Owned, Percentage Related Party Transaction, Investment Owned, Percentage Total expenses Interest And Noninterest Expenses Interest And Noninterest Expenses Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Revision of Prior Period [Domain] Revision of Prior Period [Domain] Debt interest rate Debt Instrument, Interest Rate, Stated Percentage Current expected credit losses recognized on notes receivable and reinsurance assets Accounts Receivable, Credit Loss Expense (Reversal) Common Class A Common Class A [Member] Performance compensation reduced rate as a percentage of investment income Related Party Transaction, Performance Compensation Reduced Rate as a Percentage of Investment Income The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision. Loss carry forward recoupment required Related Party Transaction, Loss Carry Forward Recoupment Required As Percentage Of Aggregate Investment Loss Earned The additional amount of investment income required after a period of investment loss, in order for the performance compensation rate to return from reduced rate to full rate. Number of stock options exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Related Party Transactions [Abstract] Related Party Transactions [Abstract] Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Promissory Note [Member] Promissory Note [Member] Promissory Note Anti-dilutive stock options outstanding Employee and Director Stock Options Share-based Payment Arrangement, Option [Member] IBNR Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount Basic (in shares) Weighted average shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Gross premiums written Gross premiums written Assumed Premiums Written Unearned premium reserves Increase (Decrease) in Unearned Premiums Investment in related party investment fund GLRE Limited Partners’ share of Net Assets Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Subsequent Events [Abstract] Motor Liability Motor Vehicle Liability Casualty Product Line [Member] Motor liability line of business for insurance operations Document Information [Line Items] Document Information [Line Items] Asset redemption notice to general partner Related Party Transaction, Asset Redemption Notice To General Partner Related Party Transaction, Asset Redemption Notice To General Partner Senior Unsecured Convertible Notes Senior Unsecured Convertible Notes [Member] Senior Unsecured Convertible Notes [Member] Motor Motor Vehicle Physical Damage Product Line [Member] Motor physical damage line of business for insurance operations Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Interest paid in cash Interest Paid, Excluding Capitalized Interest, Operating Activities Interest and convertible note payable Long-term Debt, Fiscal Year Maturity [Abstract] ORGANIZATION AND BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Non-cash addition of right-of-use asset Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Additional paid-in capital Additional Paid in Capital Total revenues Revenues Current year Current Year Claims and Claims Adjustment Expense Foreign exchange (gains) losses on investments Foreign Currency Transaction Gain (Loss), before Tax Class of Stock [Axis] Class of Stock [Axis] Income tax (expense) benefit Income Tax Expense (Benefit) Income tax paid in cash Income Taxes Paid, Net Cash, cash equivalents and restricted cash at beginning of the period (see Note 2) Cash, cash equivalents and restricted cash at end of the period (see Note 2) Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents New Accounting Pronouncements or Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Title of Individual [Domain] Title of Individual [Domain] Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure 2022 Contractual Obligation, to be Paid, Year Two Diluted (in dollars per share) Earnings Per Share, Diluted Local Phone Number Local Phone Number Cumulative Effect, Period Of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Deposit interest expense Deposit Contract Liabilities Net Investment Expense Allocation Accrued Deposit Contract Liabilities Net Investment Expense Allocation Accrued Entity Address, Address Line One Entity Address, Address Line One Other liabilities Other Liabilities, Fair Value Disclosure Entity Address, Address Line Two Entity Address, Address Line Two Related Party Transaction [Domain] Related Party Transaction [Domain] Other assets, excluding depreciation Increase (Decrease) in Other Operating Assets Entity Emerging Growth Company Entity Emerging Growth Company Maximum Facility Limit Line of Credit Facility, Maximum Borrowing Capacity Award Type [Axis] Award Type [Axis] Weighted  average grant date fair value Weighted  average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Change in net unearned premium reserves (Increase) Decrease in Unearned Premiums, Net Marine Marine Casualty Insurance [Member] Marine Casualty Insurance [Member] Class of Financing Receivable [Axis] Class of Financing Receivable [Axis] Unrealized gains Other Investments, Accumulated Gross Unrealized Holding Gain Other Investments, Accumulated Gross Unrealized Holding Gain Fair value of options vested in period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Recognized interest expense Amortization of Debt Issuance Costs Preferred share capital, authorized (in shares) Preferred Stock, Shares Authorized Net gain (loss) on investment transactions Gain (Loss) on Investments Retained earnings (deficit) Retained Earnings [Member] Net loss reserve on prior contracts increase (decrease) Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease) Schedule of Interest Income and Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Weighted average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Loss and loss adjustment expenses recoverable, allowance Accounts Receivable, Allowance for Credit Loss Green Bricks Partners Inc (GRBK) Green Bricks Partners Inc (GRBK) [Member] Green Bricks Partners Inc (GRBK) [Member] Award Type [Domain] Award Type [Domain] Investments [Domain] Investments [Domain] Financing Receivable, Allowance for Credit Loss Financing Receivable, Allowance for Credit Loss [Table Text Block] Trading Symbol Trading Symbol Income (loss) from investment in related party investment fund [net of related party expenses of $703 and $1,981, (three and nine months ended September 30, 2019: $1,325 and $9,888, respectively)] Loss (income) from investments in related party investment fund GLRE Limited Partners’ share of net income (loss) GLRE Limited Partners’ share of net income (loss) Revenue from Related Parties Unsecured Ceded Credit Risk, Unsecured [Member] Foreign currency revaluation Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Currency Translation Gain (Loss) Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Liability for Unpaid Claims and Claims Adjustment Expense Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] FINANCIAL INSTRUMENTS Financial Instruments Disclosure [Text Block] Financial Financial Guarantee Insurance and Surety Product Line [Member] Specialized insurance coverage relating to financial risks such as surety (surety bonds) and trade credit. Investments sold short, at fair value Investment Sold Note Yet Purchased, Fair Value Disclosure Investment Sold Note Yet Purchased, Fair Value Disclosure Entity Shell Company Entity Shell Company Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Unearned premiums ceded Prepaid Reinsurance Premiums Net premiums earned Premiums Earned, Net Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] EX-101.PRE 10 glre-20200930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 glre-20200930_htm.xml IDEA: XBRL DOCUMENT 0001385613 2020-01-01 2020-09-30 0001385613 us-gaap:CommonClassAMember 2020-10-30 0001385613 us-gaap:CommonClassBMember 2020-10-30 0001385613 2020-09-30 0001385613 2019-12-31 0001385613 us-gaap:CommonClassAMember 2020-09-30 0001385613 us-gaap:CommonClassAMember 2019-12-31 0001385613 us-gaap:CommonClassBMember 2019-12-31 0001385613 us-gaap:CommonClassBMember 2020-09-30 0001385613 2020-07-01 2020-09-30 0001385613 2019-07-01 2019-09-30 0001385613 2019-01-01 2019-09-30 0001385613 us-gaap:CommonStockMember 2020-06-30 0001385613 us-gaap:CommonStockMember 2019-06-30 0001385613 us-gaap:CommonStockMember 2019-12-31 0001385613 us-gaap:CommonStockMember 2018-12-31 0001385613 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001385613 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001385613 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001385613 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001385613 us-gaap:CommonStockMember 2020-09-30 0001385613 us-gaap:CommonStockMember 2019-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001385613 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001385613 us-gaap:RetainedEarningsMember 2020-06-30 0001385613 us-gaap:RetainedEarningsMember 2019-06-30 0001385613 us-gaap:RetainedEarningsMember 2019-12-31 0001385613 us-gaap:RetainedEarningsMember 2018-12-31 0001385613 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0001385613 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001385613 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001385613 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001385613 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001385613 us-gaap:RetainedEarningsMember 2020-09-30 0001385613 us-gaap:RetainedEarningsMember 2019-09-30 0001385613 2019-09-30 0001385613 2018-12-31 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-09-30 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0001385613 us-gaap:EmployeeStockOptionMember 2020-07-01 2020-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0001385613 us-gaap:RestrictedStockMember 2020-07-01 2020-09-30 0001385613 us-gaap:RestrictedStockMember 2019-07-01 2019-09-30 0001385613 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001385613 us-gaap:RestrictedStockMember 2019-01-01 2019-09-30 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2019-12-31 0001385613 glre:SILPMember glre:GreenlightCapitalReLimitedPartnersMember 2020-08-05 0001385613 glre:SILPMember glre:GreenlightCapitalReLimitedPartnersMember 2020-09-30 0001385613 glre:SILPMember glre:GreenlightCapitalReLimitedPartnersMember 2019-12-31 0001385613 us-gaap:GeneralPartnerMember 2020-09-30 0001385613 us-gaap:GeneralPartnerMember 2019-12-31 0001385613 glre:LimitedPartnershipAgreementMember 2020-01-01 2020-09-30 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentLPSILPMember 2020-09-30 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentLPSILPMember 2019-12-31 0001385613 glre:SolasglasInvestmentLPSILPMember 2020-07-01 2020-09-30 0001385613 glre:SolasglasInvestmentLPSILPMember 2019-07-01 2019-09-30 0001385613 glre:SolasglasInvestmentLPSILPMember 2020-01-01 2020-09-30 0001385613 glre:SolasglasInvestmentLPSILPMember 2019-01-01 2019-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2020-09-30 0001385613 us-gaap:EquityMethodInvestmentsMember 2020-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2019-12-31 0001385613 us-gaap:EquityMethodInvestmentsMember 2019-12-31 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2020-07-01 2020-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2020-01-01 2020-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2019-07-01 2019-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2019-01-01 2019-09-30 0001385613 glre:AccuRiskHoldingsLLCMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2020-09-30 2020-09-30 0001385613 glre:AccuRiskHoldingsLLCMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2019-12-31 2019-12-31 0001385613 glre:AccuRiskHoldingsLLCMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2020-01-01 2020-09-30 0001385613 glre:AccuRiskHoldingsLLCMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2020-07-01 2020-09-30 0001385613 glre:AccuRiskHoldingsLLCMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2019-07-01 2019-09-30 0001385613 glre:AccuRiskHoldingsLLCMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2019-01-01 2019-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2019-12-31 0001385613 us-gaap:HealthInsuranceProductLineMember 2018-12-31 0001385613 us-gaap:HealthInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2019-01-01 2019-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2020-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2019-09-30 0001385613 glre:UnratedMember us-gaap:CededCreditRiskUnsecuredMember 2020-09-30 0001385613 glre:UnratedMember us-gaap:CededCreditRiskUnsecuredMember 2019-12-31 0001385613 glre:UnratedMember us-gaap:CededCreditRiskSecuredMember 2020-09-30 0001385613 glre:UnratedMember us-gaap:CededCreditRiskSecuredMember 2019-12-31 0001385613 srt:AMBestAMinusRatingMember 2020-09-30 0001385613 srt:AMBestAMinusRatingMember 2019-12-31 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2018-08-07 0001385613 srt:ProFormaMember glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2020-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2020-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2019-12-31 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2020-07-01 2020-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2020-01-01 2020-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2019-07-01 2019-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2019-01-01 2019-09-30 0001385613 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2020-10-29 2020-10-29 0001385613 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2020-10-28 0001385613 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2020-10-29 0001385613 us-gaap:CommonClassAMember 2020-03-26 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2020-03-26 0001385613 us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001385613 us-gaap:CommonClassAMember 2019-01-01 2019-09-30 0001385613 us-gaap:CommonClassAMember 2018-12-31 0001385613 us-gaap:CommonClassBMember 2018-12-31 0001385613 us-gaap:CommonClassBMember 2020-01-01 2020-09-30 0001385613 us-gaap:CommonClassBMember 2019-01-01 2019-09-30 0001385613 us-gaap:CommonClassAMember 2019-09-30 0001385613 us-gaap:CommonClassBMember 2019-09-30 0001385613 us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001385613 us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2019-01-01 2019-09-30 0001385613 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2019-01-01 2019-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2019-01-01 2019-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2020-07-30 2020-07-30 0001385613 us-gaap:RestrictedStockMember 2019-01-01 2019-09-30 0001385613 us-gaap:RestrictedStockMember 2020-09-30 0001385613 us-gaap:RestrictedStockMember 2019-12-31 0001385613 us-gaap:RestrictedStockMember 2020-09-30 2020-09-30 0001385613 us-gaap:RestrictedStockMember 2019-12-31 2019-12-31 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2020-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2019-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2019-12-31 0001385613 us-gaap:EmployeeStockOptionMember 2020-09-30 2020-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2019-12-31 2019-12-31 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonClassAMember 2020-01-01 2020-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2020-09-30 0001385613 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001385613 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-09-30 0001385613 glre:LimitedPartnershipAgreementMember srt:BoardOfDirectorsChairmanMember 2018-08-31 2018-08-31 0001385613 glre:InvestmentAdvisoryAgreementMember srt:BoardOfDirectorsChairmanMember 2018-09-01 2018-09-01 0001385613 glre:GreenBricksPartnersIncGRBKMember srt:AffiliatedEntityMember 2020-09-30 0001385613 glre:ServiceAgreementMember srt:BoardOfDirectorsChairmanMember 2020-01-01 2020-09-30 0001385613 glre:CollateralAssetsInvestementManagementAgreementMember srt:BoardOfDirectorsChairmanMember 2019-01-01 2019-01-01 0001385613 us-gaap:FinancialStandbyLetterOfCreditMember glre:CitibankEuropePlcMember 2020-09-30 0001385613 us-gaap:FinancialStandbyLetterOfCreditMember glre:CitibankEuropePlcMember 2020-01-01 2020-09-30 0001385613 2020-08-25 0001385613 2020-08-26 0001385613 glre:GreenlightReinsuranceIrelandDACMember 2020-01-01 2020-09-30 0001385613 us-gaap:ConvertibleDebtMember 2020-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2019-07-01 2019-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2019-01-01 2019-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2020-07-01 2020-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2019-07-01 2019-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2020-01-01 2020-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2019-01-01 2019-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2019-07-01 2019-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2019-01-01 2019-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2019-07-01 2019-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2019-01-01 2019-09-30 0001385613 us-gaap:GeneralLiabilityMember 2020-07-01 2020-09-30 0001385613 us-gaap:GeneralLiabilityMember 2019-07-01 2019-09-30 0001385613 us-gaap:GeneralLiabilityMember 2020-01-01 2020-09-30 0001385613 us-gaap:GeneralLiabilityMember 2019-01-01 2019-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2020-07-01 2020-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2019-07-01 2019-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2020-01-01 2020-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2019-01-01 2019-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2020-07-01 2020-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2019-07-01 2019-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2020-01-01 2020-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2019-01-01 2019-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2019-07-01 2019-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2019-01-01 2019-09-30 0001385613 glre:MultilineMember 2020-07-01 2020-09-30 0001385613 glre:MultilineMember 2019-07-01 2019-09-30 0001385613 glre:MultilineMember 2020-01-01 2020-09-30 0001385613 glre:MultilineMember 2019-01-01 2019-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2019-07-01 2019-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2019-01-01 2019-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2019-07-01 2019-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2020-07-01 2020-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2019-07-01 2019-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2020-01-01 2020-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2019-01-01 2019-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2020-07-01 2020-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2019-07-01 2019-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2020-01-01 2020-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2019-01-01 2019-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2020-07-01 2020-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2019-07-01 2019-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2020-01-01 2020-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2019-01-01 2019-09-30 0001385613 glre:TotalSpecialtyDomain 2020-07-01 2020-09-30 0001385613 glre:TotalSpecialtyDomain 2019-07-01 2019-09-30 0001385613 glre:TotalSpecialtyDomain 2020-01-01 2020-09-30 0001385613 glre:TotalSpecialtyDomain 2019-01-01 2019-09-30 0001385613 srt:NorthAmericaMember 2020-07-01 2020-09-30 0001385613 srt:NorthAmericaMember 2019-07-01 2019-09-30 0001385613 srt:NorthAmericaMember 2020-01-01 2020-09-30 0001385613 srt:NorthAmericaMember 2019-01-01 2019-09-30 0001385613 glre:WorldwideMember 2020-07-01 2020-09-30 0001385613 glre:WorldwideMember 2019-07-01 2019-09-30 0001385613 glre:WorldwideMember 2020-01-01 2020-09-30 0001385613 glre:WorldwideMember 2019-01-01 2019-09-30 0001385613 srt:EuropeMember 2020-07-01 2020-09-30 0001385613 srt:EuropeMember 2019-07-01 2019-09-30 0001385613 srt:EuropeMember 2020-01-01 2020-09-30 0001385613 srt:EuropeMember 2019-01-01 2019-09-30 0001385613 srt:AsiaMember 2020-07-01 2020-09-30 0001385613 srt:AsiaMember 2019-07-01 2019-09-30 0001385613 srt:AsiaMember 2020-01-01 2020-09-30 0001385613 srt:AsiaMember 2019-01-01 2019-09-30 0001385613 glre:PromissoryNoteMember 2020-09-30 0001385613 glre:PromissoryNoteMember us-gaap:SubsequentEventMember 2020-10-01 2020-11-04 0001385613 srt:ScenarioForecastMember glre:PromissoryNoteMember 2020-10-01 2020-12-31 shares iso4217:USD iso4217:USD shares pure glre:facility iso4217:EUR glre:segment 0001385613 --12-31 2020 Q3 false us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member P3D 0 0 0 0 10-Q true 2020-09-30 false 001-33493 GREENLIGHT CAPITAL RE, LTD. E9 65 Market Street Suite 1207, Jasmine Court Camana Bay KY KY1-1205 345 943-4573 Class A Ordinary Shares GLRE NASDAQ Yes Yes Accelerated Filer false false false 28933957 6254715 184956000 240056000 22241000 16384000 207197000 256440000 8159000 25813000 723107000 742093000 89000 264227000 230384000 47000 47000 19949000 27531000 51696000 49665000 0 901000 1000000 18461000 20202000 3264000 2164000 1296060000 1355193000 481770000 470588000 203855000 179460000 80364000 122665000 5232000 4958000 3756000 6825000 94216000 93514000 869193000 878010000 0.10 0.10 50000000 50000000 0 0 0 0 0.10 0.10 100000000 100000000 29113702 29113702 30739395 30739395 0.10 0.10 25000000 25000000 6254715 6254715 6254715 6254715 3537000 3699000 492429000 503547000 -69099000 -30063000 426867000 477183000 1296060000 1355193000 135596000 110607000 362072000 425507000 1464000 4035000 2274000 48577000 134132000 106572000 359798000 376930000 -18613000 22582000 -24844000 -1973000 115519000 129154000 334954000 374957000 703000 1981000 1325000 9888000 6431000 6609000 -34086000 51770000 466000 3312000 11237000 9265000 1569000 -887000 2570000 1299000 123985000 138188000 314675000 437291000 88053000 92962000 252944000 294303000 27018000 30962000 76660000 89660000 5152000 7725000 18095000 22484000 1579000 1578000 4702000 4684000 121802000 133227000 352401000 411131000 2183000 4961000 -37726000 26160000 0 -179000 424000 -200000 2183000 5140000 -38150000 26360000 0.06 0.14 -1.07 0.72 0.06 0.14 -1.07 0.72 35677554 36841623 35569292 36646515 35779703 36921490 35569292 36720550 3627000 3679000 3699000 3638000 -19000 20000 25000 61000 71000 187000 3537000 3699000 3537000 3699000 497559000 501916000 503547000 499726000 4828000 12484000 -302000 645000 1366000 2835000 492429000 502561000 492429000 502561000 -71282000 -4857000 -30063000 -26077000 -886000 2183000 5140000 -38150000 26360000 -69099000 283000 -69099000 283000 426867000 506543000 426867000 506543000 -38150000 26360000 -34086000 51770000 870000 267000 19153000 14362000 -15000000 -14150000 -232000 160000 250000 0 1391000 2896000 -702000 -751000 21000 21000 33932000 -26981000 -7535000 -2170000 2031000 678000 -901000 -17242000 1121000 561000 11182000 -3227000 24395000 -15211000 -42301000 -9259000 -274000 6465000 -3069000 2709000 -44658000 -8680000 69108000 107162000 48094000 11306000 944000 4702000 0 -9642000 -741000 1016000 0 1278000 20811000 79218000 12671000 0 -12671000 0 -122000 237000 -36640000 70775000 767906000 703231000 731266000 774006000 4000000 3933000 0 0 0 36673000 0 323000 ORGANIZATION AND BASIS OF PRESENTATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s principal wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Law, 2010 and underlying regulations thereto (the “Law”) and is subject to regulation by the Cayman Islands Monetary Authority, in terms of the Law. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America.  As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE”.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2019. In the opinion of management, these unaudited condensed consolidated financial statements reflect all of the normal recurring adjustments considered necessary for a fair presentation of the Company’s financial position and results of operations as of the dates and for the periods presented. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global pandemic related to the novel coronavirus (the “COVID-19 pandemic”) is expected to have a significant adverse impact on the property and casualty insurance and reinsurance industry. </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has included in the loss and loss adjustment reserves, its best estimate of losses arising from the COVID-19 pandemic. However, there remains considerable uncertainty relating to the</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ultimate losses, which will depend on the extent and duration of economic contraction, particularly in the United States. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, significant estimates used in the preparation of the Company’s consolidated financial statements including those associated with premiums, expected credit losses on amounts owed to us and the estimations of loss and loss adjustment expense reserves may be subject to significant adjustments in future periods.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results for the nine months ended September 30, 2020 are not necessarily indicative of the results expected for the full calendar year.</span></div> SIGNIFICANT ACCOUNTING POLICIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, the Company adopted ASU No. 2016-13, Financial Instruments - Credit Losses (“ASU 2016-13”) which requires an entity to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. ASU 2016-13 was effective for public business entities for annual and interim periods beginning after December 15, 2019. The financial assets included in the captions “Reinsurance balances receivable,” “Loss and loss adjustment expenses recoverable” (collectively, “Reinsurance Assets”) and “Notes receivable,” in the Company’s condensed consolidated balance sheets are carried at amortized cost and therefore affected by ASU 2016-13. Other than the changes relating to the adoption of ASU 2016-13, there have been no changes to the Company’s significant accounting policies as described in its Annual Report on Form 10-K for the year ended December 31, 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of income and expenses during the period. Actual results could differ from these estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash and Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 11). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,813 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723,107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,266 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,906 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model that considers both the Company’s collectibility history on its reinsurance assets as well as representative external loss history. The external loss history that the Company uses includes a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties is also considered as the probability of default is calculated over the contractual length of the reinsurance contracts. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The Company manages its credit risk in its reinsurance assets by transacting with insurers and reinsurers that it considers financially sound. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its retrocessionaire counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts and/or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations or unearned premiums against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of retrocessionaires to honor their respective obligations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEyNGNmMGNiYTAwODRlYzhhZjYzYWVjZTVhYjFkNjQ2L3NlYzoxMjRjZjBjYmEwMDg0ZWM4YWY2M2FlY2U1YWIxZDY0Nl8zNC9mcmFnOmYwYjZmYWU4OTVhOTRiMTQ4YzdhMTNmNTYzMDMxYmZiL3RleHRyZWdpb246ZjBiNmZhZTg5NWE5NGIxNDhjN2ExM2Y1NjMwMzFiZmJfNDM5ODA0NjUyNTY0MA_6469235d-20bd-4c90-85f2-4e4c06915abd">ASU 2016-13</span>, the Company recorded an allowance for expected credit loss on its Reinsurance Assets of $0.1 million with an offset to retained earnings. At September 30, 2020, the allowance for expected credit losses was $0.1 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes Receivable</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes receivable represent promissory notes receivable from third parties. These notes are recorded at cost plus accrued interest, if any, net of valuation allowance for expected credit losses. Interest income, changes in the allowance for expected credit losses and unrealized and realized gains or losses on the notes receivable are included in the caption “Net investment income (loss)” in the Company’s condensed consolidated statements of operations. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for expected credit losses is calculated using a PD / LGD model that takes into account the Company’s experience as well as representative external loss history. The expected loss percentage is calculated as the product of the PD and LGD for each period over the life of a note. The Company evaluates the financial condition of the notes receivable counterparties and monitors its exposure on a regular basis. At September 30, 2020, the Company considers the notes receivable balance to be collectible and has not experienced any default on payments since inception of these notes. The notes receivable originated between 2015 and 2018.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and December 31, 2019, $0.1 million and $0.1 million, respectively, of accrued interest was included in the caption “Notes receivable” in the Company’s condensed consolidated balance sheets. When there is uncertainty as to the collection of interest contractually due, the Company places the note on non-accrual status. For notes receivable placed on non-accrual status, the notes are presented excluding any accrued interest amount. The Company resumes the accrual of interest on a note when none of the principal or interest remains past due, and the Company expects to collect the remaining contractual principal and interest. Interest collected on notes that are placed on non-accrual status is recorded as interest income when collected, provided that the recorded value of the note is deemed to be fully collectible. Where doubt exists as to the collectibility of the remaining recorded value of the notes placed on non-accrual status, the Company immediately reverses any previous accrued interest through interest income and any payments received are applied to reduce the recorded value of the notes. The allowance for expected credit losses for notes receivable is calculated on the amortized cost excluding accrued interest and interest written off due to non-accrual status.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charge offs of notes receivable are recorded when all or a portion of the financial asset is deemed uncollectible. Full or partial charge offs are recorded as reductions to the amortized cost and deducted from the allowance in the period in which the note receivable is deemed uncollectible. In instances where the Company collects cash that it has previously charged off, the recovery will be recognized through earnings or as a reduction of the amortized cost for interest and principal, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a roll-forward of the Company’s allowance for credit losses on notes receivable:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.245%"><tr><td style="width:1.0%"/><td style="width:68.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.782%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,012 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect of adoption of ASU 2016-13 at January 1, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,012 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deposit Assets and Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, an asset or liability is recognized based on the consideration paid or received. The deposit asset or liability balance is subsequently adjusted using the interest method with a corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company’s deposit assets and liabilities are recorded in the Company’s condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At September 30, 2020, deposit assets and deposit liabilities were $5.3 million and $35.2 million, respectively (December 31, 2019: $5.2 million and $56.9 million, respectively). For the three and nine months ended September 30, 2020 and 2019, the interest income/(expense) on deposit accounted contracts was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income/(expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables and deferred tax assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Liabilities</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities consist primarily of accruals for legal and other professional fees, employee bonuses and lease liabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (Loss) Per Share</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.4pt">Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting; </span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:80%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:21.4pt">additional potential common shares issuable when stock options are exercised, determined using the treasury stock method; and </span></div><div style="margin-bottom:3pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:80%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:21.4pt">those common shares with the potential to be issued by virtue of convertible debt and other such convertible instruments, determined using the treasury stock method. </span></div><div style="padding-left:63pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. In the event of a net loss, all RSUs, stock options outstanding, convertible debt and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the shares outstanding for the purposes of the calculation of earnings (loss) per share for the three and nine months ended September 30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.081%"><tr><td style="width:1.0%"/><td style="width:41.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,677,554 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,841,623 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,569,292 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,646,515 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive employee and director share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,035 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,779,703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,921,490 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,569,292 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,720,550 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock options outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participating securities excluded from calculation of loss per share </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878,498 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Taxation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2019: 21%). Verdant’s tax years 2014 and beyond remain open and subject to examination by the IRS.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income, and 25% on its non-trading income.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions that are subject to significant uncertainty that is reasonably likely to have a material impact on the Company. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Adopted</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, the Company adopted ASU 2016-13 during the first quarter of 2020 using a modified retrospective transition method. The adoption resulted in a cumulative-effect adjustment to retained earnings of $0.9 million as of January 1, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). The amendments in ASU 2020-01 clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815, which could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 is not expected to have a material impact on the Company’s consolidated financial statements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity's own equity. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, embedded conversion features would not be presented separately in equity; rather, the contract would be accounted for as a single liability measured at its amortized cost. Subtopic 815-40 simplifies the analysis of whether an embedded conversion feature meets the derivative scope exception for contracts that are indexed to, and classified in, stockholders equity, as well as addresses the computation of earnings per share for convertible debt instruments. ASU 2020-06 requires the application of the if-converted method when calculating diluted earnings per share. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 using either a modified retrospective method of transition or a fully retrospective method of transition. Early adoption is permitted no earlier than for fiscal years beginning after December 15, 2020. The Company is currently evaluating the effect the new standard will have on its consolidated financial statements.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of income and expenses during the period. Actual results could differ from these estimates. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash and Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 11). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,813 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723,107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,266 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,906 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash and Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 11). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,159 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,813 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723,107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,266 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,906 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash and Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 11). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:</span></div> 8159000 25813000 723107000 742093000 731266000 767906000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model that considers both the Company’s collectibility history on its reinsurance assets as well as representative external loss history. The external loss history that the Company uses includes a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties is also considered as the probability of default is calculated over the contractual length of the reinsurance contracts. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The Company manages its credit risk in its reinsurance assets by transacting with insurers and reinsurers that it considers financially sound. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its retrocessionaire counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts and/or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations or unearned premiums against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of retrocessionaires to honor their respective obligations.</span></div> 100000 100000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes Receivable</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes receivable represent promissory notes receivable from third parties. These notes are recorded at cost plus accrued interest, if any, net of valuation allowance for expected credit losses. Interest income, changes in the allowance for expected credit losses and unrealized and realized gains or losses on the notes receivable are included in the caption “Net investment income (loss)” in the Company’s condensed consolidated statements of operations. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for expected credit losses is calculated using a PD / LGD model that takes into account the Company’s experience as well as representative external loss history. The expected loss percentage is calculated as the product of the PD and LGD for each period over the life of a note. The Company evaluates the financial condition of the notes receivable counterparties and monitors its exposure on a regular basis. At September 30, 2020, the Company considers the notes receivable balance to be collectible and has not experienced any default on payments since inception of these notes. The notes receivable originated between 2015 and 2018.</span></div>When there is uncertainty as to the collection of interest contractually due, the Company places the note on non-accrual status. For notes receivable placed on non-accrual status, the notes are presented excluding any accrued interest amount. The Company resumes the accrual of interest on a note when none of the principal or interest remains past due, and the Company expects to collect the remaining contractual principal and interest. Interest collected on notes that are placed on non-accrual status is recorded as interest income when collected, provided that the recorded value of the note is deemed to be fully collectible. Where doubt exists as to the collectibility of the remaining recorded value of the notes placed on non-accrual status, the Company immediately reverses any previous accrued interest through interest income and any payments received are applied to reduce the recorded value of the notes. The allowance for expected credit losses for notes receivable is calculated on the amortized cost excluding accrued interest and interest written off due to non-accrual status.Charge offs of notes receivable are recorded when all or a portion of the financial asset is deemed uncollectible. Full or partial charge offs are recorded as reductions to the amortized cost and deducted from the allowance in the period in which the note receivable is deemed uncollectible. In instances where the Company collects cash that it has previously charged off, the recovery will be recognized through earnings or as a reduction of the amortized cost for interest and principal, respectively. 100000 100000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a roll-forward of the Company’s allowance for credit losses on notes receivable:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.245%"><tr><td style="width:1.0%"/><td style="width:68.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.782%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,012 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect of adoption of ASU 2016-13 at January 1, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,012 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> 15000000 9012000 750000 0 15000000 0 250000 0 1000000 9012000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deposit Assets and Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, an asset or liability is recognized based on the consideration paid or received. The deposit asset or liability balance is subsequently adjusted using the interest method with a corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company’s deposit assets and liabilities are recorded in the Company’s condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. 5300000 35200000 5200000 56900000 For the three and nine months ended September 30, 2020 and 2019, the interest income/(expense) on deposit accounted contracts was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income/(expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,358 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 560000 1023000 1812000 2493000 0 656000 0 135000 560000 367000 1812000 2358000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables and deferred tax assets.</span></div> Other LiabilitiesOther liabilities consist primarily of accruals for legal and other professional fees, employee bonuses and lease liabilities. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (Loss) Per Share</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.4pt">Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting; </span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:80%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:21.4pt">additional potential common shares issuable when stock options are exercised, determined using the treasury stock method; and </span></div><div style="margin-bottom:3pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:80%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:21.4pt">those common shares with the potential to be issued by virtue of convertible debt and other such convertible instruments, determined using the treasury stock method. </span></div><div style="padding-left:63pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. In the event of a net loss, all RSUs, stock options outstanding, convertible debt and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the shares outstanding for the purposes of the calculation of earnings (loss) per share for the three and nine months ended September 30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.081%"><tr><td style="width:1.0%"/><td style="width:41.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.548%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,677,554 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,841,623 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,569,292 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,646,515 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive employee and director share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,867 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,035 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,779,703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,921,490 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,569,292 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,720,550 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock options outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875,627 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participating securities excluded from calculation of loss per share </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878,498 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 35677554 36841623 35569292 36646515 102149 79867 0 74035 35779703 36921490 35569292 36720550 835627 875627 835627 875627 0 0 878498 0 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Taxation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2019: 21%). Verdant’s tax years 2014 and beyond remain open and subject to examination by the IRS.</span></div>GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income, and 25% on its non-trading income.The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions that are subject to significant uncertainty that is reasonably likely to have a material impact on the Company. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Adopted</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, the Company adopted ASU 2016-13 during the first quarter of 2020 using a modified retrospective transition method. The adoption resulted in a cumulative-effect adjustment to retained earnings of $0.9 million as of January 1, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). The amendments in ASU 2020-01 clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815, which could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 is not expected to have a material impact on the Company’s consolidated financial statements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity's own equity. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, embedded conversion features would not be presented separately in equity; rather, the contract would be accounted for as a single liability measured at its amortized cost. Subtopic 815-40 simplifies the analysis of whether an embedded conversion feature meets the derivative scope exception for contracts that are indexed to, and classified in, stockholders equity, as well as addresses the computation of earnings per share for convertible debt instruments. ASU 2020-06 requires the application of the if-converted method when calculating diluted earnings per share. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 using either a modified retrospective method of transition or a fully retrospective method of transition. Early adoption is permitted no earlier than for fiscal years beginning after December 15, 2020. The Company is currently evaluating the effect the new standard will have on its consolidated financial statements.</span></div> 900000 INVESTMENT IN RELATED PARTY INVESTMENT FUND <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to January 2, 2019, the Company and its reinsurance subsidiaries were party to a joint venture agreement (the “venture agreement”) with DME Advisors, LP (“DME Advisors”) and DME Advisors LLC (“DME”) under which the Company, its reinsurance subsidiaries and DME were participants in a joint venture (the “Joint Venture”) for the purpose of managing certain jointly held assets. DME and DME Advisors are related to the Company and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2018, the Company entered into an amended and restated exempted limited partnership agreement (as amended by that certain letter agreement dated as of August 5, 2020, the “SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re and GRIL, (together the “GLRE Limited Partners”), and the initial limited partner (each, a “Partner”). The SILP LPA, in conjunction with a participation agreement, replaced the venture agreement and assigned and/or transferred Greenlight Re’s and GRIL’s invested assets in the Joint Venture to SILP. The Joint Venture was terminated on January 2, 2019 by which date all assets were transferred to SILP. On September </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1, 2018, SILP also entered into a SILP investment advisory agreement (“IAA”) with DME Advisors pursuant to which DME Advisors is the investment manager for SILP.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DME II holds an interest in excess of 10% of SILP’s net assets which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consequently, the Company has concluded that DME II’s interests, and not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company’s investment in SILP is presented in the Company’s condensed consolidated balance sheets in the caption “Investment in related party investment fund.” </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2019, SILP’s investment portfolio was de-risked in order to reduce the Company’s investment volatility in the near-term. As a result, a significant proportion of the Company’s investment assets in SILP was held in cash and short-term treasuries as of December 31, 2019. On August 5, 2020, the Company entered into an amended and restated letter agreement with DME Advisors and DME II whereby the deployed Investment Portfolio can not exceed an amount equal to 50% of the Company’s shareholders’ equity, as reported in the Company’s then most recent quarterly U.S. GAAP financial statements, adjusted monthly for investment gains and losses as reported by SILP during any intervening period.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. As of September 30, 2020, the net asset value of the GLRE Limited Partners’ investment in SILP was $185.0 million (December 31, 2019: $240.1 million), representing 81.0% (December 31, 2019: 81.0%) of SILP’s total net assets. The remaining 19.0% (December 31, 2019: 19.0%) of SILP’s total net assets was held by DME II. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEyNGNmMGNiYTAwODRlYzhhZjYzYWVjZTVhYjFkNjQ2L3NlYzoxMjRjZjBjYmEwMDg0ZWM4YWY2M2FlY2U1YWIxZDY0Nl80MC9mcmFnOmQxZTZiYThlNzMyMzQ5ZGZiYmExN2Q5NmNjYjlhYTVjL3RleHRyZWdpb246ZDFlNmJhOGU3MzIzNDlkZmJiYTE3ZDk2Y2NiOWFhNWNfMzUxOQ_fdb88048-0ae8-4730-86e8-63d16d7f2f6c">three</span> business days’ notice to DME II. As of September 30, 2020, the majority of SILP’s long investments are composed of cash and publicly-traded equity securities, which can be readily liquidated to meet GLRE Limited Partners’ redemption requests. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s share of the change in the net asset value of SILP for the three and nine months ended September 30, 2020 was $6.4 million and $(34.1) million, respectively, (three and nine months ended September 30, 2019: $6.6 million and $51.8 million, respectively), and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations. The change in the net asset value of SILP for the nine months ended September 30, 2020 was primarily driven by the impact of changes in fair value primarily attributable to the disruptions in global financial markets associated with the COVID–19 pandemic.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized financial statements of SILP are presented below. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Assets and Liabilities of Solasglas Investments, LP</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,097 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from brokers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,916 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,405 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and partners’ capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments sold short, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,834)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,962)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to brokers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,563)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,997)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">228,353</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296,408</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">184,956</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,056</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Operations of Solasglas Investments, LP</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"><tr><td style="width:1.0%"/><td style="width:34.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income (net of withholding taxes)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,235)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,009)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,042)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,875)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,084)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,318)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,881)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Realized and change in unrealized gains (losses) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,989 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,708 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on investment transactions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,420 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,085 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,161)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,697 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,974</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41,570)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,816</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of net income (loss) (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,431</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,609</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(34,086)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51,770</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net of management fees and accrued performance allocation as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:35.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.209%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,234 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance allocation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,654 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.50 185000000.0 240100000 0.810 0.810 0.190 0.190 6400000 -34100000 6600000 51800000 The summarized financial statements of SILP are presented below. <div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Assets and Liabilities of Solasglas Investments, LP</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,116 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,097 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,324 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from brokers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,220 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,916 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,405 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and partners’ capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments sold short, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,834)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,962)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to brokers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,563)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,997)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">228,353</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296,408</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">184,956</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,056</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Operations of Solasglas Investments, LP</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"><tr><td style="width:1.0%"/><td style="width:34.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income (net of withholding taxes)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,235)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,009)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,042)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,875)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,084)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,318)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,881)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Realized and change in unrealized gains (losses) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,989 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,811 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,708 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on investment transactions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,420 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,085 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,161)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,697 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,974</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41,570)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,816</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of net income (loss) (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,431</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,609</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(34,086)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51,770</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net of management fees and accrued performance allocation as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:35.155%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.209%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,234 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance allocation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,654 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 220116000 162928000 3097000 6324000 130220000 68060000 2202000 111046000 281000 47000 355916000 348405000 116336000 47834000 10962000 2054000 0 1180000 32000 828000 233000 101000 127563000 51997000 228353000 296408000 184956000 240056000 170000 652000 1204000 2334000 36000 279000 262000 1869000 206000 931000 1466000 4203000 703000 653000 1981000 4235000 176000 89000 518000 2308000 213000 96000 612000 1532000 432000 204000 764000 1009000 1524000 1042000 3875000 9084000 -1318000 -111000 -2409000 -4881000 -1412000 14760000 -44972000 26989000 10832000 -5675000 5811000 45708000 9420000 9085000 -39161000 72697000 8102000 8974000 -41570000 67816000 6431000 6609000 -34086000 51770000 703000 652000 1981000 4234000 0 673000 0 5654000 FINANCIAL INSTRUMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“Other investments” include unlisted securities and investments accounted for under the equity method.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, the following securities were included in the caption “Other investments”:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.749%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,364 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,670 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment accounted for under the equity method </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,241 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2019, the following securities were included in the caption “Other investments”: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,420 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,681 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment accounted for under the equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,703 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,384 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private investments and unlisted equities include securities that do not have readily determinable fair values. The carrying values of these holdings are determined based on their original cost minus impairment, if any, plus or minus changes resulting from observable price changes. At September 30, 2020, the carrying value of private investments and unlisted equities was $15.7 million (December 31, 2019: $10.7 million), and incorporated upward adjustments of $0.0 million and $4.1 million during the three and nine months ended September 30, 2020, respectively (2019: $0.0 million and $0.2 million, respectively), excluding any unrealized gains or losses related to changes in foreign currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company’s investment accounted for under the equity method represents its investment in AccuRisk Holdings LLC (“AccuRisk”), a Chicago, Illinois-based managing general underwriter focused on employee and health insurance benefits. At September 30, 2020, the Company held a 58% (December 31, 2019: 58%) economic interest in AccuRisk and had provided a $6.0 million credit facility. In addition to providing capital and funding in support of AccuRisk’s expansion plans, the Company also provides reinsurance capacity for business produced by AccuRisk. The Company has determined that AccuRisk is a VIE, of which the Company is not the primary beneficiary. The Company’s carrying value represents its ownership share of AccuRisk’s net assets. The Company’s maximum exposure to loss relating to AccuRisk is limited to the carrying amount of its investment, plus the credit facility extended. For the three and nine months ended September 30, 2020, the Company’s share of AccuRisk’s net income was $0.1 million and $0.9 million, respectively (2019: $(0.2) million and $0.3 million, respectively), which was included in the caption “Net investment income” in the Company’s condensed consolidated statements of operations. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:31.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%"><tr><td style="width:1.0%"/><td style="width:2.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.318%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">•</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">•</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">•</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2020 and December 31, 2019, the Company did not carry any investments at fair value that were assigned a Level within the fair value hierarchy. The Company’s investment in the related party investment fund is measured at </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value using the net asset value practical expedient, and is therefore not classified within the fair value hierarchy. (See Note 3 for further details.)</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Disclosed, But Not Carried, at Fair Value</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The captions “Notes receivable (net of allowance for expected credit loss)” and “Convertible senior notes payable” represent financial instruments that are carried at amortized cost. The carrying values of the notes receivable (net of allowance for expected credit loss) approximate their fair values, which the Company has determined on the basis of Level 3 inputs. The fair value of the convertible senior notes payable is estimated based on the bid price observed in an inactive market for the identical instrument (Level 2 input) (see Note 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, the following securities were included in the caption “Other investments”:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.749%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,364 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,670 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment accounted for under the equity method </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,241 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2019, the following securities were included in the caption “Other investments”: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,420 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,681 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment accounted for under the equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,703 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,384 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 11364000 5373000 1067000 15670000 6571000 22241000 10420000 265000 4000 10681000 5703000 16384000 15700000 10700000 0.0 4100000 0.0 200000 0.58 0.58 6000000.0 100000 900000 -200000 300000 LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, the loss and loss adjustment expenses reserves included estimated amounts for several catastrophe events. For significant catastrophe events including, but not limited to, hurricanes, typhoons, floods, wildfires and pandemics, loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. To establish IBNR loss estimates, the Company makes use of, among other things, the following:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">estimates communicated by ceding companies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">industry data;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">information received from clients, brokers and loss adjusters;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">an understanding of the underlying business written and its exposures to catastrophe event related losses; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">catastrophe scenario modelling software; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">management’s judgement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The COVID-19 pandemic is unprecedented. Therefore, the Company does not have previous loss experience on which to base its estimates for loss and loss adjustment expenses related to the COVID-19 pandemic. The determination of the Company's estimate was based on:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">a review of in-force treaties that may provide coverage and incur losses;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">catastrophe and scenario modeling analyses and results shared by cedents;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">preliminary loss estimates received from clients and their analysts and loss adjusters; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">reviews of industry insured loss estimates and market share analyses; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">management’s judgement.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Significant assumptions on which the Company's estimates of reserves for the COVID-19 pandemic losses and loss adjustment expenses are based include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the scope of coverage provided by the underlying policies, particularly those that provide for business interruption coverage;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the regulatory, legislative or judicial actions and social impact that could influence contract interpretations across the insurance industry;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the extent of economic contraction caused by the COVID-19 pandemic, particularly in the United States; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">the ability of the cedents and insured to mitigate some or all of their losses.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While the Company believes its estimate of loss and loss adjustment expense reserves for the COVID-19 pandemic is adequate as of September 30, 2020 based on available information, actual losses may ultimately differ materially from the Company's current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information becomes available and will adjust its estimates accordingly. Such adjustments may be material to the Company's results of operations and financial condition. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no significant changes in the actuarial methodology or reserving process related to the Company’s loss and loss adjustment expense reserves for the nine months ended September 30, 2020. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and December 31, 2019, loss and loss adjustment expense reserves were composed of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,732 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,834 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IBNR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,038 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,754 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481,770 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,588 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the nine months ended September 30, 2020 and 2019 is as follows:  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,588 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,662 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,057 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438,957 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,385 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,944 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200,384)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294,206)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461,821 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,900 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,949 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481,770 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479,435 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2020 and 2019 are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,032 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,741)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,442)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,901)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,994 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,810 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,994 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,810 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020, the estimate of net losses incurred relating to prior accident years increased by $5.4 million, primarily in relation to certain general liability, health and multi-line contracts, partially offset by favorable loss development on professional liability contracts. The net financial impact of the prior year unfavorable loss development for the nine months ended September 30, 2020, taking into account earned reinstatement premiums assumed and ceded, adjustments to assumed and ceded acquisition costs and adjustments to deposit accounted contracts, was a loss of $4.8 million.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2019, the estimate of net losses incurred relating to prior accident years increased by $30.2 million that originated primarily from certain private passenger automobile contracts. These unanticipated automobile losses were the result of adverse court rulings that affected a significant number of loss events that occurred in Florida between 2015 and early 2018, including many claims that had previously been considered closed. The net financial impact of the prior year adverse loss development for the nine months ended September 30, 2019 was a loss of $27.7 million.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and December 31, 2019, loss and loss adjustment expense reserves were composed of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,732 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,834 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IBNR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,038 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,754 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481,770 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,588 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the nine months ended September 30, 2020 and 2019 is as follows:  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,588 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,662 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,057 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438,957 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,385 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,944 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200,384)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294,206)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461,821 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,900 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,949 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481,770 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479,435 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2020 and 2019 are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,502 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,032 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,209 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,741)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,442)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,901)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,994 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,810 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,994 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,810 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 224732000 217834000 257038000 252754000 481770000 470588000 470588000 482662000 27531000 43705000 443057000 438957000 247559000 264129000 5385000 30174000 252944000 294303000 72453000 93822000 161222000 200384000 233675000 294206000 -505000 -1154000 461821000 437900000 19949000 41535000 481770000 479435000 18063000 24502000 0 0 18063000 24502000 25032000 26013000 1341000 2196000 26373000 28209000 15115000 14741000 16327000 23160000 31442000 37901000 0 0 12994000 14810000 0 0 12994000 14810000 5400000 -4800000 30200000 -27700000 RETROCESSION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, from time to time, purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, to reduce its net liability on individual risks, to obtain additional underwriting capacity and to balance its underwriting portfolio. Loss and loss adjustment expenses recoverable from retrocessionaires are recorded as assets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2020, the Company’s earned ceded premiums were $1.7 million and $3.2 million, respectively (2019: $22.0 million and $65.8 million, respectively). For the three and nine months ended September 30, 2020, loss and loss adjustment expenses incurred of $88.1 million and $252.9 million, respectively (2019: $93.0 million and $294.3 million, respectively), reported on the condensed consolidated statements of operations are net of loss and loss expenses recovered and recoverable of $2.5 million and $6.2 million (2019: $13.9 million and $56.2 million).</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retrocession contracts do not relieve the Company from its obligations to the insureds. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At September 30, 2020, the Company’s loss reserves recoverable consisted of (i) $15.0 million (December 31, 2019: $21.2 million) from unrated retrocessionaires, of which $14.5 million (December 31, 2019: $20.0 million) were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $5.0 million (December 31, 2019: $6.4 million) from retrocessionaires rated A- or above by A.M. Best. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company regularly evaluates its net credit exposure to assess the ability of the retrocessionaires to honor their respective obligations. At September 30, 2020, the Company had recorded an allowance for expected credit losses of $0.1 million (December 31, 2019: nil).</span></div> 1700000 3200000 22000000.0 65800000 88100000 252900000 93000000.0 294300000 2500000 6200000 13900000 56200000 15000000.0 21200000 14500000 20000000.0 5000000.0 6400000 100000 0 SENIOR CONVERTIBLE NOTES <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”), which mature on August 1, 2023. The Notes bear interest at 4.0% payable semi-annually on February 1 and August 1 of each year beginning on February 1, 2019. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note holders have the option, under certain conditions, to redeem the Notes prior to maturity. </span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Notes are redeemed by the holder, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. The Company has therefore bifurcated the Notes into liability and equity components.</span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, the Company’s share price was lower than the conversion price of $17.19 per share. </span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%, which equated to an $8.2 million discount. As of September 30, 2020 and December 31, 2019, the unamortized debt discount was $4.7 million and $5.9 million, respectively, and is expected to be amortized through the maturity date. The debt discount also represents the portion of the Note’s principal amount allocated to the equity component. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred issuance costs in connection with the issuance of the Notes. As of September 30, 2020, the unamortized portion of these costs attributed to the debt component was $1.8 million (December 31, 2019: $2.3 million), which are expected to be amortized through the maturity date. The portion of these issuance costs attributed to the equity component was netted against the gross proceeds allocated to equity, resulting in $7.9 million being included in the caption “Additional paid-in capital” in the Company’s condensed consolidated balance sheets.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Notes as of September 30, 2020, including accrued interest of $0.7 million, was $94.2 million (December 31, 2019: $93.5 million). As of September 30, 2020, the fair value of the Notes was estimated to be $80.1 million (December 31, 2019: $94.9 million) (see Note 4 Financial Instruments).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2020, the Company recognized interest expense of $1.6 million and $4.7 million (2019: $1.6 million and $4.7 million) in connection with the interest coupon, amortization of issuance costs and amortization of the discount. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was in compliance with all covenants relating to the Notes as of September 30, 2020 and December 31, 2019.</span></div> 100000000.0 0.040 17.19 0.060 8200000 4700000 5900000 1800000 2300000 7900000 700000 94200000 93500000 80100000 94900000 1600000 4700000 1600000 4700000 SHARE CAPITAL<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2020, 293,939 (December 31, 2019: 555,805) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The stock incentive plan is administered by the Compensation Committee of the Board of Directors. On October 29, 2020, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board has adopted a share repurchase plan. The timing of such repurchases and actual number of shares repurchased will depend on a variety of factors including price, market conditions and applicable regulatory and corporate requirements. On March 26, 2020, the Board of Directors extended the share repurchase plan to June 30, 2021 and increased the number of shares authorized to be repurchased to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases or pursuant to one more tender offers. The Company is not required to repurchase any of the Class A ordinary shares or the Notes and the repurchase plans may be modified, suspended or terminated at the election of our Board of Directors at any time without prior notice. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2020, 1.9 million Class A ordinary shares were repurchased by the Company (2019: 0). As of September 30, 2020, 3.1 million Class A ordinary shares and $25.0 million of the Notes, remained available for repurchase under the repurchase plans. All Class A ordinary shares repurchased are canceled immediately upon repurchase.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of voting ordinary shares issued and outstanding:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.426%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,739,395 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,130,214 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issue of ordinary shares, net of forfeitures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,233 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,874,419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,113,702 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,538,447 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital includes the premium per share paid by the subscribing shareholders for Class A and B ordinary shares which have a par value of $0.10 each. It also includes the earned portion of the grant-date fair value of share-based awards that have not yet vested.</span></div> 293939 555805 3000000.0 5000000.0 8000000.0 5000000.0 25000000.0 0.0400 1900000 0 3100000 25000000.0 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of voting ordinary shares issued and outstanding:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.426%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,739,395 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,130,214 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issue of ordinary shares, net of forfeitures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,726 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,233 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,874,419)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,113,702 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,538,447 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 30739395 6254715 30130214 6254715 248726 0 408233 0 1874419 0 0 0 29113702 6254715 30538447 6254715 0.10 0.10 SHARE-BASED COMPENSATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a stock incentive plan for directors, employees and consultants that is administered by the Compensation Committee of the Board of Directors. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee and Director Restricted Shares</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020, 306,264 (2019: 235,701) Class A ordinary shares were issued to employees pursuant to the Company’s stock incentive plan. These shares contain certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment and transferability. The restricted shares cliff vest three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the nine months ended September 30, 2020, 145,089 (2019: 326,240) Class A ordinary shares were issued to the Company’s Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan. These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment and transferability. These restricted shares cliff vest 5 years after the date of issuance, subject to the performance condition being met and the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company. The weighted average grant date fair value of these restricted shares subject to performance conditions was $6.72 (2019: $10.84) per share. On July 30, 2020, the Company accelerated the vesting of a portion of the CEO’s restricted shares resulting in 72,545 shares vesting immediately. The remaining restricted shares are still subject to performance and service conditions. As the performance conditions associated with these restricted shares have not been met, no compensation cost was recognized relating to the unvested shares for the nine months ended September 30, 2020 and 2019.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020, 210,109 (2019: 27,386) restricted shares were forfeited by employees who left the Company and prior to the expiration of the applicable vesting periods. For the nine months ended September 30, 2020, $0.7 million stock compensation expense (2019: $0.2 million) relating to the forfeited restricted shares was reversed. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $0.6 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the nine months ended September 30, 2020 (2019: $2.0 million). As of September 30, 2020, there was $2.2 million (December 31, 2019: $2.7 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding CEO’s restricted shares with performance conditions) which are expected to be recognized over a weighted average period of 2.4 years (December 31, 2019: 1.6 years). For the nine months ended September 30, 2020, the total fair value of restricted shares vested was $2.8 million (2019: $3.1 million).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2020: </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>restricted<br/> shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873,087 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.83 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,353 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.72 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235,833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210,109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.90 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878,498 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.88 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee and Director Stock Options</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020, no Class A ordinary share purchase options were granted or exercised by directors or employees, while 40,000 (2019: 60,000) stock options expired and 80,000 (2019: 80,000) stock options vested. When stock options are granted, the Company reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total compensation cost expensed relating to stock options for the nine months ended September 30, 2020 was $0.5 million (2019: $0.7 million). At September 30, 2020, the total compensation cost related to non-vested options not yet recognized was $0.8 million (December 31, 2019: $1.3 million), which will be recognized over a weighted average period of 2.0 years (December 31, 2019: 2.4 years) assuming the grantee completes the service period for vesting of the options.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and December 31, 2019, there were 0.8 million and 0.9 million stock options outstanding, respectively, with a weighted average exercise price of $22.22 and $22.68 per share, respectively and weighted average grant date fair value of $10.25 and $10.25 per share, respectively. The weighted average remaining contractual term of the stock options was 5.3 years and 5.8 years, at September 30, 2020 and December 31, 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Restricted Stock Units</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issues RSUs to certain employees as part of the stock incentive plan. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability and other matters. Each RSU grant cliff vests three years after the date of issuance, subject to the grantee’s continued service with the Company. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan. For the nine months ended September 30, 2020, 60,622 (2019: 48,535) RSUs were issued to employees pursuant to the Company’s stock incentive plan. For the nine months ended September 30, 2020, no (2019: 24,165) RSUs were forfeited by employees who left the Company prior to the expiration of the applicable vesting periods.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $0.3 million of share-based compensation expense, net of forfeitures, relating to RSUs for the nine months ended September 30, 2020 (2019: $0.1 million). </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee RSU activity during the nine months ended September 30, 2020 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,582 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.76 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,622 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,482)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,722 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.60 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>For the nine months ended September 30, 2020 and 2019, the combined stock compensation expense (net of forfeitures), which was included in the caption “General and administrative expenses” in the Company’s statements of operations, was $1.4 million and $2.9 million, respectively. 306264 235701 P3Y 145089 326240 P5Y 6.72 10.84 72545 0 0 210109 27386 700000 200000 600000 2000000.0 2200000 2700000 P2Y4M24D P1Y7M6D 2800000 3100000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2020: </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>restricted<br/> shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873,087 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.83 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,353 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.72 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235,833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210,109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.90 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878,498 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.88 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee RSU activity during the nine months ended September 30, 2020 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,582 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.76 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,622 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,482)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,722 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.60 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 873087 12.83 451353 6.72 235833 13.83 210109 10.90 878498 9.88 0 0 40000 60000 80000 80000 500000 700000 800000 1300000 P2Y P2Y4M24D 800000 900000 22.22 22.68 10.25 10.25 P5Y3M18D P5Y9M18D P3Y 1 60622 48535 0 24165 300000 100000 63582 13.76 60622 6.72 7482 21.65 0 0 116722 9.60 1400000 2900000 RELATED PARTY TRANSACTIONS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Advisory Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DME, DME II and DME Advisors are related to the Company and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into the SILP LPA with DME II. DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL include the amount of losses that were to be recouped under the Joint Venture as well as any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry forward provision contained in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss, until all losses are recouped and an additional amount equal to 150% of the loss is earned. On February 26, 2019, effective as of September 1, 2018, the Company entered into Amendment No. 1 to the SILP LPA. The amendment was intended to revise the mechanics for calculating the Carryforward Account and Performance Allocation (as defined in the LPA) to take into account withdrawals from and subsequent recontributions of capital to SILP, consistent with the treatment under the Joint Venture. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio” as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023 subject to an automatic extension for successive three-year terms. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into a letter agreement with DME Advisors and DME II whereby during the period from June 1, 2019 to June 30, 2021, cash, cash equivalents and/or U.S government issued securities will not be subject to any management fee or performance allocation. For a detailed breakdown of management fees and performance compensation for the three and nine months ended September 30, 2020 and 2019, refer to Note 3 of the condensed consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II and DME Advisors for reasonable costs and expenses of investigating and/or defending such claims, provided such claims were not caused due to gross negligence, breach of contract or misrepresentation by DME, DME II or DME Advisors. There were no indemnification amounts incurred by the Company during any of the periods presented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Green Brick Partners, Inc.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly traded company. As of September 30, 2020, SILP, along with certain affiliates of DME Advisors, collectively owned 47.6% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may be limited at times in its ability to trade GRBK shares on behalf of SILP. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement is automatically renewed annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collateral Assets Investment Management Agreement</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.</span></div> 0.10 0.20 0.10 1.50 0.00125 0.015 P3Y 0.476 5000 P30D P30D COMMITMENTS AND CONTINGENCIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letters of Credit and Trusts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum Facility Limit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice period required for termination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank Europe plc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 20, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 days prior to termination date</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 26, 2020, the Company amended the credit facility to reduce the maximum facility limit from $400.0 million to $275.0 million. As of September 30, 2020, an aggregate amount of $133.0 million (December 31, 2019: $204.5 million) in letters of credit were issued under the credit facility. As of September 30, 2020, total cash and cash equivalents with a fair value in the aggregate of $135.6 million (December 31, 2019: $213.4 million) were pledged as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. The credit facility contains customary events of default and restrictive covenants, including but not limited to, limitations on liens on collateral, transactions with affiliates, mergers and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements, and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the covenants of the credit facility as of September 30, 2020 and December 31, 2019.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also established regulatory trust arrangements for certain cedents. As of September 30, 2020, collateral of $587.5 million (December 31, 2019: $528.7 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greenlight Re has entered into lease agreements for office space in the Cayman Islands that expires on December 31, 2020. The Company has determined that the current arrangement qualifies as a short term lease. The short-term lease expense for the three and nine months ended September 30, 2020 was $0.4 million (2019: $0.4 million).</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRIL has entered into a lease agreement for office space in Dublin, Ireland. Under the terms of this lease agreement, GRIL is committed to minimum annual rent payments denominated in Euros approximating €0.1 million until May 2021, and adjusted to the prevailing market rates for the subsequent five-year term. GRIL has the option to terminate the lease agreement in 2021. The Company has determined that this agreement qualifies as an operating lease under GAAP. As of September 30, 2020 the Company has recorded a right-of-use asset and a corresponding lease liability of $0.1 million (December 31, 2019: $0.2 million). The operating lease expense for the three and nine months ended September 30, 2020 and 2019 was insignificant. Included in the “Schedule of Commitments and Contingencies,” below, are the net minimum lease payment obligations relating to this lease as of September 30, 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule of Commitments and Contingencies</span></div><div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a schedule of future minimum payments required under the above commitments:  </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="39" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and convertible note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,236 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>From time to time in the normal course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or to collect funds owed to it. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition or operating results. <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.126%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum Facility Limit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice period required for termination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank Europe plc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 20, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 days prior to termination date</span></div></td></tr></table></div> 1 275000000 P120D 400000000.0 275000000.0 133000000.0 204500000 135600000 213400000 587500000 528700000 400000 400000 400000 400000 100000 P5Y 100000 100000 200000 200000 <div style="margin-bottom:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a schedule of future minimum payments required under the above commitments:  </span></div><div style="margin-bottom:6pt;text-indent:27pt"><span><br/></span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="39" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and convertible note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,236 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 171000 65000 0 0 0 0 236000 0 4000000 4000000 102000000 0 0 110000000 171000 4065000 4000000 102000000 0 0 110236000 SEGMENT REPORTING <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its business on the basis of one operating segment, Property &amp; Casualty Reinsurance. The following tables provide a breakdown of the Company’s gross premiums written by line of business and by geographic area of risks insured for the periods indicated: </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:72pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Gross Premiums Written by Line of Business</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.304%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,091 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,632 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Property</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,178 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,087 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,888 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,347 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,729 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Liability </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,077 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,908 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-line </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,778 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,104 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,135 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,114 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accident &amp; Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,704 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Specialty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,074 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,640 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,046 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #99ccff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,596 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,607 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,072 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,507 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Gross Premiums Written by Geographic Area of Risks Insured</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.857%"><tr><td style="width:1.0%"/><td style="width:21.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.317%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.317%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.608%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and Caribbean</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,798 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,811 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,511 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide (1) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,596 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,607 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,072 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,507 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 1 The following tables provide a breakdown of the Company’s gross premiums written by line of business and by geographic area of risks insured for the periods indicated: <div style="padding-left:72pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Gross Premiums Written by Line of Business</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.304%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,091 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,807 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,632 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Property</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,178 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,087 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,888 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,347 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,729 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Liability </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,979 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,077 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,908 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-line </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,082 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,173 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,778 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,104 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,135 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,114 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accident &amp; Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,704 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Specialty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,607 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,074 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,493 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,640 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,046 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #99ccff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,596 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,607 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,072 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,507 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 3396000 0.025 5088000 0.046 9426000 0.026 11752000 0.028 10091000 0.074 11367000 0.103 25136000 0.069 50807000 0.119 3691000 0.027 3632000 0.033 10326000 0.029 9788000 0.023 17178000 0.126 20087000 0.182 44888000 0.124 72347000 0.170 3224000 0.024 913000 0.008 3920000 0.011 2368000 0.006 41679000 0.307 47021000 0.425 96729000 0.267 197335000 0.464 76000 0.001 11000 0 199000 0.001 117000 0 21979000 0.162 14077000 0.127 60908000 0.168 35121000 0.083 25820000 0.190 15082000 0.136 67379000 0.186 61173000 0.144 92778000 0.684 77104000 0.696 229135000 0.633 296114000 0.697 12418000 0.093 7527000 0.068 40522000 0.112 31065000 0.072 1817000 0.013 315000 0.003 15704000 0.043 15394000 0.036 127000 0.001 -33000 0 749000 0.002 94000 0 11278000 0.083 5607000 0.051 31074000 0.086 10493000 0.025 25640000 0.190 13416000 0.122 88049000 0.243 57046000 0.133 135596000 1.000 110607000 1.000 362072000 1.000 425507000 1.000 Gross Premiums Written by Geographic Area of Risks Insured<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.857%"><tr><td style="width:1.0%"/><td style="width:21.867%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.317%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.317%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.175%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.513%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.608%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and Caribbean</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,798 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,811 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,511 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide (1) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,596 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,607 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,072 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,507 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table>(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 110798000 0.817 89811000 0.812 291511000 0.805 358099000 0.841 22738000 0.168 18450000 0.167 66150000 0.183 64590000 0.152 0 0 0 0 0 0 -13000 0 2060000 0.015 2346000 0.021 4411000 0.012 2831000 0.007 135596000 1.000 110607000 1.000 362072000 1.000 425507000 1.000 SUBSEQUENT EVENTSSubsequent to September 30, 2020, the Company agreed to settle a promissory note that had been entered into with a reinsurance counterparty. The Company’s amortized cost associated with the promissory note at September 30, 2020 was $13.3 million, which was included in the caption “Notes receivable (net of allowance for expected credit loss).” In connection with this settlement, the Company received $19.1 million, resulting in a gain of $5.8 million that will be recognized in the fourth quarter of 2020. 13300000 19100000 5800000 XML 12 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover Page - shares
 9 Months Ended
Sep. 30, 2020
Oct. 30, 2020
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2020  
Document Transition Report false  
Entity File Number 001-33493  
Entity Registrant Name GREENLIGHT CAPITAL RE, LTD.  
Entity Incorporation, State or Country Code E9  
Entity Address, Address Line One 65 Market Street  
Entity Address, Address Line Two Suite 1207, Jasmine Court  
Entity Address, City or Town Camana Bay  
Entity Address, Country KY  
Entity Address, Postal Zip Code KY1-1205  
City Area Code 345  
Local Phone Number 943-4573  
Title of 12(b) Security Class A Ordinary Shares  
Trading Symbol GLRE  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001385613  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Common Class A    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   28,933,957
Common Class B    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   6,254,715
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Investments    
Investment in related party investment fund $ 184,956 $ 240,056
Other investments 22,241 16,384
Total investments 207,197 256,440
Cash and cash equivalents 8,159 25,813
Restricted cash and cash equivalents 723,107 742,093
Reinsurance balances receivable (net of allowance for expected credit losses of $89) 264,227 230,384
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47) 19,949 27,531
Deferred acquisition costs 51,696 49,665
Unearned premiums ceded 0 901
Notes receivable (net of allowance for expected credit losses of $1,000) 18,461 20,202
Other assets 3,264 2,164
Total assets 1,296,060 1,355,193
Liabilities    
Loss and loss adjustment expense reserves 481,770 470,588
Unearned premium reserves 203,855 179,460
Reinsurance balances payable 80,364 122,665
Funds withheld 5,232 4,958
Other liabilities 3,756 6,825
Convertible senior notes payable 94,216 93,514
Total liabilities 869,193 878,010
Shareholders' equity    
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued) 0 0
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 29,113,702 (2019: 30,739,395): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2019: 6,254,715)) 3,537 3,699
Additional paid-in capital 492,429 503,547
Retained earnings (deficit) (69,099) (30,063)
Total shareholders' equity 426,867 477,183
Total liabilities and equity $ 1,296,060 $ 1,355,193
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Reinsurance balances receivable, allowance $ 89,000 $ 0
Loss and loss adjustment expenses recoverable, allowance 47,000 47,000
Notes receivable, allowance $ 1,000,000 $ 15,000,000
Preferred share capital, par value (in dollars per share) $ 0.10 $ 0.10
Preferred share capital, authorized (in shares) 50,000,000 50,000,000
Preferred share capital, issued (in shares) 0 0
Common Class A    
Ordinary share capital, par value (in dollars per share) $ 0.10 $ 0.10
Ordinary share capital, authorized (in shares) 100,000,000 100,000,000
Ordinary share capital, issued (in shares) 29,113,702 30,739,395
Ordinary share capital, outstanding (in shares) 29,113,702 30,739,395
Common Class B    
Ordinary share capital, par value (in dollars per share) $ 0.10 $ 0.10
Ordinary share capital, authorized (in shares) 25,000,000 25,000,000
Ordinary share capital, issued (in shares) 6,254,715 6,254,715
Ordinary share capital, outstanding (in shares) 6,254,715 6,254,715
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues        
Gross premiums written $ 135,596 $ 110,607 $ 362,072 $ 425,507
Gross premiums ceded (1,464) (4,035) (2,274) (48,577)
Net premiums written 134,132 106,572 359,798 376,930
Change in net unearned premium reserves (18,613) 22,582 (24,844) (1,973)
Net premiums earned 115,519 129,154 334,954 374,957
Income (loss) from investment in related party investment fund [net of related party expenses of $703 and $1,981, (three and nine months ended September 30, 2019: $1,325 and $9,888, respectively)] 6,431 6,609 (34,086) 51,770
Net investment income 466 3,312 11,237 9,265
Other income (expense), net 1,569 (887) 2,570 1,299
Total revenues 123,985 138,188 314,675 437,291
Expenses        
Net loss and loss adjustment expenses incurred 88,053 92,962 252,944 294,303
Acquisition costs 27,018 30,962 76,660 89,660
General and administrative expenses 5,152 7,725 18,095 22,484
Interest expense 1,579 1,578 4,702 4,684
Total expenses 121,802 133,227 352,401 411,131
Income (loss) before income tax 2,183 4,961 (37,726) 26,160
Income tax (expense) benefit 0 179 (424) 200
Net income (loss) $ 2,183 $ 5,140 $ (38,150) $ 26,360
Earnings (loss) per share        
Basic (in dollars per share) $ 0.06 $ 0.14 $ (1.07) $ 0.72
Diluted (in dollars per share) $ 0.06 $ 0.14 $ (1.07) $ 0.72
Weighted average number of ordinary shares used in the determination of earnings and loss per share        
Basic (in shares) 35,677,554 36,841,623 35,569,292 36,646,515
Diluted (in shares) 35,779,703 36,921,490 35,569,292 36,720,550
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Management fee $ 703 $ 1,981 $ 1,325 $ 9,888
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Ordinary share capital
Additional paid-in capital
Retained earnings (deficit)
Retained earnings (deficit)
Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2020
Beginning balance at Dec. 31, 2018   $ 3,638 $ 499,726 $ (26,077)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issue of Class A ordinary shares, net of forfeitures   61      
Share-based compensation expense     2,835    
Net income (loss) $ 26,360     26,360  
Ending balance at Sep. 30, 2019 506,543 3,699 502,561 283  
Beginning balance at Jun. 30, 2019   3,679 501,916 (4,857)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issue of Class A ordinary shares, net of forfeitures   20      
Share-based compensation expense     645    
Net income (loss) 5,140     5,140  
Ending balance at Sep. 30, 2019 506,543 3,699 502,561 283  
Beginning balance at Dec. 31, 2019 477,183 3,699 503,547 (30,063) $ (886)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issue of Class A ordinary shares, net of forfeitures   25      
Repurchase of Class A ordinary shares   (187) (12,484)    
Share-based compensation expense     1,366    
Net income (loss) (38,150)     (38,150)  
Ending balance at Sep. 30, 2020 $ 426,867 3,537 492,429 (69,099)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member        
Beginning balance at Jun. 30, 2020   3,627 497,559 (71,282)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issue of Class A ordinary shares, net of forfeitures   (19)      
Repurchase of Class A ordinary shares   (71) (4,828)    
Share-based compensation expense     (302)    
Net income (loss) $ 2,183     2,183  
Ending balance at Sep. 30, 2020 $ 426,867 $ 3,537 $ 492,429 $ (69,099)  
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash provided by (used in) operating activities    
Net income (loss) $ (38,150) $ 26,360
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities    
Loss (income) from investments in related party investment fund 34,086 (51,770)
Loss (income) from investment accounted for under the equity method (870) (267)
Net change in unrealized gains and losses on investments and notes receivable (19,153) (14,362)
Net realized (gains) losses on investments 15,000 14,150
Foreign exchange (gains) losses on investments 232 (160)
Current expected credit losses recognized on notes receivable and reinsurance assets 250 0
Share-based compensation expense 1,391 2,896
Amortization and interest expense, net of change in accruals 702 751
Depreciation expense 21 21
Net change in    
Reinsurance balances receivable (33,932) 26,981
Loss and loss adjustment expenses recoverable 7,535 2,170
Deferred acquisition costs (2,031) (678)
Unearned premiums ceded 901 17,242
Other assets, excluding depreciation (1,121) (561)
Loss and loss adjustment expense reserves 11,182 (3,227)
Unearned premium reserves 24,395 (15,211)
Reinsurance balances payable (42,301) (9,259)
Funds withheld 274 (6,465)
Other liabilities (3,069) 2,709
Net cash provided by (used in) operating activities (44,658) (8,680)
Investing activities    
Proceeds from redemptions from related party investment fund 69,108 107,162
Contributions to related party investment fund (48,094) (11,306)
Purchases of investments (944) (4,702)
Change in due to related party investment fund 0 (9,642)
Notes receivable collected (issued) 741 (1,016)
Non-controlling interest contribution into (withdrawal from) related party joint venture, net 0 (1,278)
Net cash provided by (used in) investing activities 20,811 79,218
Financing activities    
Repurchase of Class A ordinary shares (12,671) 0
Net cash provided by (used in) financing activities (12,671) 0
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash (122) 237
Net increase (decrease) in cash, cash equivalents and restricted cash (36,640) 70,775
Cash, cash equivalents and restricted cash at beginning of the period (see Note 2) 767,906 703,231
Cash, cash equivalents and restricted cash at end of the period (see Note 2) 731,266 774,006
Supplementary information    
Interest paid in cash 4,000 3,933
Income tax paid in cash 0 0
Non-cash transfer of investments (Note 3) 0 36,673
Non-cash addition of right-of-use asset $ 0 $ 323
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2
ORGANIZATION AND BASIS OF PRESENTATION
 9 Months Ended
Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BASIS OF PRESENTATION ORGANIZATION AND BASIS OF PRESENTATION
 
Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s principal wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Law, 2010 and underlying regulations thereto (the “Law”) and is subject to regulation by the Cayman Islands Monetary Authority, in terms of the Law. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America.  As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries.

The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE”.

These unaudited condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2019. In the opinion of management, these unaudited condensed consolidated financial statements reflect all of the normal recurring adjustments considered necessary for a fair presentation of the Company’s financial position and results of operations as of the dates and for the periods presented.

The global pandemic related to the novel coronavirus (the “COVID-19 pandemic”) is expected to have a significant adverse impact on the property and casualty insurance and reinsurance industry. The Company has included in the loss and loss adjustment reserves, its best estimate of losses arising from the COVID-19 pandemic. However, there remains considerable uncertainty relating to the ultimate losses, which will depend on the extent and duration of economic contraction, particularly in the United States. Accordingly, significant estimates used in the preparation of the Company’s consolidated financial statements including those associated with premiums, expected credit losses on amounts owed to us and the estimations of loss and loss adjustment expense reserves may be subject to significant adjustments in future periods.

The results for the nine months ended September 30, 2020 are not necessarily indicative of the results expected for the full calendar year.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.20.2
SIGNIFICANT ACCOUNTING POLICIES
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUNTING POLICIES
 
In the first quarter of 2020, the Company adopted ASU No. 2016-13, Financial Instruments - Credit Losses (“ASU 2016-13”) which requires an entity to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. ASU 2016-13 was effective for public business entities for annual and interim periods beginning after December 15, 2019. The financial assets included in the captions “Reinsurance balances receivable,” “Loss and loss adjustment expenses recoverable” (collectively, “Reinsurance Assets”) and “Notes receivable,” in the Company’s condensed consolidated balance sheets are carried at amortized cost and therefore affected by ASU 2016-13. Other than the changes relating to the adoption of ASU 2016-13, there have been no changes to the Company’s significant accounting policies as described in its Annual Report on Form 10-K for the year ended December 31, 2019.
Use of Estimates
 
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of income and expenses during the period. Actual results could differ from these estimates. 

Restricted Cash and Cash Equivalents
 
The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 11). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:

 September 30, 2020December 31, 2019
 ($ in thousands)
Cash and cash equivalents$8,159 $25,813 
Restricted cash and cash equivalents723,107 742,093 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$731,266 $767,906 

Reinsurance Assets

Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model that considers both the Company’s collectibility history on its reinsurance assets as well as representative external loss history. The external loss history that the Company uses includes a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties is also considered as the probability of default is calculated over the contractual length of the reinsurance contracts.

The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The Company manages its credit risk in its reinsurance assets by transacting with insurers and reinsurers that it considers financially sound.

For its retrocessionaire counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts and/or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations or unearned premiums against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of retrocessionaires to honor their respective obligations.

Upon adoption of ASU 2016-13, the Company recorded an allowance for expected credit loss on its Reinsurance Assets of $0.1 million with an offset to retained earnings. At September 30, 2020, the allowance for expected credit losses was $0.1 million.

Notes Receivable
 
Notes receivable represent promissory notes receivable from third parties. These notes are recorded at cost plus accrued interest, if any, net of valuation allowance for expected credit losses. Interest income, changes in the allowance for expected credit losses and unrealized and realized gains or losses on the notes receivable are included in the caption “Net investment income (loss)” in the Company’s condensed consolidated statements of operations.

The allowance for expected credit losses is calculated using a PD / LGD model that takes into account the Company’s experience as well as representative external loss history. The expected loss percentage is calculated as the product of the PD and LGD for each period over the life of a note. The Company evaluates the financial condition of the notes receivable counterparties and monitors its exposure on a regular basis. At September 30, 2020, the Company considers the notes receivable balance to be collectible and has not experienced any default on payments since inception of these notes. The notes receivable originated between 2015 and 2018.
At September 30, 2020 and December 31, 2019, $0.1 million and $0.1 million, respectively, of accrued interest was included in the caption “Notes receivable” in the Company’s condensed consolidated balance sheets. When there is uncertainty as to the collection of interest contractually due, the Company places the note on non-accrual status. For notes receivable placed on non-accrual status, the notes are presented excluding any accrued interest amount. The Company resumes the accrual of interest on a note when none of the principal or interest remains past due, and the Company expects to collect the remaining contractual principal and interest. Interest collected on notes that are placed on non-accrual status is recorded as interest income when collected, provided that the recorded value of the note is deemed to be fully collectible. Where doubt exists as to the collectibility of the remaining recorded value of the notes placed on non-accrual status, the Company immediately reverses any previous accrued interest through interest income and any payments received are applied to reduce the recorded value of the notes. The allowance for expected credit losses for notes receivable is calculated on the amortized cost excluding accrued interest and interest written off due to non-accrual status.

Charge offs of notes receivable are recorded when all or a portion of the financial asset is deemed uncollectible. Full or partial charge offs are recorded as reductions to the amortized cost and deducted from the allowance in the period in which the note receivable is deemed uncollectible. In instances where the Company collects cash that it has previously charged off, the recovery will be recognized through earnings or as a reduction of the amortized cost for interest and principal, respectively.

The following table provides a roll-forward of the Company’s allowance for credit losses on notes receivable:
Nine months ended September 30
20202019
($ in thousands)
Balance at beginning of period$15,000 $9,012 
Cumulative effect of adoption of ASU 2016-13 at January 1, 2020750 — 
Charge offs(15,000)— 
Net increase (decrease) in allowance250 — 
Balance at end of period$1,000 $9,012 

Deposit Assets and Liabilities
 
The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, an asset or liability is recognized based on the consideration paid or received. The deposit asset or liability balance is subsequently adjusted using the interest method with a corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company’s deposit assets and liabilities are recorded in the Company’s condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At September 30, 2020, deposit assets and deposit liabilities were $5.3 million and $35.2 million, respectively (December 31, 2019: $5.2 million and $56.9 million, respectively). For the three and nine months ended September 30, 2020 and 2019, the interest income/(expense) on deposit accounted contracts was as follows:
 Three months ended September 30Nine months ended September 30
 2020201920202019
($ in thousands)($ in thousands)
Deposit interest income$560 $1,023 $1,812 $2,493 
Deposit interest expense$— $(656)$— $(135)
Deposit interest income/(expense), net$560 $367 $1,812 $2,358 
Other Assets

Other assets consist primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables and deferred tax assets.

Other Liabilities

Other liabilities consist primarily of accruals for legal and other professional fees, employee bonuses and lease liabilities.

Earnings (Loss) Per Share
 
The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:

•Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting;
•additional potential common shares issuable when stock options are exercised, determined using the treasury stock method; and
•those common shares with the potential to be issued by virtue of convertible debt and other such convertible instruments, determined using the treasury stock method.

Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. In the event of a net loss, all RSUs, stock options outstanding, convertible debt and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.

The table below presents the shares outstanding for the purposes of the calculation of earnings (loss) per share for the three and nine months ended September 30, 2020 and 2019:
 Three months ended September 30Nine months ended September 30
 2020201920202019
Weighted average shares outstanding - basic35,677,554 36,841,623 35,569,292 36,646,515 
Effect of dilutive employee and director share-based awards102,149 79,867 — 74,035 
Weighted average shares outstanding - diluted35,779,703 36,921,490 35,569,292 36,720,550 
Anti-dilutive stock options outstanding835,627 875,627 835,627 875,627 
Participating securities excluded from calculation of loss per share — — 878,498 — 

Taxation
 
Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.
 
Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2019: 21%). Verdant’s tax years 2014 and beyond remain open and subject to examination by the IRS.
GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income, and 25% on its non-trading income.

The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions that are subject to significant uncertainty that is reasonably likely to have a material impact on the Company. 

Recent Accounting Pronouncements

Recently Issued Accounting Standards Adopted

As discussed above, the Company adopted ASU 2016-13 during the first quarter of 2020 using a modified retrospective transition method. The adoption resulted in a cumulative-effect adjustment to retained earnings of $0.9 million as of January 1, 2020.

Recently Issued Accounting Standards Not Yet Adopted

In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). The amendments in ASU 2020-01 clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815, which could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 is not expected to have a material impact on the Company’s consolidated financial statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity's own equity. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, embedded conversion features would not be presented separately in equity; rather, the contract would be accounted for as a single liability measured at its amortized cost. Subtopic 815-40 simplifies the analysis of whether an embedded conversion feature meets the derivative scope exception for contracts that are indexed to, and classified in, stockholders equity, as well as addresses the computation of earnings per share for convertible debt instruments. ASU 2020-06 requires the application of the if-converted method when calculating diluted earnings per share. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 using either a modified retrospective method of transition or a fully retrospective method of transition. Early adoption is permitted no earlier than for fiscal years beginning after December 15, 2020. The Company is currently evaluating the effect the new standard will have on its consolidated financial statements.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND
 9 Months Ended
Sep. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]  
INVESTMENT IN RELATED PARTY INVESTMENT FUND INVESTMENT IN RELATED PARTY INVESTMENT FUND
Prior to January 2, 2019, the Company and its reinsurance subsidiaries were party to a joint venture agreement (the “venture agreement”) with DME Advisors, LP (“DME Advisors”) and DME Advisors LLC (“DME”) under which the Company, its reinsurance subsidiaries and DME were participants in a joint venture (the “Joint Venture”) for the purpose of managing certain jointly held assets. DME and DME Advisors are related to the Company and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors.

On September 1, 2018, the Company entered into an amended and restated exempted limited partnership agreement (as amended by that certain letter agreement dated as of August 5, 2020, the “SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re and GRIL, (together the “GLRE Limited Partners”), and the initial limited partner (each, a “Partner”). The SILP LPA, in conjunction with a participation agreement, replaced the venture agreement and assigned and/or transferred Greenlight Re’s and GRIL’s invested assets in the Joint Venture to SILP. The Joint Venture was terminated on January 2, 2019 by which date all assets were transferred to SILP. On September
1, 2018, SILP also entered into a SILP investment advisory agreement (“IAA”) with DME Advisors pursuant to which DME Advisors is the investment manager for SILP.

The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:

•DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.

•DME II holds an interest in excess of 10% of SILP’s net assets which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP.

Consequently, the Company has concluded that DME II’s interests, and not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company’s investment in SILP is presented in the Company’s condensed consolidated balance sheets in the caption “Investment in related party investment fund.”

During 2019, SILP’s investment portfolio was de-risked in order to reduce the Company’s investment volatility in the near-term. As a result, a significant proportion of the Company’s investment assets in SILP was held in cash and short-term treasuries as of December 31, 2019. On August 5, 2020, the Company entered into an amended and restated letter agreement with DME Advisors and DME II whereby the deployed Investment Portfolio can not exceed an amount equal to 50% of the Company’s shareholders’ equity, as reported in the Company’s then most recent quarterly U.S. GAAP financial statements, adjusted monthly for investment gains and losses as reported by SILP during any intervening period.

The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. As of September 30, 2020, the net asset value of the GLRE Limited Partners’ investment in SILP was $185.0 million (December 31, 2019: $240.1 million), representing 81.0% (December 31, 2019: 81.0%) of SILP’s total net assets. The remaining 19.0% (December 31, 2019: 19.0%) of SILP’s total net assets was held by DME II. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing three business days’ notice to DME II. As of September 30, 2020, the majority of SILP’s long investments are composed of cash and publicly-traded equity securities, which can be readily liquidated to meet GLRE Limited Partners’ redemption requests.

The Company’s share of the change in the net asset value of SILP for the three and nine months ended September 30, 2020 was $6.4 million and $(34.1) million, respectively, (three and nine months ended September 30, 2019: $6.6 million and $51.8 million, respectively), and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations. The change in the net asset value of SILP for the nine months ended September 30, 2020 was primarily driven by the impact of changes in fair value primarily attributable to the disruptions in global financial markets associated with the COVID–19 pandemic.

The summarized financial statements of SILP are presented below.
Summarized Statement of Assets and Liabilities of Solasglas Investments, LP
September 30, 2020December 31, 2019
($ in thousands)
Assets
Investments, at fair value$220,116 $162,928 
Derivative contracts, at fair value3,097 6,324 
Due from brokers130,220 68,060 
Cash and cash equivalents2,202 111,046 
Interest and dividends receivable281 47 
Total assets355,916 348,405 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(116,336)(47,834)
Derivative contracts, at fair value(10,962)(2,054)
Due to brokers— (1,180)
Interest and dividends payable(32)(828)
Other liabilities(233)(101)
Total liabilities(127,563)(51,997)
Net Assets$228,353 $296,408 
GLRE Limited Partners’ share of Net Assets$184,956 $240,056 
Summarized Statement of Operations of Solasglas Investments, LP
Three months ended September 30Nine months ended September 30
2020201920202019
($ in thousands)
Investment income
Dividend income (net of withholding taxes)$170 $652 $1,204 $2,334 
Interest income36 279 262 1,869 
Total Investment income206 931 1,466 4,203 
Expenses
Management fee(703)(653)(1,981)(4,235)
Interest(176)(89)(518)(2,308)
Dividends(213)(96)(612)(1,532)
Professional fees and other(432)(204)(764)(1,009)
Total expenses(1,524)(1,042)(3,875)(9,084)
Net investment income (loss)(1,318)(111)(2,409)(4,881)
Realized and change in unrealized gains (losses)
Net realized gain (loss) (1,412)14,760 (44,972)26,989 
Net change in unrealized appreciation (depreciation) 10,832 (5,675)5,811 45,708 
Net gain (loss) on investment transactions9,420 9,085 (39,161)72,697 
Net income (loss)$8,102 $8,974 $(41,570)$67,816 
GLRE Limited Partners’ share of net income (loss) (1)$6,431 $6,609 $(34,086)$51,770 

(1) Net of management fees and accrued performance allocation as follows:

Three months ended September 30Nine months ended September 30
2020201920202019
($ in thousands)
Management fees$703 $652 $1,981 $4,234 
Performance allocation$— $673 $— $5,654 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL INSTRUMENTS
 9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS 
 
Investments
  
Other Investments
 
“Other investments” include unlisted securities and investments accounted for under the equity method.
At September 30, 2020, the following securities were included in the caption “Other investments”:
September 30, 2020CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities $11,364 $5,373 $(1,067)$15,670 
Investment accounted for under the equity method — — — 6,571 
Total other investments$22,241 

At December 31, 2019, the following securities were included in the caption “Other investments”: 
December 31, 2019CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities$10,420 $265 $(4)$10,681 
Investment accounted for under the equity method— — — 5,703 
Total other investments$16,384 

Private investments and unlisted equities include securities that do not have readily determinable fair values. The carrying values of these holdings are determined based on their original cost minus impairment, if any, plus or minus changes resulting from observable price changes. At September 30, 2020, the carrying value of private investments and unlisted equities was $15.7 million (December 31, 2019: $10.7 million), and incorporated upward adjustments of $0.0 million and $4.1 million during the three and nine months ended September 30, 2020, respectively (2019: $0.0 million and $0.2 million, respectively), excluding any unrealized gains or losses related to changes in foreign currency exchange rates.

 The Company’s investment accounted for under the equity method represents its investment in AccuRisk Holdings LLC (“AccuRisk”), a Chicago, Illinois-based managing general underwriter focused on employee and health insurance benefits. At September 30, 2020, the Company held a 58% (December 31, 2019: 58%) economic interest in AccuRisk and had provided a $6.0 million credit facility. In addition to providing capital and funding in support of AccuRisk’s expansion plans, the Company also provides reinsurance capacity for business produced by AccuRisk. The Company has determined that AccuRisk is a VIE, of which the Company is not the primary beneficiary. The Company’s carrying value represents its ownership share of AccuRisk’s net assets. The Company’s maximum exposure to loss relating to AccuRisk is limited to the carrying amount of its investment, plus the credit facility extended. For the three and nine months ended September 30, 2020, the Company’s share of AccuRisk’s net income was $0.1 million and $0.9 million, respectively (2019: $(0.2) million and $0.3 million, respectively), which was included in the caption “Net investment income” in the Company’s condensed consolidated statements of operations.

Fair Value Hierarchy

The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

•Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
•Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.
•Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.

As of September 30, 2020 and December 31, 2019, the Company did not carry any investments at fair value that were assigned a Level within the fair value hierarchy. The Company’s investment in the related party investment fund is measured at
fair value using the net asset value practical expedient, and is therefore not classified within the fair value hierarchy. (See Note 3 for further details.)

Financial Instruments Disclosed, But Not Carried, at Fair Value

The captions “Notes receivable (net of allowance for expected credit loss)” and “Convertible senior notes payable” represent financial instruments that are carried at amortized cost. The carrying values of the notes receivable (net of allowance for expected credit loss) approximate their fair values, which the Company has determined on the basis of Level 3 inputs. The fair value of the convertible senior notes payable is estimated based on the bid price observed in an inactive market for the identical instrument (Level 2 input) (see Note 7).
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.2
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES
 9 Months Ended
Sep. 30, 2020
Insurance Loss Reserves [Abstract]  
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES
At September 30, 2020, the loss and loss adjustment expenses reserves included estimated amounts for several catastrophe events. For significant catastrophe events including, but not limited to, hurricanes, typhoons, floods, wildfires and pandemics, loss reserves are generally established based on loss payments and case reserves reported by clients when, and if, received. To establish IBNR loss estimates, the Company makes use of, among other things, the following:

•estimates communicated by ceding companies;
•industry data;
•information received from clients, brokers and loss adjusters;
•an understanding of the underlying business written and its exposures to catastrophe event related losses;
•catastrophe scenario modelling software; and
•management’s judgement.

The COVID-19 pandemic is unprecedented. Therefore, the Company does not have previous loss experience on which to base its estimates for loss and loss adjustment expenses related to the COVID-19 pandemic. The determination of the Company's estimate was based on:

•a review of in-force treaties that may provide coverage and incur losses;
•catastrophe and scenario modeling analyses and results shared by cedents;
•preliminary loss estimates received from clients and their analysts and loss adjusters;
•reviews of industry insured loss estimates and market share analyses; and
•management’s judgement.

Significant assumptions on which the Company's estimates of reserves for the COVID-19 pandemic losses and loss adjustment expenses are based include:

•the scope of coverage provided by the underlying policies, particularly those that provide for business interruption coverage;
•the regulatory, legislative or judicial actions and social impact that could influence contract interpretations across the insurance industry;
•the extent of economic contraction caused by the COVID-19 pandemic, particularly in the United States; and
•the ability of the cedents and insured to mitigate some or all of their losses.

While the Company believes its estimate of loss and loss adjustment expense reserves for the COVID-19 pandemic is adequate as of September 30, 2020 based on available information, actual losses may ultimately differ materially from the Company's current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information becomes available and will adjust its estimates accordingly. Such adjustments may be material to the Company's results of operations and financial condition.

There were no significant changes in the actuarial methodology or reserving process related to the Company’s loss and loss adjustment expense reserves for the nine months ended September 30, 2020.
At September 30, 2020 and December 31, 2019, loss and loss adjustment expense reserves were composed of the following:
September 30, 2020December 31, 2019
 ($ in thousands)
Case reserves$224,732 $217,834 
IBNR257,038 252,754 
Total$481,770 $470,588 

A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated
for the nine months ended September 30, 2020 and 2019 is as follows: 
Consolidated20202019
 ($ in thousands)
Gross balance at January 1$470,588 $482,662 
Less: Losses recoverable(27,531)(43,705)
Net balance at January 1443,057 438,957 
Incurred losses related to:  
Current year247,559 264,129 
Prior years5,385 30,174 
Total incurred252,944 294,303 
Paid losses related to:  
Current year(72,453)(93,822)
Prior years(161,222)(200,384)
Total paid(233,675)(294,206)
Foreign currency revaluation(505)(1,154)
Net balance at September 30461,821 437,900 
Add: Losses recoverable19,949 41,535 
Gross balance at September 30$481,770 $479,435 
    
The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2020 and 2019 are as follows:
Health20202019
 ($ in thousands)
Gross balance at January 1$18,063 $24,502 
Less: Losses recoverable— — 
Net balance at January 118,063 24,502 
Incurred losses related to: 
Current year25,032 26,013 
Prior years1,341 2,196 
Total incurred26,373 28,209 
Paid losses related to: 
Current year(15,115)(14,741)
Prior years(16,327)(23,160)
Total paid(31,442)(37,901)
Foreign currency revaluation— — 
Net balance at September 3012,994 14,810 
Add: Losses recoverable— — 
Gross balance at September 30$12,994 $14,810 

For the nine months ended September 30, 2020, the estimate of net losses incurred relating to prior accident years increased by $5.4 million, primarily in relation to certain general liability, health and multi-line contracts, partially offset by favorable loss development on professional liability contracts. The net financial impact of the prior year unfavorable loss development for the nine months ended September 30, 2020, taking into account earned reinstatement premiums assumed and ceded, adjustments to assumed and ceded acquisition costs and adjustments to deposit accounted contracts, was a loss of $4.8 million.

For the nine months ended September 30, 2019, the estimate of net losses incurred relating to prior accident years increased by $30.2 million that originated primarily from certain private passenger automobile contracts. These unanticipated automobile losses were the result of adverse court rulings that affected a significant number of loss events that occurred in Florida between 2015 and early 2018, including many claims that had previously been considered closed. The net financial impact of the prior year adverse loss development for the nine months ended September 30, 2019 was a loss of $27.7 million.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.20.2
RETROCESSION
 9 Months Ended
Sep. 30, 2020
Reinsurance Disclosures [Abstract]  
RETROCESSION RETROCESSION
 
The Company, from time to time, purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, to reduce its net liability on individual risks, to obtain additional underwriting capacity and to balance its underwriting portfolio. Loss and loss adjustment expenses recoverable from retrocessionaires are recorded as assets.

For the three and nine months ended September 30, 2020, the Company’s earned ceded premiums were $1.7 million and $3.2 million, respectively (2019: $22.0 million and $65.8 million, respectively). For the three and nine months ended September 30, 2020, loss and loss adjustment expenses incurred of $88.1 million and $252.9 million, respectively (2019: $93.0 million and $294.3 million, respectively), reported on the condensed consolidated statements of operations are net of loss and loss expenses recovered and recoverable of $2.5 million and $6.2 million (2019: $13.9 million and $56.2 million).

Retrocession contracts do not relieve the Company from its obligations to the insureds. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At September 30, 2020, the Company’s loss reserves recoverable consisted of (i) $15.0 million (December 31, 2019: $21.2 million) from unrated retrocessionaires, of which $14.5 million (December 31, 2019: $20.0 million) were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $5.0 million (December 31, 2019: $6.4 million) from retrocessionaires rated A- or above by A.M. Best.

The Company regularly evaluates its net credit exposure to assess the ability of the retrocessionaires to honor their respective obligations. At September 30, 2020, the Company had recorded an allowance for expected credit losses of $0.1 million (December 31, 2019: nil).
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.20.2
SENIOR CONVERTIBLE NOTES
 9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
SENIOR CONVERTIBLE NOTES SENIOR CONVERTIBLE NOTES
On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”), which mature on August 1, 2023. The Notes bear interest at 4.0% payable semi-annually on February 1 and August 1 of each year beginning on February 1, 2019.

Note holders have the option, under certain conditions, to redeem the Notes prior to maturity.
If the Notes are redeemed by the holder, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. The Company has therefore bifurcated the Notes into liability and equity components.
At September 30, 2020, the Company’s share price was lower than the conversion price of $17.19 per share.
The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%, which equated to an $8.2 million discount. As of September 30, 2020 and December 31, 2019, the unamortized debt discount was $4.7 million and $5.9 million, respectively, and is expected to be amortized through the maturity date. The debt discount also represents the portion of the Note’s principal amount allocated to the equity component.
The Company incurred issuance costs in connection with the issuance of the Notes. As of September 30, 2020, the unamortized portion of these costs attributed to the debt component was $1.8 million (December 31, 2019: $2.3 million), which are expected to be amortized through the maturity date. The portion of these issuance costs attributed to the equity component was netted against the gross proceeds allocated to equity, resulting in $7.9 million being included in the caption “Additional paid-in capital” in the Company’s condensed consolidated balance sheets.

The carrying value of the Notes as of September 30, 2020, including accrued interest of $0.7 million, was $94.2 million (December 31, 2019: $93.5 million). As of September 30, 2020, the fair value of the Notes was estimated to be $80.1 million (December 31, 2019: $94.9 million) (see Note 4 Financial Instruments).
For the three and nine months ended September 30, 2020, the Company recognized interest expense of $1.6 million and $4.7 million (2019: $1.6 million and $4.7 million) in connection with the interest coupon, amortization of issuance costs and amortization of the discount.

The Company was in compliance with all covenants relating to the Notes as of September 30, 2020 and December 31, 2019.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE CAPITAL
 9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
SHARE CAPITAL SHARE CAPITAL
As of September 30, 2020, 293,939 (December 31, 2019: 555,805) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The stock incentive plan is administered by the Compensation Committee of the Board of Directors. On October 29, 2020, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million.

The Board has adopted a share repurchase plan. The timing of such repurchases and actual number of shares repurchased will depend on a variety of factors including price, market conditions and applicable regulatory and corporate requirements. On March 26, 2020, the Board of Directors extended the share repurchase plan to June 30, 2021 and increased the number of shares authorized to be repurchased to 5.0 million Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. In addition, the Board of Directors also authorized the Company to repurchase up to $25.0 million aggregate face amount of the Company’s 4.00% Convertible Senior Notes due 2023 (the “Notes”) in privately negotiated transactions, in open market repurchases or pursuant to one more tender offers. The Company is not required to repurchase any of the Class A ordinary shares or the Notes and the repurchase plans may be modified, suspended or terminated at the election of our Board of Directors at any time without prior notice.

During the nine months ended September 30, 2020, 1.9 million Class A ordinary shares were repurchased by the Company (2019: 0). As of September 30, 2020, 3.1 million Class A ordinary shares and $25.0 million of the Notes, remained available for repurchase under the repurchase plans. All Class A ordinary shares repurchased are canceled immediately upon repurchase.
The following table is a summary of voting ordinary shares issued and outstanding:
Nine months ended September 30Nine months ended September 30
 20202019
Class AClass BClass AClass B
Balance – beginning of period30,739,395 6,254,715 30,130,214 6,254,715 
Issue of ordinary shares, net of forfeitures248,726 — 408,233 — 
Repurchase of ordinary shares(1,874,419)— — — 
Balance – end of period29,113,702 6,254,715 30,538,447 6,254,715 

Additional paid-in capital includes the premium per share paid by the subscribing shareholders for Class A and B ordinary shares which have a par value of $0.10 each. It also includes the earned portion of the grant-date fair value of share-based awards that have not yet vested.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE-BASED COMPENSATION
 9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION SHARE-BASED COMPENSATION
 
The Company has a stock incentive plan for directors, employees and consultants that is administered by the Compensation Committee of the Board of Directors.
 
Employee and Director Restricted Shares
 
For the nine months ended September 30, 2020, 306,264 (2019: 235,701) Class A ordinary shares were issued to employees pursuant to the Company’s stock incentive plan. These shares contain certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment and transferability. The restricted shares cliff vest three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company.

For the nine months ended September 30, 2020, 145,089 (2019: 326,240) Class A ordinary shares were issued to the Company’s Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan. These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of employment and transferability. These restricted shares cliff vest 5 years after the date of issuance, subject to the performance condition being met and the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retains voting rights and is entitled to any dividends declared by the Company. The weighted average grant date fair value of these restricted shares subject to performance conditions was $6.72 (2019: $10.84) per share. On July 30, 2020, the Company accelerated the vesting of a portion of the CEO’s restricted shares resulting in 72,545 shares vesting immediately. The remaining restricted shares are still subject to performance and service conditions. As the performance conditions associated with these restricted shares have not been met, no compensation cost was recognized relating to the unvested shares for the nine months ended September 30, 2020 and 2019.

For the nine months ended September 30, 2020, 210,109 (2019: 27,386) restricted shares were forfeited by employees who left the Company and prior to the expiration of the applicable vesting periods. For the nine months ended September 30, 2020, $0.7 million stock compensation expense (2019: $0.2 million) relating to the forfeited restricted shares was reversed.

The Company recorded $0.6 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the nine months ended September 30, 2020 (2019: $2.0 million). As of September 30, 2020, there was $2.2 million (December 31, 2019: $2.7 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding CEO’s restricted shares with performance conditions) which are expected to be recognized over a weighted average period of 2.4 years (December 31, 2019: 1.6 years). For the nine months ended September 30, 2020, the total fair value of restricted shares vested was $2.8 million (2019: $3.1 million).
The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2020:

 Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value
Balance at December 31, 2019873,087 $12.83 
Granted451,353 6.72 
Vested(235,833)13.83 
Forfeited(210,109)10.90 
Balance at September 30, 2020878,498 $9.88 
 
Employee and Director Stock Options

For the nine months ended September 30, 2020, no Class A ordinary share purchase options were granted or exercised by directors or employees, while 40,000 (2019: 60,000) stock options expired and 80,000 (2019: 80,000) stock options vested. When stock options are granted, the Company reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.

The total compensation cost expensed relating to stock options for the nine months ended September 30, 2020 was $0.5 million (2019: $0.7 million). At September 30, 2020, the total compensation cost related to non-vested options not yet recognized was $0.8 million (December 31, 2019: $1.3 million), which will be recognized over a weighted average period of 2.0 years (December 31, 2019: 2.4 years) assuming the grantee completes the service period for vesting of the options.

At September 30, 2020 and December 31, 2019, there were 0.8 million and 0.9 million stock options outstanding, respectively, with a weighted average exercise price of $22.22 and $22.68 per share, respectively and weighted average grant date fair value of $10.25 and $10.25 per share, respectively. The weighted average remaining contractual term of the stock options was 5.3 years and 5.8 years, at September 30, 2020 and December 31, 2019, respectively.

 Employee Restricted Stock Units

The Company issues RSUs to certain employees as part of the stock incentive plan.

These RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability and other matters. Each RSU grant cliff vests three years after the date of issuance, subject to the grantee’s continued service with the Company. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan. For the nine months ended September 30, 2020, 60,622 (2019: 48,535) RSUs were issued to employees pursuant to the Company’s stock incentive plan. For the nine months ended September 30, 2020, no (2019: 24,165) RSUs were forfeited by employees who left the Company prior to the expiration of the applicable vesting periods.

The Company recorded $0.3 million of share-based compensation expense, net of forfeitures, relating to RSUs for the nine months ended September 30, 2020 (2019: $0.1 million).
 
Employee RSU activity during the nine months ended September 30, 2020 was as follows:
 Number of
non-vested
RSUs		Weighted
 average
grant date
fair value
Balance at December 31, 201963,582 $13.76 
Granted60,622 6.72 
Vested(7,482)21.65 
Forfeited— — 
Balance at September 30, 2020116,722 $9.60 
For the nine months ended September 30, 2020 and 2019, the combined stock compensation expense (net of forfeitures), which was included in the caption “General and administrative expenses” in the Company’s statements of operations, was $1.4 million and $2.9 million, respectively.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.20.2
RELATED PARTY TRANSACTIONS
 9 Months Ended
Sep. 30, 2020
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS 
 
Investment Advisory Agreement
 
DME, DME II and DME Advisors are related to the Company and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors.

The Company has entered into the SILP LPA with DME II. DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL include the amount of losses that were to be recouped under the Joint Venture as well as any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry forward provision contained in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss, until all losses are recouped and an additional amount equal to 150% of the loss is earned. On February 26, 2019, effective as of September 1, 2018, the Company entered into Amendment No. 1 to the SILP LPA. The amendment was intended to revise the mechanics for calculating the Carryforward Account and Performance Allocation (as defined in the LPA) to take into account withdrawals from and subsequent recontributions of capital to SILP, consistent with the treatment under the Joint Venture.

In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio” as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023 subject to an automatic extension for successive three-year terms.

The Company has entered into a letter agreement with DME Advisors and DME II whereby during the period from June 1, 2019 to June 30, 2021, cash, cash equivalents and/or U.S government issued securities will not be subject to any management fee or performance allocation. For a detailed breakdown of management fees and performance compensation for the three and nine months ended September 30, 2020 and 2019, refer to Note 3 of the condensed consolidated financial statements.
 
Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II and DME Advisors for reasonable costs and expenses of investigating and/or defending such claims, provided such claims were not caused due to gross negligence, breach of contract or misrepresentation by DME, DME II or DME Advisors. There were no indemnification amounts incurred by the Company during any of the periods presented.

Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly traded company. As of September 30, 2020, SILP, along with certain affiliates of DME Advisors, collectively owned 47.6% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may be limited at times in its ability to trade GRBK shares on behalf of SILP.

Service Agreement
 
The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement is automatically renewed annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. 
Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES 
 
Letters of Credit and Trusts
 
At September 30, 2020, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:
Maximum Facility LimitTermination DateNotice period required for termination
 ($ in thousands)  
Citibank Europe plc$275,000 August 20, 2021
120 days prior to termination date

Effective August 26, 2020, the Company amended the credit facility to reduce the maximum facility limit from $400.0 million to $275.0 million. As of September 30, 2020, an aggregate amount of $133.0 million (December 31, 2019: $204.5 million) in letters of credit were issued under the credit facility. As of September 30, 2020, total cash and cash equivalents with a fair value in the aggregate of $135.6 million (December 31, 2019: $213.4 million) were pledged as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. The credit facility contains customary events of default and restrictive covenants, including but not limited to, limitations on liens on collateral, transactions with affiliates, mergers and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements, and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the covenants of the credit facility as of September 30, 2020 and December 31, 2019.

The Company has also established regulatory trust arrangements for certain cedents. As of September 30, 2020, collateral of $587.5 million (December 31, 2019: $528.7 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets.

Lease Obligations
 
Greenlight Re has entered into lease agreements for office space in the Cayman Islands that expires on December 31, 2020. The Company has determined that the current arrangement qualifies as a short term lease. The short-term lease expense for the three and nine months ended September 30, 2020 was $0.4 million (2019: $0.4 million).

GRIL has entered into a lease agreement for office space in Dublin, Ireland. Under the terms of this lease agreement, GRIL is committed to minimum annual rent payments denominated in Euros approximating €0.1 million until May 2021, and adjusted to the prevailing market rates for the subsequent five-year term. GRIL has the option to terminate the lease agreement in 2021. The Company has determined that this agreement qualifies as an operating lease under GAAP. As of September 30, 2020 the Company has recorded a right-of-use asset and a corresponding lease liability of $0.1 million (December 31, 2019: $0.2 million). The operating lease expense for the three and nine months ended September 30, 2020 and 2019 was insignificant. Included in the “Schedule of Commitments and Contingencies,” below, are the net minimum lease payment obligations relating to this lease as of September 30, 2020.
Schedule of Commitments and Contingencies
The following is a schedule of future minimum payments required under the above commitments:  

 20202021202220232024ThereafterTotal
 ($ in thousands)
Operating lease obligations$171 $65 $— $— $— $— $236 
Interest and convertible note payable— 4,000 4,000 102,000 — — 110,000 
 $171 $4,065 $4,000 $102,000 $— $— $110,236 

Litigation
 
From time to time in the normal course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or to collect funds owed to it. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition or operating results.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT REPORTING
 9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
 
The Company manages its business on the basis of one operating segment, Property & Casualty Reinsurance. The following tables provide a breakdown of the Company’s gross premiums written by line of business and by geographic area of risks insured for the periods indicated: 

Gross Premiums Written by Line of Business
  Three months ended September 30Nine months ended September 30
2020201920202019
  ($ in thousands)($ in thousands)
Property
Commercial$3,396 2.5 %$5,088 4.6 %$9,426 2.6 %$11,752 2.8 %
Motor10,091 7.4 11,367 10.3 25,136 6.9 50,807 11.9 
Personal3,691 2.7 3,632 3.3 10,326 2.9 9,788 2.3 
Total Property17,178 12.6 20,087 18.2 44,888 12.4 72,347 17.0 
Casualty
General Liability3,224 2.4 913 0.8 3,920 1.1 2,368 0.6 
Motor Liability41,679 30.7 47,021 42.5 96,729 26.7 197,335 46.4 
Professional Liability 76 0.1 11 — 199 0.1 117 — 
Workers' Compensation21,979 16.2 14,077 12.7 60,908 16.8 35,121 8.3 
Multi-line 25,820 19.0 15,082 13.6 67,379 18.6 61,173 14.4 
Total Casualty92,778 68.4 77,104 69.6 229,135 63.3 296,114 69.7 
Other
Accident & Health12,418 9.3 7,527 6.8 40,522 11.2 31,065 7.2 
Financial1,817 1.3 315 0.3 15,704 4.3 15,394 3.6 
Marine127 0.1 (33)— 749 0.2 94 — 
Other Specialty11,278 8.3 5,607 5.1 31,074 8.6 10,493 2.5 
Total Other25,640 19.0 13,416 12.2 88,049 24.3 57,046 13.3 
$135,596 100.0 %$110,607 100.0 %$362,072 100.0 %$425,507 100.0 %

Gross Premiums Written by Geographic Area of Risks Insured
 Three months ended September 30Nine months ended September 30
2020201920202019
 ($ in thousands)($ in thousands)
U.S. and Caribbean$110,798 81.7 %$89,811 81.2 %$291,511 80.5 %$358,099 84.1 %
Worldwide (1) $22,738 16.8 %$18,450 16.7 %$66,150 18.3 %$64,590 15.2 %
Europe$— — %$— — %$— — %$(13)— %
Asia$2,060 1.5 %$2,346 2.1 %$4,411 1.2 %$2,831 0.7 %
$135,596 100.0 %$110,607 100.0 %$362,072 100.0 %$425,507 100.0 %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
SUBSEQUENT EVENTS
 9 Months Ended
Sep. 30, 2020
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTSSubsequent to September 30, 2020, the Company agreed to settle a promissory note that had been entered into with a reinsurance counterparty. The Company’s amortized cost associated with the promissory note at September 30, 2020 was $13.3 million, which was included in the caption “Notes receivable (net of allowance for expected credit loss).” In connection with this settlement, the Company received $19.1 million, resulting in a gain of $5.8 million that will be recognized in the fourth quarter of 2020.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Policies)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates
 
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of income and expenses during the period. Actual results could differ from these estimates.
Restricted Cash and Cash Equivalents
Restricted Cash and Cash Equivalents
 
The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 11). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:
Reinsurance Assets
Reinsurance Assets

Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model that considers both the Company’s collectibility history on its reinsurance assets as well as representative external loss history. The external loss history that the Company uses includes a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties is also considered as the probability of default is calculated over the contractual length of the reinsurance contracts.

The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The Company manages its credit risk in its reinsurance assets by transacting with insurers and reinsurers that it considers financially sound.

For its retrocessionaire counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts and/or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations or unearned premiums against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of retrocessionaires to honor their respective obligations.
Notes Receivable
Notes Receivable
 
Notes receivable represent promissory notes receivable from third parties. These notes are recorded at cost plus accrued interest, if any, net of valuation allowance for expected credit losses. Interest income, changes in the allowance for expected credit losses and unrealized and realized gains or losses on the notes receivable are included in the caption “Net investment income (loss)” in the Company’s condensed consolidated statements of operations.

The allowance for expected credit losses is calculated using a PD / LGD model that takes into account the Company’s experience as well as representative external loss history. The expected loss percentage is calculated as the product of the PD and LGD for each period over the life of a note. The Company evaluates the financial condition of the notes receivable counterparties and monitors its exposure on a regular basis. At September 30, 2020, the Company considers the notes receivable balance to be collectible and has not experienced any default on payments since inception of these notes. The notes receivable originated between 2015 and 2018.
When there is uncertainty as to the collection of interest contractually due, the Company places the note on non-accrual status. For notes receivable placed on non-accrual status, the notes are presented excluding any accrued interest amount. The Company resumes the accrual of interest on a note when none of the principal or interest remains past due, and the Company expects to collect the remaining contractual principal and interest. Interest collected on notes that are placed on non-accrual status is recorded as interest income when collected, provided that the recorded value of the note is deemed to be fully collectible. Where doubt exists as to the collectibility of the remaining recorded value of the notes placed on non-accrual status, the Company immediately reverses any previous accrued interest through interest income and any payments received are applied to reduce the recorded value of the notes. The allowance for expected credit losses for notes receivable is calculated on the amortized cost excluding accrued interest and interest written off due to non-accrual status.Charge offs of notes receivable are recorded when all or a portion of the financial asset is deemed uncollectible. Full or partial charge offs are recorded as reductions to the amortized cost and deducted from the allowance in the period in which the note receivable is deemed uncollectible. In instances where the Company collects cash that it has previously charged off, the recovery will be recognized through earnings or as a reduction of the amortized cost for interest and principal, respectively.
Deposit Assets and Liabilities
Deposit Assets and Liabilities
 
The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, an asset or liability is recognized based on the consideration paid or received. The deposit asset or liability balance is subsequently adjusted using the interest method with a corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the caption “Other income (expense).” The Company’s deposit assets and liabilities are recorded in the Company’s condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively.
Other Assets
Other Assets

Other assets consist primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables and deferred tax assets.
Other Liabilities Other LiabilitiesOther liabilities consist primarily of accruals for legal and other professional fees, employee bonuses and lease liabilities.
Earnings (Loss) Per Share
Earnings (Loss) Per Share
 
The Company’s unvested restricted stock awards, which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of common shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect of the following:

•Restricted Stock Units (“RSUs”) issued that would convert to common shares upon vesting;
•additional potential common shares issuable when stock options are exercised, determined using the treasury stock method; and
•those common shares with the potential to be issued by virtue of convertible debt and other such convertible instruments, determined using the treasury stock method.

Diluted earnings (or loss) per share contemplates a conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share. In the event of a net loss, all RSUs, stock options outstanding, convertible debt and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.
Taxation
Taxation
 
Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.
 
Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2019: 21%). Verdant’s tax years 2014 and beyond remain open and subject to examination by the IRS.
GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income, and 25% on its non-trading income.The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions that are subject to significant uncertainty that is reasonably likely to have a material impact on the Company.
Recent Accounting Pronouncements
Recent Accounting Pronouncements

Recently Issued Accounting Standards Adopted

As discussed above, the Company adopted ASU 2016-13 during the first quarter of 2020 using a modified retrospective transition method. The adoption resulted in a cumulative-effect adjustment to retained earnings of $0.9 million as of January 1, 2020.

Recently Issued Accounting Standards Not Yet Adopted

In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force) (“ASU 2020-01”). The amendments in ASU 2020-01 clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815, which could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. ASU 2020-01 is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The adoption of ASU 2020-01 is not expected to have a material impact on the Company’s consolidated financial statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity's own equity. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, embedded conversion features would not be presented separately in equity; rather, the contract would be accounted for as a single liability measured at its amortized cost. Subtopic 815-40 simplifies the analysis of whether an embedded conversion feature meets the derivative scope exception for contracts that are indexed to, and classified in, stockholders equity, as well as addresses the computation of earnings per share for convertible debt instruments. ASU 2020-06 requires the application of the if-converted method when calculating diluted earnings per share. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021 using either a modified retrospective method of transition or a fully retrospective method of transition. Early adoption is permitted no earlier than for fiscal years beginning after December 15, 2020. The Company is currently evaluating the effect the new standard will have on its consolidated financial statements.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
Restricted Cash and Cash Equivalents
 
The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 11). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:

 September 30, 2020December 31, 2019
 ($ in thousands)
Cash and cash equivalents$8,159 $25,813 
Restricted cash and cash equivalents723,107 742,093 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$731,266 $767,906 
Restrictions on Cash and Cash Equivalents
Restricted Cash and Cash Equivalents
 
The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 11). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:

 September 30, 2020December 31, 2019
 ($ in thousands)
Cash and cash equivalents$8,159 $25,813 
Restricted cash and cash equivalents723,107 742,093 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$731,266 $767,906 
Financing Receivable, Allowance for Credit Loss
The following table provides a roll-forward of the Company’s allowance for credit losses on notes receivable:
Nine months ended September 30
20202019
($ in thousands)
Balance at beginning of period$15,000 $9,012 
Cumulative effect of adoption of ASU 2016-13 at January 1, 2020750 — 
Charge offs(15,000)— 
Net increase (decrease) in allowance250 — 
Balance at end of period$1,000 $9,012 
Schedule of Interest Income and Interest Expense For the three and nine months ended September 30, 2020 and 2019, the interest income/(expense) on deposit accounted contracts was as follows:
 Three months ended September 30Nine months ended September 30
 2020201920202019
($ in thousands)($ in thousands)
Deposit interest income$560 $1,023 $1,812 $2,493 
Deposit interest expense$— $(656)$— $(135)
Deposit interest income/(expense), net$560 $367 $1,812 $2,358 
Schedule of Weighted Average Number of Shares
The table below presents the shares outstanding for the purposes of the calculation of earnings (loss) per share for the three and nine months ended September 30, 2020 and 2019:
 Three months ended September 30Nine months ended September 30
 2020201920202019
Weighted average shares outstanding - basic35,677,554 36,841,623 35,569,292 36,646,515 
Effect of dilutive employee and director share-based awards102,149 79,867 — 74,035 
Weighted average shares outstanding - diluted35,779,703 36,921,490 35,569,292 36,720,550 
Anti-dilutive stock options outstanding835,627 875,627 835,627 875,627 
Participating securities excluded from calculation of loss per share — — 878,498 — 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)
 9 Months Ended
Sep. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Summarized Financial Information of Investment The summarized financial statements of SILP are presented below.
Summarized Statement of Assets and Liabilities of Solasglas Investments, LP
September 30, 2020December 31, 2019
($ in thousands)
Assets
Investments, at fair value$220,116 $162,928 
Derivative contracts, at fair value3,097 6,324 
Due from brokers130,220 68,060 
Cash and cash equivalents2,202 111,046 
Interest and dividends receivable281 47 
Total assets355,916 348,405 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(116,336)(47,834)
Derivative contracts, at fair value(10,962)(2,054)
Due to brokers— (1,180)
Interest and dividends payable(32)(828)
Other liabilities(233)(101)
Total liabilities(127,563)(51,997)
Net Assets$228,353 $296,408 
GLRE Limited Partners’ share of Net Assets$184,956 $240,056 
Summarized Statement of Operations of Solasglas Investments, LP
Three months ended September 30Nine months ended September 30
2020201920202019
($ in thousands)
Investment income
Dividend income (net of withholding taxes)$170 $652 $1,204 $2,334 
Interest income36 279 262 1,869 
Total Investment income206 931 1,466 4,203 
Expenses
Management fee(703)(653)(1,981)(4,235)
Interest(176)(89)(518)(2,308)
Dividends(213)(96)(612)(1,532)
Professional fees and other(432)(204)(764)(1,009)
Total expenses(1,524)(1,042)(3,875)(9,084)
Net investment income (loss)(1,318)(111)(2,409)(4,881)
Realized and change in unrealized gains (losses)
Net realized gain (loss) (1,412)14,760 (44,972)26,989 
Net change in unrealized appreciation (depreciation) 10,832 (5,675)5,811 45,708 
Net gain (loss) on investment transactions9,420 9,085 (39,161)72,697 
Net income (loss)$8,102 $8,974 $(41,570)$67,816 
GLRE Limited Partners’ share of net income (loss) (1)$6,431 $6,609 $(34,086)$51,770 

(1) Net of management fees and accrued performance allocation as follows:

Three months ended September 30Nine months ended September 30
2020201920202019
($ in thousands)
Management fees$703 $652 $1,981 $4,234 
Performance allocation$— $673 $— $5,654 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL INSTRUMENTS (Tables)
 9 Months Ended
Sep. 30, 2020
Fair Value Disclosures [Abstract]  
Other Investments
At September 30, 2020, the following securities were included in the caption “Other investments”:
September 30, 2020CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities $11,364 $5,373 $(1,067)$15,670 
Investment accounted for under the equity method — — — 6,571 
Total other investments$22,241 

At December 31, 2019, the following securities were included in the caption “Other investments”: 
December 31, 2019CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities$10,420 $265 $(4)$10,681 
Investment accounted for under the equity method— — — 5,703 
Total other investments$16,384 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.2
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)
 9 Months Ended
Sep. 30, 2020
Insurance Loss Reserves [Abstract]  
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense
At September 30, 2020 and December 31, 2019, loss and loss adjustment expense reserves were composed of the following:
September 30, 2020December 31, 2019
 ($ in thousands)
Case reserves$224,732 $217,834 
IBNR257,038 252,754 
Total$481,770 $470,588 

A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated
for the nine months ended September 30, 2020 and 2019 is as follows: 
Consolidated20202019
 ($ in thousands)
Gross balance at January 1$470,588 $482,662 
Less: Losses recoverable(27,531)(43,705)
Net balance at January 1443,057 438,957 
Incurred losses related to:  
Current year247,559 264,129 
Prior years5,385 30,174 
Total incurred252,944 294,303 
Paid losses related to:  
Current year(72,453)(93,822)
Prior years(161,222)(200,384)
Total paid(233,675)(294,206)
Foreign currency revaluation(505)(1,154)
Net balance at September 30461,821 437,900 
Add: Losses recoverable19,949 41,535 
Gross balance at September 30$481,770 $479,435 
    
The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2020 and 2019 are as follows:
Health20202019
 ($ in thousands)
Gross balance at January 1$18,063 $24,502 
Less: Losses recoverable— — 
Net balance at January 118,063 24,502 
Incurred losses related to: 
Current year25,032 26,013 
Prior years1,341 2,196 
Total incurred26,373 28,209 
Paid losses related to: 
Current year(15,115)(14,741)
Prior years(16,327)(23,160)
Total paid(31,442)(37,901)
Foreign currency revaluation— — 
Net balance at September 3012,994 14,810 
Add: Losses recoverable— — 
Gross balance at September 30$12,994 $14,810 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE CAPITAL (Tables)
 9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Schedule of Stock by Class
The following table is a summary of voting ordinary shares issued and outstanding:
Nine months ended September 30Nine months ended September 30
 20202019
Class AClass BClass AClass B
Balance – beginning of period30,739,395 6,254,715 30,130,214 6,254,715 
Issue of ordinary shares, net of forfeitures248,726 — 408,233 — 
Repurchase of ordinary shares(1,874,419)— — — 
Balance – end of period29,113,702 6,254,715 30,538,447 6,254,715 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2020:

 Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value
Balance at December 31, 2019873,087 $12.83 
Granted451,353 6.72 
Vested(235,833)13.83 
Forfeited(210,109)10.90 
Balance at September 30, 2020878,498 $9.88 
Employee RSU activity during the nine months ended September 30, 2020 was as follows:
 Number of
non-vested
RSUs		Weighted
 average
grant date
fair value
Balance at December 31, 201963,582 $13.76 
Granted60,622 6.72 
Vested(7,482)21.65 
Forfeited— — 
Balance at September 30, 2020116,722 $9.60 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES (Tables)
 9 Months Ended
Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
Letters of Credit Facilities
At September 30, 2020, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:
Maximum Facility LimitTermination DateNotice period required for termination
 ($ in thousands)  
Citibank Europe plc$275,000 August 20, 2021
120 days prior to termination date
Schedule of Commitments and Contingencies, Fiscal Year Maturity Schedule
The following is a schedule of future minimum payments required under the above commitments:  

 20202021202220232024ThereafterTotal
 ($ in thousands)
Operating lease obligations$171 $65 $— $— $— $— $236 
Interest and convertible note payable— 4,000 4,000 102,000 — — 110,000 
 $171 $4,065 $4,000 $102,000 $— $— $110,236 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT REPORTING (Tables)
 9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Gross Premiums Written by Line of Business The following tables provide a breakdown of the Company’s gross premiums written by line of business and by geographic area of risks insured for the periods indicated: 
Gross Premiums Written by Line of Business
  Three months ended September 30Nine months ended September 30
2020201920202019
  ($ in thousands)($ in thousands)
Property
Commercial$3,396 2.5 %$5,088 4.6 %$9,426 2.6 %$11,752 2.8 %
Motor10,091 7.4 11,367 10.3 25,136 6.9 50,807 11.9 
Personal3,691 2.7 3,632 3.3 10,326 2.9 9,788 2.3 
Total Property17,178 12.6 20,087 18.2 44,888 12.4 72,347 17.0 
Casualty
General Liability3,224 2.4 913 0.8 3,920 1.1 2,368 0.6 
Motor Liability41,679 30.7 47,021 42.5 96,729 26.7 197,335 46.4 
Professional Liability 76 0.1 11 — 199 0.1 117 — 
Workers' Compensation21,979 16.2 14,077 12.7 60,908 16.8 35,121 8.3 
Multi-line 25,820 19.0 15,082 13.6 67,379 18.6 61,173 14.4 
Total Casualty92,778 68.4 77,104 69.6 229,135 63.3 296,114 69.7 
Other
Accident & Health12,418 9.3 7,527 6.8 40,522 11.2 31,065 7.2 
Financial1,817 1.3 315 0.3 15,704 4.3 15,394 3.6 
Marine127 0.1 (33)— 749 0.2 94 — 
Other Specialty11,278 8.3 5,607 5.1 31,074 8.6 10,493 2.5 
Total Other25,640 19.0 13,416 12.2 88,049 24.3 57,046 13.3 
$135,596 100.0 %$110,607 100.0 %$362,072 100.0 %$425,507 100.0 %
Gross Premiums Written by Geographic Area of Risks Insured Gross Premiums Written by Geographic Area of Risks Insured
 Three months ended September 30Nine months ended September 30
2020201920202019
 ($ in thousands)($ in thousands)
U.S. and Caribbean$110,798 81.7 %$89,811 81.2 %$291,511 80.5 %$358,099 84.1 %
Worldwide (1) $22,738 16.8 %$18,450 16.7 %$66,150 18.3 %$64,590 15.2 %
Europe$— — %$— — %$— — %$(13)— %
Asia$2,060 1.5 %$2,346 2.1 %$4,411 1.2 %$2,831 0.7 %
$135,596 100.0 %$110,607 100.0 %$362,072 100.0 %$425,507 100.0 %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S.
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.20.2
SIGNIFICANT ACCOUNTING POLICIES Cash Flow, Supplemental Cash Equivalents Reconciliation (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2018
Accounting Policies [Abstract]        
Cash and cash equivalents $ 8,159 $ 25,813    
Restricted cash and cash equivalents 723,107 742,093    
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows $ 731,266 $ 767,906 $ 774,006 $ 703,231
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.20.2
SIGNIFICANT ACCOUNTING POLICIES Narrative (Details) - USD ($)
 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Retained earnings (deficit) $ (69,099,000) $ (30,063,000)
Provision for uncollectible losses recoverable 89,000 0
Accrued interest 100,000 100,000
Deposit contracts, assets 5,300,000 5,200,000
Deposit contracts, liabilities $ 35,200,000 56,900,000
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member  
Cumulative Effect Period Of Adoption Adjustment    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Retained earnings (deficit) $ 100,000  
Provision for uncollectible losses recoverable $ 100,000  
Cumulative Effect Period Of Adoption Adjustment | Accounting Standards Update 2016-13    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Retained earnings (deficit)   $ 900,000
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.20.2
SIGNIFICANT ACCOUNTING POLICIES Schedule of Allowance For Credit Losses on Notes Receivable (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Financing Receivable, Allowance for Credit Loss [Roll Forward]    
Balance at beginning of period $ 15,000 $ 9,012
Charge offs (15,000) 0
Net increase (decrease) in allowance 250 0
Balance at end of period 1,000 9,012
Cumulative Effect Period Of Adoption Adjustment    
Financing Receivable, Allowance for Credit Loss [Roll Forward]    
Balance at beginning of period $ 750 $ 0
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.20.2
SIGNIFICANT ACCOUNTING POLICIES Interest Income and Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Accounting Policies [Abstract]        
Deposit interest income $ 560 $ 1,023 $ 1,812 $ 2,493
Deposit interest expense 0 (656) 0 (135)
Deposit interest income/(expense), net $ 560 $ 367 $ 1,812 $ 2,358
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.20.2
SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share Reconciliation (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Weighted average shares outstanding - basic (in shares) 35,677,554 36,841,623 35,569,292 36,646,515
Effect of dilutive employee and director share-based awards (in shares) 102,149 79,867 0 74,035
Weighted average shares outstanding - diluted (in shares) 35,779,703 36,921,490 35,569,292 36,720,550
Anti-dilutive stock options outstanding        
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Anti-dilutive stock options outstanding (in shares) 835,627 875,627 835,627 875,627
Participating securities excluded from calculation of loss per share         
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Anti-dilutive stock options outstanding (in shares) 0 0 878,498 0
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Aug. 05, 2020
Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]            
GLRE Limited Partners’ share of net income (loss) $ 6,431 $ 6,609 $ (34,086) $ 51,770    
General Partner            
Schedule of Equity Method Investments [Line Items]            
Equity method investment, ownership percentage 19.00%   19.00%     19.00%
SILP            
Schedule of Equity Method Investments [Line Items]            
Asset redemption notice to general partner     3 days      
SILP | Greenlight Capital Re Limited Partners            
Schedule of Equity Method Investments [Line Items]            
Investment portfolio percent of shareholders equity maximum         50.00%  
Equity method investments, fair value $ 185,000   $ 185,000     $ 240,100
Equity method investment, ownership percentage 81.00%   81.00%     81.00%
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Liabilities    
GLRE Limited Partners’ share of Net Assets $ 184,956 $ 240,056
Solasglas Investment LP (SILP) | Equity Method Investment, Nonconsolidated Investee or Group of Investees    
Assets    
Investments, at fair value 220,116 162,928
Derivative contracts, at fair value 3,097 6,324
Due from brokers 130,220 68,060
Cash and cash equivalents 2,202 111,046
Interest and dividends receivable 281 47
Total assets 355,916 348,405
Liabilities    
Investments sold short, at fair value (116,336) (47,834)
Derivative contracts, at fair value (10,962) (2,054)
Due to brokers 0 (1,180)
Interest and dividends payable (32) (828)
Other liabilities (233) (101)
Total liabilities (127,563) (51,997)
Net Assets 228,353 296,408
GLRE Limited Partners’ share of Net Assets $ 184,956 $ 240,056
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Income Statements of SILP (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Expenses        
Management fee $ (703) $ (1,981) $ (1,325) $ (9,888)
Interest (1,579) (1,578) (4,702) (4,684)
Realized and change in unrealized gains (losses)        
Net income (loss) 2,183 5,140 (38,150) 26,360
GLRE Limited Partners’ share of net income (loss) 6,431 6,609 (34,086) 51,770
Management fees 703 652 1,981 4,234
Performance allocation 0 673 0 5,654
Solasglas Investment LP (SILP)        
Investment income        
Dividend income (net of withholding taxes) 170 652 1,204 2,334
Interest income 36 279 262 1,869
Total Investment income 206 931 1,466 4,203
Expenses        
Management fee (703) (653) (1,981) (4,235)
Interest (176) (89) (518) (2,308)
Dividends (213) (96) (612) (1,532)
Professional fees and other (432) (204) (764) (1,009)
Total expenses (1,524) (1,042) (3,875) (9,084)
Net investment income (loss) (1,318) (111) (2,409) (4,881)
Realized and change in unrealized gains (losses)        
Net realized gain (loss) (1,412) 14,760 (44,972) 26,989
Net change in unrealized appreciation (depreciation) 10,832 (5,675) 5,811 45,708
Net gain (loss) on investment transactions 9,420 9,085 (39,161) 72,697
Net income (loss) 8,102 8,974 (41,570) 67,816
GLRE Limited Partners’ share of net income (loss) $ 6,431 $ 6,609 $ (34,086) $ 51,770
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL INSTRUMENTS Schedule of Other Investments (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Debt and Equity Securities, FV-NI [Line Items]    
Fair value / carrying value $ 22,241 $ 16,384
Private investments and unlisted equities    
Debt and Equity Securities, FV-NI [Line Items]    
Cost 11,364 10,420
Unrealized gains 5,373 265
Unrealized losses (1,067) (4)
Fair value / carrying value 15,670 10,681
Investment accounted for under the equity method    
Debt and Equity Securities, FV-NI [Line Items]    
Fair value / carrying value $ 6,571 $ 5,703
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL INSTRUMENTS Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Fair value / carrying value $ 22,241 $ 16,384 $ 22,241   $ 22,241  
Income (loss) from equity method investments         870 $ 267
AccuRisk Holdings LLC | Variable Interest Entity, Not Primary Beneficiary            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Equity method investment, ownership percentage 58.00% 58.00%        
Line of credit facility increase accrued interest         6,000  
Income (loss) from equity method investments     100 $ (200) 900 300
Private investments and unlisted equities            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Fair value / carrying value $ 15,670 $ 10,681 15,670   15,670  
Other investments, adjustment     $ 0 $ 0 $ 4,100 $ 200
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.20.2
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Change in Outstanding Loss and Loss Adjustment Expense Reserve For Health Claims (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2018
Liability for Claims and Claims Adjustment Expense [Line Items]            
Case reserves     $ 224,732 $ 217,834    
IBNR     257,038 252,754    
Total $ 470,588 $ 479,435 481,770 470,588 $ 479,435 $ 482,662
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]            
Gross balance at January 1 470,588 482,662        
Less: Losses recoverable       (27,531)   (43,705)
Net balance at January 1 443,057 438,957        
Incurred losses related to:            
Current year 247,559 264,129        
Prior years 5,385 30,174        
Total incurred 252,944 294,303        
Paid losses related to:            
Current year (72,453) (93,822)        
Prior years (161,222) (200,384)        
Total paid (233,675) (294,206)        
Foreign currency revaluation (505) (1,154)        
Net balance at September 30 461,821 437,900        
Add: Losses recoverable     19,949 27,531 41,535  
Gross balance at September 30 481,770 479,435        
Prior years adjustment increase (decrease) 5,385 30,174        
Net loss reserve on prior contracts increase (decrease) (4,800) (27,700)        
Health            
Liability for Claims and Claims Adjustment Expense [Line Items]            
Total 12,994 14,810 12,994 18,063 14,810 24,502
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]            
Gross balance at January 1 18,063 24,502        
Less: Losses recoverable       $ 0   $ 0
Net balance at January 1 18,063 24,502        
Incurred losses related to:            
Current year 25,032 26,013        
Prior years 1,341 2,196        
Total incurred 26,373 28,209        
Paid losses related to:            
Current year (15,115) (14,741)        
Prior years (16,327) (23,160)        
Total paid (31,442) (37,901)        
Foreign currency revaluation 0 0        
Net balance at September 30 12,994 14,810        
Add: Losses recoverable     $ 0   $ 0  
Gross balance at September 30 12,994 14,810        
Prior years adjustment increase (decrease) $ 1,341 $ 2,196        
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.20.2
RETROCESSION (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Ceded Credit Risk [Line Items]            
Ceded premiums earned $ 1,700,000 $ 22,000,000.0 $ 3,200,000 $ 65,800,000    
Net loss and loss adjustment expenses incurred 88,053,000 92,962,000 252,944,000 294,303,000    
Loss and loss expenses recovered and recoverable 2,500,000 $ 13,900,000 6,200,000 $ 56,200,000    
Loss and loss adjustment expenses recoverable         $ 27,531,000 $ 43,705,000
Provision for uncollectible losses recoverable 89,000   89,000   0  
AM Best, A- Rating            
Ceded Credit Risk [Line Items]            
Loss and loss adjustment expenses recoverable 5,000,000.0   5,000,000.0   6,400,000  
Unsecured | Unrated            
Ceded Credit Risk [Line Items]            
Loss and loss adjustment expenses recoverable 15,000,000.0   15,000,000.0   21,200,000  
Secured | Unrated            
Ceded Credit Risk [Line Items]            
Loss and loss adjustment expenses recoverable $ 14,500,000   $ 14,500,000   $ 20,000,000.0  
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.20.2
SENIOR CONVERTIBLE NOTES (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Aug. 07, 2018
Debt Instrument [Line Items]            
Convertible senior notes payable $ 94,216,000   $ 94,216,000   $ 93,514,000  
Senior Notes | Senior Unsecured Convertible Notes            
Debt Instrument [Line Items]            
Convertible debt, amount 25,000,000.0   25,000,000.0     $ 100,000,000.0
Debt interest rate           4.00%
Effective interest rate           6.00%
Unamortized discount 4,700,000   4,700,000   5,900,000 $ 8,200,000
Unamortized debt issuance expense 1,800,000   1,800,000   2,300,000  
Convertible debt, carrying amount of equity component 7,900,000   7,900,000      
Accrued interest 700,000   700,000      
Convertible senior notes payable 94,200,000   94,200,000   93,500,000  
Fair value of debt 80,100,000   80,100,000   $ 94,900,000  
Recognized interest expense $ 1,600,000 $ 1,600,000 $ 4,700,000 $ 4,700,000    
Senior Notes | Senior Unsecured Convertible Notes | Pro Forma            
Debt Instrument [Line Items]            
Debt conversion price (in dollars per share) $ 17.19   $ 17.19      
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE CAPITAL Narrative (Details) - USD ($)
 9 Months Ended
Oct. 29, 2020
Sep. 30, 2020
Sep. 30, 2019
Oct. 28, 2020
Mar. 26, 2020
Dec. 31, 2019
Aug. 07, 2018
Senior Unsecured Convertible Notes | Senior Notes              
Class of Stock [Line Items]              
Debt instrument, amount authorized for repurchase (up to)         $ 25,000,000.0    
Debt interest rate             4.00%
Convertible debt, amount   $ 25,000,000.0         $ 100,000,000.0
Common Class A              
Class of Stock [Line Items]              
Number of shares authorized for issuance (in shares)         5,000,000.0    
Number of shares available for grant (in shares)   293,939       555,805  
Repurchase of ordinary shares (in shares)   1,874,419 0        
Stock repurchase program, remaining number of shares to be repurchased (in shares)   3,100,000          
Ordinary share capital, par value (in dollars per share)   $ 0.10       $ 0.10  
Common Class A | Subsequent Event              
Class of Stock [Line Items]              
Number of shares authorized for issuance period increase (in shares) 3,000,000.0            
Number of shares authorized for issuance (in shares) 8,000,000.0     5,000,000.0      
Common Class B              
Class of Stock [Line Items]              
Repurchase of ordinary shares (in shares)   0 0        
Ordinary share capital, par value (in dollars per share)   $ 0.10       $ 0.10  
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE CAPITAL Schedule of Voting Ordinary Shares Issued And Outstanding (Details) - shares
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Common Class A    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance – beginning of period (in shares) 30,739,395 30,130,214
Issue of ordinary shares, net of forfeitures (in shares) 248,726 408,233
Repurchase of ordinary shares (in shares) (1,874,419) 0
Balance – end of period (in shares) 29,113,702 30,538,447
Common Class B    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance – beginning of period (in shares) 6,254,715 6,254,715
Issue of ordinary shares, net of forfeitures (in shares) 0 0
Repurchase of ordinary shares (in shares) 0 0
Balance – end of period (in shares) 6,254,715 6,254,715
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE-BASED COMPENSATION Narrative (Details) - USD ($)
 9 Months Ended
Sep. 30, 2020
Jul. 30, 2020
Dec. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
General and Administrative Expense          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock based compensation expense       $ 1,400,000 $ 2,900,000
Employee and Director Restricted Shares          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period       3 years  
Fair value (in dollars per share)       $ 6.72  
Stock based compensation expense       $ 600,000 2,000,000.0
Shares forfeited       700,000 200,000
Unrecognized cost $ 2,200,000   $ 2,700,000 2,200,000  
Period of recognition 2 years 4 months 24 days   1 year 7 months 6 days    
Fair value of options vested in period       $ 2,800,000 $ 3,100,000
Number of RSUs issued to employees (in shares)       451,353  
Shares forfeited (in shares)       210,109  
Employee and Director Restricted Shares | Chief Executive Officer          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period       5 years  
Fair value (in dollars per share)       $ 6.72 $ 10.84
Number of shares with accelerated vesting   72,545      
Stock based compensation expense       $ 0 $ 0
Employee and Director Restricted Shares | Common Class A          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares issued (in shares)       306,264 235,701
Number of restricted shares forfeited (in shares)       210,109 27,386
Employee and Director Restricted Shares | Common Class A | Chief Executive Officer          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares issued (in shares)       145,089 326,240
Employee and Director Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock based compensation expense       $ 500,000 $ 700,000
Period of recognition       2 years 2 years 4 months 24 days
Number of options granted (in shares)       40,000 60,000
Vested number of shares (in shares)       80,000 80,000
Cost not yet recognized $ 800,000     $ 800,000 $ 1,300,000
Options outstanding (in shares) 800,000   900,000 800,000  
Exercise price (in dollars per share) $ 22.22   $ 22.68 $ 22.22  
Weighted average grant date fair value, granted (in dollars per share)       $ 10.25 $ 10.25
Weighted average remaining contractual term 5 years 3 months 18 days   5 years 9 months 18 days    
Employee and Director Stock Options | Common Class A | Chief Executive Officer          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of options granted (in shares)       0  
Number of stock options exercised (in shares)       0  
RSUs          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period       3 years  
Fair value (in dollars per share)       $ 6.72  
Stock based compensation expense       $ 300,000 $ 100,000
Number of RSUs issued to employees (in shares)       60,622 48,535
Shares forfeited (in shares)       0 24,165
RSUs | Common Class A          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Conversion ratio (in shares)       1  
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE-BASED COMPENSATION Restricted Shares (Details) - Employee and Director Restricted Shares
 9 Months Ended
Sep. 30, 2020
$ / shares
shares
Number of non-vested restricted  shares  
Balance at December 31, 2019 (in shares) | shares 873,087
Granted (in shares) | shares 451,353
Vested (in shares) | shares (235,833)
Forfeited (in shares) | shares (210,109)
Balance at September 30, 2020 (in shares) | shares 878,498
Weighted  average grant date fair value  
Balance at December 31, 2019 (in dollars per share) | $ / shares $ 12.83
Granted (in dollars per share) | $ / shares 6.72
Vested (in dollars per share) | $ / shares 13.83
Forfeited (in dollars per share) | $ / shares 10.90
Balance at September 30, 2020 (in dollars per share) | $ / shares $ 9.88
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE-BASED COMPENSATION Restricted Stock Units (Details) - RSUs - $ / shares
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Number of non-vested RSUs    
Balance at December 31, 2019 (in shares) 63,582  
Granted (in shares) 60,622 48,535
Vested (in shares) (7,482)  
Forfeited (in shares) 0 (24,165)
Balance at September 30, 2020 (in shares) 116,722  
Weighted  average grant date fair value    
Balance at December 31, 2019 (in dollars per share) $ 13.76  
Granted (in dollars per share) 6.72  
Vested (in dollars per share) 21.65  
Forfeited (in dollars per share) 0  
Balance at September 30, 2020 (in dollars per share) $ 9.60  
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.20.2
RELATED PARTY TRANSACTIONS (Details) - USD ($)
 9 Months Ended
Jan. 01, 2019
Sep. 01, 2018
Aug. 31, 2018
Sep. 30, 2020
Green Bricks Partners Inc (GRBK) | Affiliated Entity        
Related Party Transaction [Line Items]        
Ownership percentage       47.60%
SILP | Board of Directors Chairman        
Related Party Transaction [Line Items]        
Performance compensation reduced rate as a percentage of investment income     10.00%  
Performance compensation full rate     20.00%  
Performance compensation reduced rate     10.00%  
Loss carry forward recoupment required     150.00%  
Investment Advisory Agreement | Board of Directors Chairman        
Related Party Transaction [Line Items]        
Investment management fee rate - monthly   0.125%    
Investment management fee rate - annual   1.50%    
Automatic agreement extension, term   3 years    
Service Agreement | Board of Directors Chairman        
Related Party Transaction [Line Items]        
Investor relations monthly fee       $ 5,000
Contract termination prior notice period       30 days
Collateral Assets Investment Management Agreement | Board of Directors Chairman        
Related Party Transaction [Line Items]        
Contract termination prior notice period 30 days      
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES Narrative (Details)
€ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
facility
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
facility
Sep. 30, 2020
EUR (€)
Sep. 30, 2019
USD ($)
Aug. 26, 2020
USD ($)
Aug. 25, 2020
USD ($)
Dec. 31, 2019
USD ($)
Line of Credit Facility [Line Items]                
Number of credit facilities | facility 1   1          
Amount of letters of credit issued $ 133,000,000.0   $ 133,000,000.0         $ 204,500,000
Total equity securities, restricted cash, and cash and cash equivalents fair value pledged as security against the letters of credit 135,600,000   135,600,000         213,400,000
Collateral held in trust 587,500,000   587,500,000         528,700,000
Maximum Facility Limit           $ 275,000,000.0 $ 400,000,000.0  
Short term lease cost $ 400,000 $ 400,000 $ 400,000   $ 400,000      
Term of contract 5 years   5 years          
Operating lease, ROU asset $ 100,000   $ 100,000         200,000
Operating lease, liability 100,000   100,000         $ 200,000
Operating lease expense $ 0 $ 0 $ 0   $ 0      
GRIL                
Line of Credit Facility [Line Items]                
Short term lease cost | €       € 0.1        
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES Schedule of Letters of Credit (Details) - USD ($)
 9 Months Ended
Sep. 30, 2020
Aug. 26, 2020
Aug. 25, 2020
Line of Credit Facility [Line Items]      
Maximum Facility Limit   $ 275,000,000.0 $ 400,000,000.0
Citibank Europe plc | Facility      
Line of Credit Facility [Line Items]      
Maximum Facility Limit $ 275,000,000    
Notice period required for termination 120 days    
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES Schedule of Commitments and Contingencies (Details)
$ in Thousands
Sep. 30, 2020
USD ($)
Operating lease obligations  
2020 $ 171
2021 65
2022 0
2023 0
2024 0
Thereafter 0
Total 236
Total future obligations by year  
2020 171
2021 4,065
2022 4,000
2023 102,000
2024 0
Thereafter 0
Total 110,236
Convertible Debt  
Interest and convertible note payable  
2020 0
2021 4,000
2022 4,000
2023 102,000
2024 0
Thereafter 0
Total $ 110,000
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT REPORTING Gross Premiums Written by Line of Business (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
segment
Sep. 30, 2019
USD ($)
Segment Reporting Information [Line Items]        
Number of operating segments | segment     1  
Gross premiums written $ 135,596 $ 110,607 $ 362,072 $ 425,507
Gross premiums written, percent 100.00% 100.00% 100.00% 100.00%
Commercial        
Segment Reporting Information [Line Items]        
Gross premiums written $ 3,396 $ 5,088 $ 9,426 $ 11,752
Gross premiums written, percent 2.50% 4.60% 2.60% 2.80%
Motor        
Segment Reporting Information [Line Items]        
Gross premiums written $ 10,091 $ 11,367 $ 25,136 $ 50,807
Gross premiums written, percent 7.40% 10.30% 6.90% 11.90%
Personal        
Segment Reporting Information [Line Items]        
Gross premiums written $ 3,691 $ 3,632 $ 10,326 $ 9,788
Gross premiums written, percent 2.70% 3.30% 2.90% 2.30%
Total Property        
Segment Reporting Information [Line Items]        
Gross premiums written $ 17,178 $ 20,087 $ 44,888 $ 72,347
Gross premiums written, percent 12.60% 18.20% 12.40% 17.00%
General Liability        
Segment Reporting Information [Line Items]        
Gross premiums written $ 3,224 $ 913 $ 3,920 $ 2,368
Gross premiums written, percent 2.40% 0.80% 1.10% 0.60%
Motor Liability        
Segment Reporting Information [Line Items]        
Gross premiums written $ 41,679 $ 47,021 $ 96,729 $ 197,335
Gross premiums written, percent 30.70% 42.50% 26.70% 46.40%
Professional Liability        
Segment Reporting Information [Line Items]        
Gross premiums written $ 76 $ 11 $ 199 $ 117
Gross premiums written, percent 0.10% 0.00% 0.10% 0.00%
Workers' Compensation        
Segment Reporting Information [Line Items]        
Gross premiums written $ 21,979 $ 14,077 $ 60,908 $ 35,121
Gross premiums written, percent 16.20% 12.70% 16.80% 8.30%
Multi-line        
Segment Reporting Information [Line Items]        
Gross premiums written $ 25,820 $ 15,082 $ 67,379 $ 61,173
Gross premiums written, percent 19.00% 13.60% 18.60% 14.40%
Total Casualty        
Segment Reporting Information [Line Items]        
Gross premiums written $ 92,778 $ 77,104 $ 229,135 $ 296,114
Gross premiums written, percent 68.40% 69.60% 63.30% 69.70%
Accident & Health        
Segment Reporting Information [Line Items]        
Gross premiums written $ 12,418 $ 7,527 $ 40,522 $ 31,065
Gross premiums written, percent 9.30% 6.80% 11.20% 7.20%
Financial        
Segment Reporting Information [Line Items]        
Gross premiums written $ 1,817 $ 315 $ 15,704 $ 15,394
Gross premiums written, percent 1.30% 0.30% 4.30% 3.60%
Marine        
Segment Reporting Information [Line Items]        
Gross premiums written $ 127 $ (33) $ 749 $ 94
Gross premiums written, percent 0.10% 0.00% 0.20% 0.00%
Other Specialty        
Segment Reporting Information [Line Items]        
Gross premiums written $ 11,278 $ 5,607 $ 31,074 $ 10,493
Gross premiums written, percent 8.30% 5.10% 8.60% 2.50%
Total Other        
Segment Reporting Information [Line Items]        
Gross premiums written $ 25,640 $ 13,416 $ 88,049 $ 57,046
Gross premiums written, percent 19.00% 12.20% 24.30% 13.30%
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT REPORTING Geographic Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenue from External Customer [Line Items]        
Gross premiums written $ 135,596 $ 110,607 $ 362,072 $ 425,507
Gross premiums by geographical area as a percentage of total gross premiums 100.00% 100.00% 100.00% 100.00%
U.S. and Caribbean        
Revenue from External Customer [Line Items]        
Gross premiums written $ 110,798 $ 89,811 $ 291,511 $ 358,099
Gross premiums by geographical area as a percentage of total gross premiums 81.70% 81.20% 80.50% 84.10%
Worldwide        
Revenue from External Customer [Line Items]        
Gross premiums written $ 22,738 $ 18,450 $ 66,150 $ 64,590
Gross premiums by geographical area as a percentage of total gross premiums 16.80% 16.70% 18.30% 15.20%
Europe        
Revenue from External Customer [Line Items]        
Gross premiums written $ 0 $ 0 $ 0 $ (13)
Gross premiums by geographical area as a percentage of total gross premiums 0.00% 0.00% 0.00% 0.00%
Asia        
Revenue from External Customer [Line Items]        
Gross premiums written $ 2,060 $ 2,346 $ 4,411 $ 2,831
Gross premiums by geographical area as a percentage of total gross premiums 1.50% 2.10% 1.20% 0.70%
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended
Nov. 04, 2020
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2019
Subsequent Event [Line Items]        
Note     $ 18,461 $ 20,202
Promissory Note [Member]        
Subsequent Event [Line Items]        
Note     $ 13,300  
Forecast | Promissory Note [Member]        
Subsequent Event [Line Items]        
Gains on restructuring of debt   $ 5,800    
Subsequent Event | Promissory Note [Member]        
Subsequent Event [Line Items]        
Receivable collection amount $ 19,100      
EXCEL 66 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 68 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 69 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 232 379 1 false 65 0 false 7 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.greenlightre.ky/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY Statements 6 false false R7.htm 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION Sheet http://www.greenlightre.ky/role/ORGANIZATIONANDBASISOFPRESENTATION ORGANIZATION AND BASIS OF PRESENTATION Notes 8 false false R9.htm 2102102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 2110103 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND INVESTMENT IN RELATED PARTY INVESTMENT FUND Notes 10 false false R11.htm 2115104 - Disclosure - FINANCIAL INSTRUMENTS Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS FINANCIAL INSTRUMENTS Notes 11 false false R12.htm 2119105 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Sheet http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Notes 12 false false R13.htm 2122106 - Disclosure - RETROCESSION Sheet http://www.greenlightre.ky/role/RETROCESSION RETROCESSION Notes 13 false false R14.htm 2124107 - Disclosure - SENIOR CONVERTIBLE NOTES Notes http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES SENIOR CONVERTIBLE NOTES Notes 14 false false R15.htm 2126108 - Disclosure - SHARE CAPITAL Sheet http://www.greenlightre.ky/role/SHARECAPITAL SHARE CAPITAL Notes 15 false false R16.htm 2130109 - Disclosure - SHARE-BASED COMPENSATION Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION SHARE-BASED COMPENSATION Notes 16 false false R17.htm 2135110 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 17 false false R18.htm 2137111 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 2142112 - Disclosure - SEGMENT REPORTING Sheet http://www.greenlightre.ky/role/SEGMENTREPORTING SEGMENT REPORTING Notes 19 false false R20.htm 2146113 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.greenlightre.ky/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 20 false false R21.htm 2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 21 false false R22.htm 2304301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES 22 false false R23.htm 2311302 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) Tables http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND 23 false false R24.htm 2316303 - Disclosure - FINANCIAL INSTRUMENTS (Tables) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables FINANCIAL INSTRUMENTS (Tables) Tables http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS 24 false false R25.htm 2320304 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables) Sheet http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESTables LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables) Tables http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES 25 false false R26.htm 2327305 - Disclosure - SHARE CAPITAL (Tables) Sheet http://www.greenlightre.ky/role/SHARECAPITALTables SHARE CAPITAL (Tables) Tables http://www.greenlightre.ky/role/SHARECAPITAL 26 false false R27.htm 2331306 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables SHARE-BASED COMPENSATION (Tables) Tables http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION 27 false false R28.htm 2338307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES 28 false false R29.htm 2343308 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://www.greenlightre.ky/role/SEGMENTREPORTINGTables SEGMENT REPORTING (Tables) Tables http://www.greenlightre.ky/role/SEGMENTREPORTING 29 false false R30.htm 2405401 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Cash Flow, Supplemental Cash Equivalents Reconciliation (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashFlowSupplementalCashEquivalentsReconciliationDetails SIGNIFICANT ACCOUNTING POLICIES Cash Flow, Supplemental Cash Equivalents Reconciliation (Details) Details 30 false false R31.htm 2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Narrative (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails SIGNIFICANT ACCOUNTING POLICIES Narrative (Details) Details 31 false false R32.htm 2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Schedule of Allowance For Credit Losses on Notes Receivable (Details) Notes http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails SIGNIFICANT ACCOUNTING POLICIES Schedule of Allowance For Credit Losses on Notes Receivable (Details) Details 32 false false R33.htm 2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Interest Income and Expense (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandExpenseDetails SIGNIFICANT ACCOUNTING POLICIES Interest Income and Expense (Details) Details 33 false false R34.htm 2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share Reconciliation (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share Reconciliation (Details) Details 34 false false R35.htm 2412406 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Narrative (Details) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails INVESTMENT IN RELATED PARTY INVESTMENT FUND Narrative (Details) Details http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables 35 false false R36.htm 2413407 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details) Details 36 false false R37.htm 2414408 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Income Statements of SILP (Details) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Income Statements of SILP (Details) Details 37 false false R38.htm 2417409 - Disclosure - FINANCIAL INSTRUMENTS Schedule of Other Investments (Details) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails FINANCIAL INSTRUMENTS Schedule of Other Investments (Details) Details 38 false false R39.htm 2418410 - Disclosure - FINANCIAL INSTRUMENTS Narrative (Details) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails FINANCIAL INSTRUMENTS Narrative (Details) Details 39 false false R40.htm 2421411 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Change in Outstanding Loss and Loss Adjustment Expense Reserve For Health Claims (Details) Sheet http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Change in Outstanding Loss and Loss Adjustment Expense Reserve For Health Claims (Details) Details 40 false false R41.htm 2423412 - Disclosure - RETROCESSION (Details) Sheet http://www.greenlightre.ky/role/RETROCESSIONDetails RETROCESSION (Details) Details http://www.greenlightre.ky/role/RETROCESSION 41 false false R42.htm 2425413 - Disclosure - SENIOR CONVERTIBLE NOTES (Details) Notes http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails SENIOR CONVERTIBLE NOTES (Details) Details http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES 42 false false R43.htm 2428414 - Disclosure - SHARE CAPITAL Narrative (Details) Sheet http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails SHARE CAPITAL Narrative (Details) Details 43 false false R44.htm 2429415 - Disclosure - SHARE CAPITAL Schedule of Voting Ordinary Shares Issued And Outstanding (Details) Sheet http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails SHARE CAPITAL Schedule of Voting Ordinary Shares Issued And Outstanding (Details) Details 44 false false R45.htm 2432416 - Disclosure - SHARE-BASED COMPENSATION Narrative (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails SHARE-BASED COMPENSATION Narrative (Details) Details 45 false false R46.htm 2433417 - Disclosure - SHARE-BASED COMPENSATION Restricted Shares (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails SHARE-BASED COMPENSATION Restricted Shares (Details) Details 46 false false R47.htm 2434418 - Disclosure - SHARE-BASED COMPENSATION Restricted Stock Units (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails SHARE-BASED COMPENSATION Restricted Stock Units (Details) Details 47 false false R48.htm 2436419 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS 48 false false R49.htm 2439420 - Disclosure - COMMITMENTS AND CONTINGENCIES Narrative (Details) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails COMMITMENTS AND CONTINGENCIES Narrative (Details) Details 49 false false R50.htm 2440421 - Disclosure - COMMITMENTS AND CONTINGENCIES Schedule of Letters of Credit (Details) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails COMMITMENTS AND CONTINGENCIES Schedule of Letters of Credit (Details) Details 50 false false R51.htm 2441422 - Disclosure - COMMITMENTS AND CONTINGENCIES Schedule of Commitments and Contingencies (Details) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails COMMITMENTS AND CONTINGENCIES Schedule of Commitments and Contingencies (Details) Details 51 false false R52.htm 2444423 - Disclosure - SEGMENT REPORTING Gross Premiums Written by Line of Business (Details) Sheet http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails SEGMENT REPORTING Gross Premiums Written by Line of Business (Details) Details 52 false false R53.htm 2445424 - Disclosure - SEGMENT REPORTING Geographic Information (Details) Sheet http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails SEGMENT REPORTING Geographic Information (Details) Details 53 false false R54.htm 2447425 - Disclosure - Subsequent Events (Details) Sheet http://www.greenlightre.ky/role/SubsequentEventsDetails Subsequent Events (Details) Details 54 false false All Reports Book All Reports glre-20200930.htm glre-20200930.xsd glre-20200930_cal.xml glre-20200930_def.xml glre-20200930_lab.xml glre-20200930_pre.xml glre-20200930exhibit311.htm glre-20200930exhibit312.htm glre-20200930exhibit321.htm glre-20200930exhibit322.htm http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 true true JSON 72 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "glre-20200930.htm": { "axisCustom": 0, "axisStandard": 27, "contextCount": 232, "dts": { "calculationLink": { "local": [ "glre-20200930_cal.xml" ] }, "definitionLink": { "local": [ "glre-20200930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "glre-20200930.htm" ] }, "labelLink": { "local": [ "glre-20200930_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "glre-20200930_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml" ] }, "schema": { "local": [ "glre-20200930.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 514, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 6, "http://www.greenlightre.ky/20200930": 1, "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 12 }, "keyCustom": 46, "keyStandard": 333, "memberCustom": 24, "memberStandard": 38, "nsprefix": "glre", "nsuri": "http://www.greenlightre.ky/20200930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.greenlightre.ky/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110103 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115104 - Disclosure - FINANCIAL INSTRUMENTS", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS", "shortName": "FINANCIAL INSTRUMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119105 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES", "role": "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES", "shortName": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReinsuranceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2122106 - Disclosure - RETROCESSION", "role": "http://www.greenlightre.ky/role/RETROCESSION", "shortName": "RETROCESSION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReinsuranceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2124107 - Disclosure - SENIOR CONVERTIBLE NOTES", "role": "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES", "shortName": "SENIOR CONVERTIBLE NOTES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2126108 - Disclosure - SHARE CAPITAL", "role": "http://www.greenlightre.ky/role/SHARECAPITAL", "shortName": "SHARE CAPITAL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2130109 - Disclosure - SHARE-BASED COMPENSATION", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION", "shortName": "SHARE-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2135110 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2137111 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2142112 - Disclosure - SEGMENT REPORTING", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTING", "shortName": "SEGMENT REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2146113 - Disclosure - SUBSEQUENT EVENTS", "role": "http://www.greenlightre.ky/role/SUBSEQUENTEVENTS", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311302 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2316303 - Disclosure - FINANCIAL INSTRUMENTS (Tables)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables", "shortName": "FINANCIAL INSTRUMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2320304 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)", "role": "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESTables", "shortName": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2327305 - Disclosure - SHARE CAPITAL (Tables)", "role": "http://www.greenlightre.ky/role/SHARECAPITALTables", "shortName": "SHARE CAPITAL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2331306 - Disclosure - SHARE-BASED COMPENSATION (Tables)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables", "shortName": "SHARE-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2338307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2343308 - Disclosure - SEGMENT REPORTING (Tables)", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTINGTables", "shortName": "SEGMENT REPORTING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ReinsuranceRecoverablesAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405401 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Cash Flow, Supplemental Cash Equivalents Reconciliation (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashFlowSupplementalCashEquivalentsReconciliationDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES Cash Flow, Supplemental Cash Equivalents Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Narrative (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:InterestReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i4ee3d7bb6b4b43849cd16784988d9ab5_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Schedule of Allowance For Credit Losses on Notes Receivable (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES Schedule of Allowance For Credit Losses on Notes Receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "ibeb1596f536846f1bc16ef0d4945028a_I20181231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "glre:DepositContractLiabilitiesNetInvestmentIncomeAllocationAccrued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Interest Income and Expense (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandExpenseDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES Interest Income and Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "glre:DepositContractLiabilitiesNetInvestmentIncomeAllocationAccrued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share Reconciliation (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "0", "lang": "en-US", "name": "glre:IncrementalCommonSharesAttributableToDilutiveEffectOfSharebasedPaymentArrangementsEmployeesAndDirectors", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412406 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Narrative (Details)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "ib9cded5d6ffa47b5b5adf52fa6f30d5a_I20191231", "decimals": "3", "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413407 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i40828e6f0f3d4581b7f1b97dc810a4f3_I20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ManagementFeeExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414408 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Income Statements of SILP (Details)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND Summarized Income Statements of SILP (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-3", "lang": "en-US", "name": "glre:EquityMethodInvestmentSummarizedFinancialInformationManagementFeeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "glre:OtherInvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417409 - Disclosure - FINANCIAL INSTRUMENTS Schedule of Other Investments (Details)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails", "shortName": "FINANCIAL INSTRUMENTS Schedule of Other Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i561cde3626c244a8b61fb7d5358a9654_I20200930", "decimals": "-3", "lang": "en-US", "name": "glre:OtherInvestmentsCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "glre:OtherInvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418410 - Disclosure - FINANCIAL INSTRUMENTS Narrative (Details)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "shortName": "FINANCIAL INSTRUMENTS Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "ideded16c37064b378fc1e57c74e3e1bf_D20200930-20200930", "decimals": "2", "lang": "en-US", "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssumedPremiumsWritten", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CededPremiumsWritten", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421411 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Change in Outstanding Loss and Loss Adjustment Expense Reserve For Health Claims (Details)", "role": "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails", "shortName": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Change in Outstanding Loss and Loss Adjustment Expense Reserve For Health Claims (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CededPremiumsEarned", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423412 - Disclosure - RETROCESSION (Details)", "role": "http://www.greenlightre.ky/role/RETROCESSIONDetails", "shortName": "RETROCESSION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CededPremiumsEarned", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425413 - Disclosure - SENIOR CONVERTIBLE NOTES (Details)", "role": "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "shortName": "SENIOR CONVERTIBLE NOTES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i311d153f165e491f82337503d20a5eab_I20180807", "decimals": "3", "lang": "en-US", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "if881eb72fe89447e96dbe8a5bf0f7d54_I20200326", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:DebtInstrumentAmountAuthorizedForRepurchase", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428414 - Disclosure - SHARE CAPITAL Narrative (Details)", "role": "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "shortName": "SHARE CAPITAL Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "if881eb72fe89447e96dbe8a5bf0f7d54_I20200326", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:DebtInstrumentAmountAuthorizedForRepurchase", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "ib00abb85aee9424c991b609729c817cb_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429415 - Disclosure - SHARE CAPITAL Schedule of Voting Ordinary Shares Issued And Outstanding (Details)", "role": "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails", "shortName": "SHARE CAPITAL Schedule of Voting Ordinary Shares Issued And Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "ife4a46fd7bfb4893a5fbc473626f534b_I20181231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "iaaa56896f93b4006af64ddea35c9a7f9_D20200101-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432416 - Disclosure - SHARE-BASED COMPENSATION Narrative (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "shortName": "SHARE-BASED COMPENSATION Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "iaaa56896f93b4006af64ddea35c9a7f9_D20200101-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "ib34c41629d5d4c08816140e0a3b1e0bf_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433417 - Disclosure - SHARE-BASED COMPENSATION Restricted Shares (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "shortName": "SHARE-BASED COMPENSATION Restricted Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "ib34c41629d5d4c08816140e0a3b1e0bf_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i0ef7ec9bc43b4a5da504289bac0cc3b0_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434418 - Disclosure - SHARE-BASED COMPENSATION Restricted Stock Units (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "shortName": "SHARE-BASED COMPENSATION Restricted Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i0ef7ec9bc43b4a5da504289bac0cc3b0_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i2f8c12902a2048f08a199574113a684b_I20200930", "decimals": "3", "first": true, "lang": "en-US", "name": "glre:RelatedPartyTransactionInvestmentOwnedPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436419 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "role": "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i2f8c12902a2048f08a199574113a684b_I20200930", "decimals": "3", "first": true, "lang": "en-US", "name": "glre:RelatedPartyTransactionInvestmentOwnedPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:NumberOfCreditFacilities", "reportCount": 1, "unitRef": "facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2439420 - Disclosure - COMMITMENTS AND CONTINGENCIES Narrative (Details)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "shortName": "COMMITMENTS AND CONTINGENCIES Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i4ee3d7bb6b4b43849cd16784988d9ab5_I20191231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ManagementFeeExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i852054e4eefe441daeba07bebf509e58_I20200826", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440421 - Disclosure - COMMITMENTS AND CONTINGENCIES Schedule of Letters of Credit (Details)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails", "shortName": "COMMITMENTS AND CONTINGENCIES Schedule of Letters of Credit (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i47d05ac21df9465185c90da588dff7c7_I20200930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2441422 - Disclosure - COMMITMENTS AND CONTINGENCIES Schedule of Commitments and Contingencies (Details)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES Schedule of Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2444423 - Disclosure - SEGMENT REPORTING Gross Premiums Written by Line of Business (Details)", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails", "shortName": "SEGMENT REPORTING Gross Premiums Written by Line of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssumedPremiumsWritten", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2445424 - Disclosure - SEGMENT REPORTING Geographic Information (Details)", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails", "shortName": "SEGMENT REPORTING Geographic Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i123d9e07251f46f0b23204e8a4a5eebc_D20200701-20200930", "decimals": "INF", "lang": "en-US", "name": "glre:GrossPremiumsByGeographicalAreaAsPercentageOfTotalGrossPremiums", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "icbc24fe0cff547da8740159c94af3cf9_I20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NotesReceivableNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2447425 - Disclosure - Subsequent Events (Details)", "role": "http://www.greenlightre.ky/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "iaa3a71ed6d48499d8084c23bc5428b0c_I20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:NotesReceivableNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i0abba8c77be14222a864c63080b229ff_I20181231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i0abba8c77be14222a864c63080b229ff_I20181231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": "-3", "lang": "en-US", "name": "glre:ChangeInUnrealizedGainsLossesOnInvestmentsAndDerivatives", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION", "role": "http://www.greenlightre.ky/role/ORGANIZATIONANDBASISOFPRESENTATION", "shortName": "ORGANIZATION AND BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20200930.htm", "contextRef": "i736a8067cded4d48aa2c7b4b17d9e3a9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 65, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r480" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r481" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r482" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r482" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r482" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r484" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r482" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r482" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r482" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r478" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r479" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "glre_AccuRiskHoldingsLLCMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "AccuRisk Holdings LLC [Member]", "label": "AccuRisk Holdings LLC [Member]", "terseLabel": "AccuRisk Holdings LLC" } } }, "localname": "AccuRiskHoldingsLLCMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_AmortizationAndInterestExpenseNet": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amortization And Interest Expense Net", "label": "Amortization And Interest Expense Net", "negatedTerseLabel": "Amortization and interest expense, net of change in accruals" } } }, "localname": "AmortizationAndInterestExpenseNet", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "glre_ChangeInUnrealizedGainsLossesOnInvestmentsAndDerivatives": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net increase (decrease) in fair value of unsold investments and derivatives not held for hedging whose gains and losses are included in net income.", "label": "Change In Unrealized Gains Losses On Investments And Derivatives", "negatedLabel": "Net change in unrealized gains and losses on investments and notes receivable" } } }, "localname": "ChangeInUnrealizedGainsLossesOnInvestmentsAndDerivatives", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "glre_CitibankEuropePlcMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Citibank Europe plc", "label": "Citibank Europe plc [Member]", "terseLabel": "Citibank Europe plc" } } }, "localname": "CitibankEuropePlcMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "domainItemType" }, "glre_CollateralAssetsInvestementManagementAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collateral Assets Investement Management Agreement [Member]", "label": "Collateral Assets Investement Management Agreement [Member]", "terseLabel": "Collateral Assets Investment Management Agreement" } } }, "localname": "CollateralAssetsInvestementManagementAgreementMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_CollateralHeldInTrust": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cash and securities posted as collateral by the retrocessionaire in a trust account for the benefit of the ceding reinsurer.", "label": "Collateral Held In Trust", "terseLabel": "Collateral held in trust" } } }, "localname": "CollateralHeldInTrust", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_ContractualObligationDueAfterYearFour": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails_1": { "order": 5.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Contractual Obligation Due After Year Four", "label": "Contractual Obligation Due After Year Four", "totalLabel": "Thereafter" } } }, "localname": "ContractualObligationDueAfterYearFour", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "glre_DebtInstrumentAmountAuthorizedForRepurchase": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Amount Authorized For Repurchase", "label": "Debt Instrument, Amount Authorized For Repurchase", "terseLabel": "Debt instrument, amount authorized for repurchase (up to)" } } }, "localname": "DebtInstrumentAmountAuthorizedForRepurchase", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_DepositContractLiabilitiesNetInvestmentExpenseAllocationAccrued": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Deposit Contract Liabilities Net Investment Expense Allocation Accrued", "label": "Deposit Contract Liabilities Net Investment Expense Allocation Accrued", "negatedLabel": "Deposit interest expense" } } }, "localname": "DepositContractLiabilitiesNetInvestmentExpenseAllocationAccrued", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandExpenseDetails" ], "xbrltype": "monetaryItemType" }, "glre_DepositContractLiabilitiesNetInvestmentIncomeAllocationAccrued": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Deposit Contract Liabilities Net Investment Income Allocation Accrued", "label": "Deposit Contract Liabilities Net Investment Income Allocation Accrued", "terseLabel": "Deposit interest income" } } }, "localname": "DepositContractLiabilitiesNetInvestmentIncomeAllocationAccrued", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandExpenseDetails" ], "xbrltype": "monetaryItemType" }, "glre_DueFromBrokersFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Due From Brokers, Fair Value Disclosure", "label": "Due From Brokers, Fair Value Disclosure", "terseLabel": "Due from brokers" } } }, "localname": "DueFromBrokersFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationGainLossOnInvestmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment", "label": "Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment [Abstract]", "terseLabel": "Realized and change in unrealized gains (losses)" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationGainLossOnInvestmentAbstract", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "stringItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndPartnersCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract]", "label": "Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract]", "terseLabel": "Liabilities and partners\u2019 capital" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndPartnersCapitalAbstract", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationManagementFeeExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Management Fee Expense", "label": "Equity Method Investment, Summarized Financial Information, Management Fee Expense", "terseLabel": "Management fees" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationManagementFeeExpense", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_FinancialGuaranteeInsuranceandSuretyProductLineMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Specialized insurance coverage relating to financial risks such as surety (surety bonds) and trade credit.", "label": "Financial Guarantee Insurance and Surety Product Line [Member]", "terseLabel": "Financial" } } }, "localname": "FinancialGuaranteeInsuranceandSuretyProductLineMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_GreenBricksPartnersIncGRBKMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Green Bricks Partners Inc (GRBK) [Member]", "label": "Green Bricks Partners Inc (GRBK) [Member]", "terseLabel": "Green Bricks Partners Inc (GRBK)" } } }, "localname": "GreenBricksPartnersIncGRBKMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_GreenlightCapitalReLimitedPartnersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Greenlight Capital Re Limited Partners [Member]", "label": "Greenlight Capital Re Limited Partners [Member]", "terseLabel": "Greenlight Capital Re Limited Partners" } } }, "localname": "GreenlightCapitalReLimitedPartnersMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_GreenlightReinsuranceIrelandDACMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Greenlight Reinsurance Ireland, DAC", "label": "Greenlight Reinsurance Ireland, DAC [Member]", "terseLabel": "GRIL" } } }, "localname": "GreenlightReinsuranceIrelandDACMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_GrossPremiumsByGeographicalAreaAsPercentageOfTotalGrossPremiums": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross written premiums by geographical area as a percentage of total gross written premiums", "label": "Gross premiums by geographical area as a percentage of total gross premiums", "terseLabel": "Gross premiums by geographical area as a percentage of total gross premiums" } } }, "localname": "GrossPremiumsByGeographicalAreaAsPercentageOfTotalGrossPremiums", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails" ], "xbrltype": "percentItemType" }, "glre_IncrementalCommonSharesAttributableToDilutiveEffectOfSharebasedPaymentArrangementsEmployeesAndDirectors": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements, Employees and Directors", "label": "Incremental Common Shares Attributable To Dilutive Effect Of Share-based Payment Arrangements, Employees And Directors", "terseLabel": "Effect of dilutive employee and director share-based awards (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfSharebasedPaymentArrangementsEmployeesAndDirectors", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "sharesItemType" }, "glre_IncurredLossesRelatedToAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Incurred Losses Related To [Abstract]", "label": "Incurred Losses Related To [Abstract]", "terseLabel": "Incurred losses related to:" } } }, "localname": "IncurredLossesRelatedToAbstract", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "stringItemType" }, "glre_InterestAndDividendsPayableFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Interest And Dividends Payable, Fair Value Disclosure", "label": "Interest And Dividends Payable, Fair Value Disclosure", "negatedLabel": "Interest and dividends payable" } } }, "localname": "InterestAndDividendsPayableFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_InterestAndDividendsReceivableFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Interest And Dividends Receivable, Fair Value Disclosure", "label": "Interest And Dividends Receivable, Fair Value Disclosure", "terseLabel": "Interest and dividends receivable" } } }, "localname": "InterestAndDividendsReceivableFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_InterestAndNoninterestExpenses": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 1.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Interest And Noninterest Expenses", "label": "Interest And Noninterest Expenses", "negatedTotalLabel": "Total expenses" } } }, "localname": "InterestAndNoninterestExpenses", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_InvestmentAdvisoryAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investment Advisory Agreement [Member]", "label": "Investment Advisory Agreement [Member]", "terseLabel": "Investment Advisory Agreement" } } }, "localname": "InvestmentAdvisoryAgreementMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_InvestmentIncome": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net income earned from investments in securities and other investments including derivatives. It includes dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It also includes realized and unrealized gains and losses on all investments.", "label": "Investment Income", "terseLabel": "Net investment income" } } }, "localname": "InvestmentIncome", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "glre_InvestmentSoldNoteYetPurchasedFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Investment Sold Note Yet Purchased, Fair Value Disclosure", "label": "Investment Sold Note Yet Purchased, Fair Value Disclosure", "negatedLabel": "Investments sold short, at fair value" } } }, "localname": "InvestmentSoldNoteYetPurchasedFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Lessee Operating Lease Liability Payments Due After Year Four", "label": "Lessee Operating Lease Liability Payments Due After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "glre_LiabilityandCasualtyInsuranceProductLineMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Total casualty line of business for insurance operations", "label": "Liability and Casualty Insurance Product Line [Member]", "terseLabel": "Total Casualty" } } }, "localname": "LiabilityandCasualtyInsuranceProductLineMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_LimitedPartnershipAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Limited Partnership Agreement between SILP and its partners", "label": "Limited Partnership Agreement [Member]", "terseLabel": "SILP" } } }, "localname": "LimitedPartnershipAgreementMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_LineOfCreditFacilityTerminationNoticePeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Termination notice period for LOC facilities", "label": "Line Of Credit Facility, Termination Notice Period", "verboseLabel": "Notice period required for termination" } } }, "localname": "LineOfCreditFacilityTerminationNoticePeriod", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "durationItemType" }, "glre_LongTermDebtMaturityAfterYearFour": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Long Term Debt Maturity After Year Four", "label": "Long Term Debt Maturity After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturityAfterYearFour", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "glre_MarineCasualtyInsuranceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Marine Casualty Insurance [Member]", "label": "Marine Casualty Insurance [Member]", "terseLabel": "Marine" } } }, "localname": "MarineCasualtyInsuranceMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_MotorVehicleLiabilityCasualtyProductLineMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Motor liability line of business for insurance operations", "label": "Motor Vehicle Liability Casualty Product Line [Member]", "terseLabel": "Motor Liability" } } }, "localname": "MotorVehicleLiabilityCasualtyProductLineMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_MotorVehiclePhysicalDamageProductLineMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Motor physical damage line of business for insurance operations", "label": "Motor Vehicle Physical Damage Product Line [Member]", "terseLabel": "Motor" } } }, "localname": "MotorVehiclePhysicalDamageProductLineMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_MultilineMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Multi-line [Member]", "label": "Multi-line [Member]", "terseLabel": "Multi-line" } } }, "localname": "MultilineMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_NetAssetsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Net Assets, Fair Value Disclosure", "label": "Net Assets, Fair Value Disclosure", "totalLabel": "Net Assets" } } }, "localname": "NetAssetsFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_NumberOfCreditFacilities": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number Of Credit Facilities", "label": "Number Of Credit Facilities", "terseLabel": "Number of credit facilities" } } }, "localname": "NumberOfCreditFacilities", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "integerItemType" }, "glre_OtherAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of immaterial items aggregated and included under the Other Assets line item on the balance sheet.", "label": "Other Assets [Policy Text Block]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsPolicyTextBlock", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "glre_OtherInvestmentsAccumulatedGrossUnrealizedHoldingGain": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails": { "order": 1.0, "parentTag": "glre_OtherInvestmentsCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other Investments, Accumulated Gross Unrealized Holding Gain", "label": "Other Investments, Accumulated Gross Unrealized Holding Gain", "terseLabel": "Unrealized gains" } } }, "localname": "OtherInvestmentsAccumulatedGrossUnrealizedHoldingGain", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherInvestmentsAccumulatedGrossUnrealizedHoldingLoss": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails": { "order": 2.0, "parentTag": "glre_OtherInvestmentsCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other Investments, Accumulated Gross Unrealized Holding Loss", "label": "Other Investments, Accumulated Gross Unrealized Holding Loss", "negatedLabel": "Unrealized losses" } } }, "localname": "OtherInvestmentsAccumulatedGrossUnrealizedHoldingLoss", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherInvestmentsAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other Investments, Adjustment", "label": "Other Investments, Adjustment", "terseLabel": "Other investments, adjustment" } } }, "localname": "OtherInvestmentsAdjustment", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherInvestmentsCost": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other Investments, Cost", "label": "Other Investments, Cost", "totalLabel": "Cost" } } }, "localname": "OtherInvestmentsCost", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherInvestmentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails": { "order": 3.0, "parentTag": "glre_OtherInvestmentsCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other Investments, Fair Value Disclosure", "label": "Other Investments, Fair Value Disclosure", "terseLabel": "Fair value / carrying value" } } }, "localname": "OtherInvestmentsFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of items aggregated and included under Other Liabilities on the balance sheet.", "label": "Other Liabilities [Policy Text Block]", "terseLabel": "Other Liabilities" } } }, "localname": "OtherLiabilitiesPolicyTextBlock", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "glre_PaidLossesRelatedToAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Paid Losses Related To [Abstract]", "label": "Paid Losses Related To [Abstract]", "terseLabel": "Paid losses related to:" } } }, "localname": "PaidLossesRelatedToAbstract", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "stringItemType" }, "glre_PayablesToBrokerDealersFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payables To Broker-Dealers, Fair Value Disclosure", "label": "Payables To Broker-Dealers, Fair Value Disclosure", "negatedLabel": "Due to brokers" } } }, "localname": "PayablesToBrokerDealersFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_PremiumsWrittenGrossAsPercentageOfTotalGrossPremiumsWritten": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross written premiums by line of business as a percentage of total gross written premiums", "label": "Premiums Written, Gross As Percentage Of Total Gross Premiums Written", "terseLabel": "Gross premiums written, percent" } } }, "localname": "PremiumsWrittenGrossAsPercentageOfTotalGrossPremiumsWritten", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "percentItemType" }, "glre_PrivateAndUnlistedEquitySecuritiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Private equities and unlisted equity securities", "label": "Private and unlisted equity securities [Member]", "terseLabel": "Private investments and unlisted equities" } } }, "localname": "PrivateAndUnlistedEquitySecuritiesMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "glre_ProfessionalFeesAndOtherNoninterestExpense": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 3.0, "parentTag": "glre_InterestAndNoninterestExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Professional Fees And Other Noninterest Expense", "label": "Professional Fees And Other Noninterest Expense", "negatedLabel": "Professional fees and other" } } }, "localname": "ProfessionalFeesAndOtherNoninterestExpense", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Promissory Note", "label": "Promissory Note [Member]", "terseLabel": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "glre_RealizedGainsLossesOnSaleOfInvestmentsAndDerivatives": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net realized gains (losses) on investments and derivatives sold during the period.", "label": "Realized Gains Losses On Sale Of Investments And Derivatives", "negatedLabel": "Net realized (gains)\u00a0losses on investments" } } }, "localname": "RealizedGainsLossesOnSaleOfInvestmentsAndDerivatives", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "glre_RelatedPartyTransactionAnnualManagementFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The annual rate charged by investment advisor calculated as a percentage of assets under management", "label": "Related Party Transaction, Annual Management Fee Percentage", "terseLabel": "Investment management fee rate - annual" } } }, "localname": "RelatedPartyTransactionAnnualManagementFeePercentage", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionAssetRedemptionNoticeToGeneralPartner": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Related Party Transaction, Asset Redemption Notice To General Partner", "label": "Related Party Transaction, Asset Redemption Notice To General Partner", "terseLabel": "Asset redemption notice to general partner" } } }, "localname": "RelatedPartyTransactionAssetRedemptionNoticeToGeneralPartner", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "durationItemType" }, "glre_RelatedPartyTransactionInvestmentOwnedPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Related Party Transaction, Investment Owned, Percentage", "label": "Related Party Transaction, Investment Owned, Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "RelatedPartyTransactionInvestmentOwnedPercentage", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionLossCarryForwardRecoupmentRequiredAsPercentageOfAggregateInvestmentLossEarned": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The additional amount of investment income required after a period of investment loss, in order for the performance compensation rate to return from reduced rate to full rate.", "label": "Related Party Transaction, Loss Carry Forward Recoupment Required As Percentage Of Aggregate Investment Loss Earned", "terseLabel": "Loss carry forward recoupment required" } } }, "localname": "RelatedPartyTransactionLossCarryForwardRecoupmentRequiredAsPercentageOfAggregateInvestmentLossEarned", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionMonthlyManagementFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The monthly rate charged by investment advisor calculated as a percentage of assets under management", "label": "Related Party Transaction, Monthly Management Fee Percentage", "terseLabel": "Investment management fee rate - monthly" } } }, "localname": "RelatedPartyTransactionMonthlyManagementFeePercentage", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionPerformanceCompensationFullRateAsPercentageOfInvestmentIncome": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The full rate of performance compensation as a percent of investment income charged by a related party.", "label": "Related Party Transaction, Performance Compensation Full Rate As Percentage Of Investment Income", "terseLabel": "Performance compensation full rate" } } }, "localname": "RelatedPartyTransactionPerformanceCompensationFullRateAsPercentageOfInvestmentIncome", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionPerformanceCompensationReducedRateAsPercentageofInvestmentIncome": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision.", "label": "Related Party Transaction, Performance Compensation Reduced Rate As Percentage of Investment Income", "terseLabel": "Performance compensation reduced rate" } } }, "localname": "RelatedPartyTransactionPerformanceCompensationReducedRateAsPercentageofInvestmentIncome", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionPerformanceCompensationReducedRateasaPercentageofInvestmentIncome": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision.", "label": "Related Party Transaction, Performance Compensation Reduced Rate as a Percentage of Investment Income", "terseLabel": "Performance compensation reduced rate as a percentage of investment income" } } }, "localname": "RelatedPartyTransactionPerformanceCompensationReducedRateasaPercentageofInvestmentIncome", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionsAutomaticAgreementExtensionTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Related Party Transactions, Automatic Agreement Extension, Term", "label": "Related Party Transactions, Automatic Agreement Extension, Term", "terseLabel": "Automatic agreement extension, term" } } }, "localname": "RelatedPartyTransactionsAutomaticAgreementExtensionTerm", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "durationItemType" }, "glre_RelatedPartyTransactionsContractTerminationPriorNoticePeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Related Party Transactions, Contract Termination Prior Notice Period", "label": "Related Party Transactions, Contract Termination Prior Notice Period", "terseLabel": "Contract termination prior notice period" } } }, "localname": "RelatedPartyTransactionsContractTerminationPriorNoticePeriod", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "durationItemType" }, "glre_RelatedPartyTransactionsInvestmentPortfolioPercentOfShareholdersEquityMaximum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Related Party Transactions, Investment Portfolio Percent Of Shareholders Equity Maximum", "label": "Related Party Transactions, Investment Portfolio Percent Of Shareholders Equity Maximum", "terseLabel": "Investment portfolio percent of shareholders equity maximum" } } }, "localname": "RelatedPartyTransactionsInvestmentPortfolioPercentOfShareholdersEquityMaximum", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "percentItemType" }, "glre_SILPMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "SILP [Member] Solasglas Investments, LP", "label": "SILP [Member]", "terseLabel": "SILP" } } }, "localname": "SILPMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_SeniorUnsecuredConvertibleNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Convertible Notes [Member]", "label": "Senior Unsecured Convertible Notes [Member]", "terseLabel": "Senior Unsecured Convertible Notes" } } }, "localname": "SeniorUnsecuredConvertibleNotesMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_ServiceAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Service Agreement [Member]", "label": "Service Agreement [Member]", "terseLabel": "Service Agreement" } } }, "localname": "ServiceAgreementMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionRatio": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio", "terseLabel": "Conversion ratio (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionRatio", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "glre_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized, Period Increase (Decrease)", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized, Period Increase (Decrease)", "terseLabel": "Number of shares authorized for issuance period increase (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPeriodIncreaseDecrease", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "glre_SolasglasInvestmentLPSILPMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Solasglas Investment LP (SILP) [Member]", "label": "Solasglas Investment LP (SILP) [Member]", "terseLabel": "Solasglas Investment LP (SILP)" } } }, "localname": "SolasglasInvestmentLPSILPMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "domainItemType" }, "glre_TotalSpecialtyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Total of all Specialty lines insurance products types [Domain]", "label": "Total Specialty [Domain]", "terseLabel": "Total Other" } } }, "localname": "TotalSpecialtyDomain", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_TransferFromAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Transfer From Assets", "label": "Transfer From Assets", "terseLabel": "Non-cash transfer of investments (Note 3)" } } }, "localname": "TransferFromAssets", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "glre_UnratedMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "No rating assigned by any external rating agencies.", "label": "Unrated [Member]", "terseLabel": "Unrated" } } }, "localname": "UnratedMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "glre_WorkersCompensationInsuranceProductLineMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Workers' compensation line of business of insurance coverage", "label": "Workers' Compensation Insurance Product Line [Member]", "terseLabel": "Workers' Compensation" } } }, "localname": "WorkersCompensationInsuranceProductLineMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_WorldwideMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Worldwide", "label": "Worldwide [Member]", "terseLabel": "Worldwide" } } }, "localname": "WorldwideMember", "nsuri": "http://www.greenlightre.ky/20200930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "srt_AMBestAMinusRatingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A- credit rating as defined by the external credit rating agency, AM Best.", "label": "AM Best, A- Rating [Member]", "terseLabel": "AM Best, A- Rating" } } }, "localname": "AMBestAMinusRatingMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r234", "r324", "r325", "r328", "r477", "r487" ], "lang": { "en-US": { "role": { "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity.", "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Continent of Asia.", "label": "Asia [Member]", "terseLabel": "Asia" } } }, "localname": "AsiaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r153" ], "lang": { "en-US": { "role": { "documentation": "Leader of board of directors.", "label": "Board of Directors Chairman [Member]", "terseLabel": "Board of Directors Chairman" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r153" ], "lang": { "en-US": { "role": { "documentation": "Person with designation of chief executive officer.", "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r483" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Schedule of Commitments and Contingencies, Fiscal Year Maturity Schedule" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r32", "r72", "r489" ], "lang": { "en-US": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "srt_CreditRatingAMBestAxis": { "auth_ref": [ "r160", "r190", "r193", "r207", "r291" ], "lang": { "en-US": { "role": { "documentation": "Information by AM Best rating.", "label": "Credit Rating, AM Best [Axis]", "terseLabel": "Credit Rating Source [Axis]" } } }, "localname": "CreditRatingAMBestAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "srt_CreditRatingAMBestDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Credit rating as defined by AM Best.", "label": "Credit Rating, AM Best [Domain]", "terseLabel": "Credit Rating Source [Domain]" } } }, "localname": "CreditRatingAMBestDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r81", "r89", "r179", "r264", "r265", "r266", "r281", "r282" ], "lang": { "en-US": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect Period Of Adoption Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r81", "r89", "r179", "r264", "r265", "r266", "r281", "r282" ], "lang": { "en-US": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period Of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r81", "r89", "r179", "r264", "r265", "r266", "r281", "r282" ], "lang": { "en-US": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period Of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Continent of Europe.", "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Continent of North America.", "label": "North America [Member]", "terseLabel": "U.S. and Caribbean" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProFormaMember": { "auth_ref": [ "r204", "r333" ], "lang": { "en-US": { "role": { "documentation": "Information reported based on historical fact adjusted for fully or partially assumed fact. Excludes information reported for future period (forecast).", "label": "Pro Forma [Member]", "terseLabel": "Pro Forma" } } }, "localname": "ProFormaMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r146", "r231", "r232", "r336", "r415", "r416" ], "lang": { "en-US": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]", "verboseLabel": "Insurance Product Line [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r146", "r231", "r232", "r336", "r415", "r416" ], "lang": { "en-US": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "verboseLabel": "Insurance Product Line [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r77", "r78", "r79", "r80", "r82", "r83", "r87", "r88", "r89", "r91", "r92", "r93", "r94", "r95", "r108", "r180", "r181", "r267", "r282", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430" ], "lang": { "en-US": { "role": { "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Axis]", "terseLabel": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r77", "r78", "r79", "r80", "r82", "r83", "r87", "r88", "r89", "r91", "r92", "r93", "r94", "r95", "r108", "r180", "r181", "r267", "r282", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430" ], "lang": { "en-US": { "role": { "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Domain]", "terseLabel": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": { "auth_ref": [ "r82", "r83", "r89", "r180", "r181", "r267", "r282", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430" ], "lang": { "en-US": { "role": { "documentation": "Cumulative increase (decrease) to previously issued financial statements for retrospective application of amendment to accounting standards and adjustment for reclassification from amendment to accounting standards.", "label": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]", "terseLabel": "Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2020" } } }, "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r235", "r485" ], "lang": { "en-US": { "role": { "documentation": "Information reported for future period.", "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r235" ], "lang": { "en-US": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r147", "r148", "r231", "r233", "r417", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475" ], "lang": { "en-US": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r147", "r148", "r231", "r233", "r417", "r466", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r486", "r488" ], "lang": { "en-US": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r204", "r235", "r333" ], "lang": { "en-US": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r153", "r327" ], "lang": { "en-US": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201613Member": { "auth_ref": [ "r175" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.", "label": "Accounting Standards Update 2016-13 [Member]", "terseLabel": "Accounting Standards Update 2016-13" } } }, "localname": "AccountingStandardsUpdate201613Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r82", "r83", "r84", "r85", "r176", "r177", "r178", "r179", "r180", "r181", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r281", "r282", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430" ], "lang": { "en-US": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible List]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r14", "r267" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r77", "r78", "r80", "r264", "r265", "r266" ], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r82", "r83", "r84", "r85", "r176", "r177", "r178", "r179", "r180", "r181", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r279", "r280", "r281", "r282", "r337", "r338", "r339", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430" ], "lang": { "en-US": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r236", "r238", "r269", "r270" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income or loss to net cash provided by\u00a0(used in)\u00a0operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r238", "r256", "r268" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": { "auth_ref": [ "r158", "r186" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Financing Receivable, Allowance for Credit Loss" } } }, "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r162", "r182", "r183", "r185" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "terseLabel": "Loss and loss adjustment expenses recoverable, allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r43", "r60", "r312" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Recognized interest expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r105" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive stock options outstanding (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r105" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r105" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r69", "r130", "r135", "r142", "r172", "r285", "r287", "r296", "r354", "r379" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r292" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 1.0, "parentTag": "glre_NetAssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssumedPremiumsWritten": { "auth_ref": [ "r436" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_PremiumsWrittenNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of written premiums assumed from other entities.", "label": "Assumed Premiums Written", "terseLabel": "Gross premiums written", "verboseLabel": "Gross premiums written" } } }, "localname": "AssumedPremiumsWritten", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r240", "r259" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BenefitsLossesAndExpenses": { "auth_ref": [ "r400" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.", "label": "Benefits, Losses and Expenses", "totalLabel": "Total expenses" } } }, "localname": "BenefitsLossesAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_BenefitsLossesAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Benefits, Losses and Expenses [Abstract]", "terseLabel": "Expenses" } } }, "localname": "BenefitsLossesAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r19", "r62" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashFlowSupplementalCashEquivalentsReconciliationDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashFlowSupplementalCashEquivalentsReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 5.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r5", "r63", "r66", "r352" ], "lang": { "en-US": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Restricted Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r55", "r62", "r65" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashFlowSupplementalCashEquivalentsReconciliationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of the period (see Note 2)", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of the period (see Note 2)", "totalLabel": "Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashFlowSupplementalCashEquivalentsReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r55", "r301" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CededCreditRiskCollateralizationAxis": { "auth_ref": [ "r446" ], "lang": { "en-US": { "role": { "documentation": "Information as to collaterization of reinsurance recoverables.", "label": "Ceded Credit Risk, Collateralization [Axis]", "terseLabel": "Ceded Credit Risk, Collateralization [Axis]" } } }, "localname": "CededCreditRiskCollateralizationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskCollateralizationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collateralization of ceded credit risk.", "label": "Ceded Credit Risk, Collateralization [Domain]", "terseLabel": "Ceded Credit Risk, Collateralization [Domain]" } } }, "localname": "CededCreditRiskCollateralizationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CededCreditRiskLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Ceded Credit Risk [Line Items]", "terseLabel": "Ceded Credit Risk [Line Items]" } } }, "localname": "CededCreditRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskSecuredMember": { "auth_ref": [ "r446" ], "lang": { "en-US": { "role": { "documentation": "Reinsurance recoverable that is secured by collateral.", "label": "Ceded Credit Risk, Secured [Member]", "terseLabel": "Secured" } } }, "localname": "CededCreditRiskSecuredMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CededCreditRiskTable": { "auth_ref": [ "r446" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.", "label": "Ceded Credit Risk [Table]", "terseLabel": "Ceded Credit Risk [Table]" } } }, "localname": "CededCreditRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskUnsecuredMember": { "auth_ref": [ "r446" ], "lang": { "en-US": { "role": { "documentation": "Reinsurance recoverable that is not secured by collateral.", "label": "Ceded Credit Risk, Unsecured [Member]", "terseLabel": "Unsecured" } } }, "localname": "CededCreditRiskUnsecuredMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CededPremiumsEarned": { "auth_ref": [ "r391", "r401", "r433", "r434", "r437", "r439" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of earned premiums ceded to other entities.", "label": "Ceded Premiums Earned", "terseLabel": "Ceded premiums earned" } } }, "localname": "CededPremiumsEarned", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CededPremiumsWritten": { "auth_ref": [ "r437", "r439" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_PremiumsWrittenNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of written premiums ceded to other entities.", "label": "Ceded Premiums Written", "negatedLabel": "Gross premiums ceded" } } }, "localname": "CededPremiumsWritten", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r67", "r69", "r98", "r99", "r100", "r102", "r104", "r111", "r112", "r113", "r172", "r296" ], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/CoverPage", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r201", "r202", "r203", "r205" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Common Class A" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/CoverPage", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Common Class B" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/CoverPage", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r77", "r78" ], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "verboseLabel": "Ordinary share capital" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Ordinary share capital, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Ordinary share capital, authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Ordinary share capital, issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r222" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance \u2013 end of period (in shares)", "periodStartLabel": "Balance \u2013 beginning of period (in shares)", "terseLabel": "Ordinary share capital, outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 29,113,702 (2019: 30,739,395): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2019: 6,254,715))" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.", "label": "Contractual Obligation", "totalLabel": "Total" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInFourthYear": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails_1": { "order": 3.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, to be Paid, Year Four", "totalLabel": "2024" } } }, "localname": "ContractualObligationDueInFourthYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInNextTwelveMonths": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails_1": { "order": 2.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, to be Paid, Year One", "totalLabel": "2021" } } }, "localname": "ContractualObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInSecondYear": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails_1": { "order": 6.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, to be Paid, Year Two", "totalLabel": "2022" } } }, "localname": "ContractualObligationDueInSecondYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInThirdYear": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails_1": { "order": 4.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, to be Paid, Year Three", "totalLabel": "2023" } } }, "localname": "ContractualObligationDueInThirdYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationFiscalYearMaturityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Contractual Obligation, Fiscal Year Maturity [Abstract]", "terseLabel": "Total future obligations by year" } } }, "localname": "ContractualObligationFiscalYearMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails_1": { "order": 1.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of contractual obligation to be paid in remainder of current fiscal year.", "label": "Contractual Obligation, to be Paid, Remainder of Fiscal Year", "totalLabel": "2020" } } }, "localname": "ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r211" ], "lang": { "en-US": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r9", "r356", "r381", "r448" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "terseLabel": "Convertible senior notes payable" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r217" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "SENIOR CONVERTIBLE NOTES" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r7", "r8", "r9", "r355", "r356", "r377" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r212" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Convertible debt, carrying amount of equity component" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r214" ], "lang": { "en-US": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r311", "r313" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Convertible debt, amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r295" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value of debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r25", "r215", "r311" ], "lang": { "en-US": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r25" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r26" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r26", "r73", "r223", "r226", "r227", "r228", "r310", "r311", "r313", "r371" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r310", "r313" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense": { "auth_ref": [ "r60", "r372", "r396", "r403", "r404", "r406", "r424" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.", "label": "Deferred Policy Acquisition Costs, Amortization Expense", "terseLabel": "Acquisition costs" } } }, "localname": "DeferredPolicyAcquisitionCostAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredPolicyAcquisitionCosts": { "auth_ref": [ "r387", "r404", "r405", "r406", "r424", "r444" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force.", "label": "Deferred Policy Acquisition Cost", "verboseLabel": "Deferred acquisition costs" } } }, "localname": "DeferredPolicyAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsAssets": { "auth_ref": [ "r196", "r197" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount of assets as of the balance sheet date pertaining to amounts paid by the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred.", "label": "Deposit Contracts, Assets", "terseLabel": "Deposit contracts, assets" } } }, "localname": "DepositContractsAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsLiabilities": { "auth_ref": [ "r196", "r197" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount of liabilities as of the balance sheet date pertaining to amounts received by the insurer or reinsurer from the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred.", "label": "Deposit Contracts, Liabilities", "terseLabel": "Deposit contracts, liabilities" } } }, "localname": "DepositContractsLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsPolicy": { "auth_ref": [ "r66", "r443" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer.", "label": "Deposit Contracts, Policy [Policy Text Block]", "terseLabel": "Deposit Assets and Liabilities" } } }, "localname": "DepositContractsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepreciationNonproduction": { "auth_ref": [ "r60", "r199" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.", "label": "Depreciation, Nonproduction", "terseLabel": "Depreciation expense" } } }, "localname": "DepreciationNonproduction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r30", "r31", "r295" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative contracts, at fair value" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r30", "r31", "r295" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedLabel": "Derivative contracts, at fair value" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r271" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "verboseLabel": "SHARE-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendIncomeOperating": { "auth_ref": [ "r367" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 2.0, "parentTag": "us-gaap_InterestAndDividendIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of operating dividend income on securities.", "label": "Dividend Income, Operating", "terseLabel": "Dividend income (net of withholding taxes)" } } }, "localname": "DividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r229", "r370" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 4.0, "parentTag": "glre_InterestAndNoninterestExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "Dividends", "negatedLabel": "Dividends" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings (loss) per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r40", "r87", "r88", "r89", "r90", "r91", "r96", "r98", "r102", "r103", "r104", "r108", "r109", "r363", "r395" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r40", "r87", "r88", "r89", "r90", "r91", "r98", "r102", "r103", "r104", "r108", "r109", "r363", "r395" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]", "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareDilutedLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r66", "r105", "r107" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r301" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r257" ], "lang": { "en-US": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Period of recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r257" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r257" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Cost not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r255" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Anti-dilutive stock options outstanding", "verboseLabel": "Employee and Director Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r77", "r78", "r80", "r83", "r92", "r95", "r110", "r179", "r222", "r229", "r264", "r265", "r266", "r281", "r282", "r302", "r303", "r304", "r305", "r306", "r307", "r421", "r422", "r423" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "auth_ref": [ "r0", "r69", "r172", "r296" ], "lang": { "en-US": { "role": { "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Axis]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "auth_ref": [ "r0", "r69", "r172", "r296" ], "lang": { "en-US": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Domain]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": { "auth_ref": [ "r0", "r69", "r172", "r296" ], "lang": { "en-US": { "role": { "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r170" ], "lang": { "en-US": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]", "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r174" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "INVESTMENT IN RELATED PARTY INVESTMENT FUND" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsFairValueDisclosure": { "auth_ref": [ "r168" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of investments accounted under the equity method.", "label": "Equity Method Investments, Fair Value Disclosure", "terseLabel": "Equity method investments, fair value" } } }, "localname": "EquityMethodInvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsMember": { "auth_ref": [ "r167" ], "lang": { "en-US": { "role": { "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition.", "label": "Equity Method Investments [Member]", "terseLabel": "Investment accounted for under the equity method" } } }, "localname": "EquityMethodInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r173" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Summarized Financial Information of Investment" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r293", "r294" ], "lang": { "en-US": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "verboseLabel": "FINANCIAL INSTRUMENTS" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialStandbyLetterOfCreditMember": { "auth_ref": [ "r206", "r208" ], "lang": { "en-US": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation if defined events occur or fail to occur.", "label": "Financial Standby Letter of Credit [Member]", "terseLabel": "Facility" } } }, "localname": "FinancialStandbyLetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "auth_ref": [ "r156", "r182", "r183", "r185", "r358" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, Allowance for Credit Loss", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "terseLabel": "Notes receivable, allowance" } } }, "localname": "FinancingReceivableAllowanceForCreditLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease": { "auth_ref": [ "r155", "r186" ], "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease)", "terseLabel": "Net increase (decrease) in allowance" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Financing Receivable, Allowance for Credit Loss [Roll Forward]" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": { "auth_ref": [ "r161", "r163", "r164", "r187", "r188", "r190", "r191", "r192", "r194", "r195" ], "lang": { "en-US": { "role": { "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Axis]", "terseLabel": "Class of Financing Receivable [Axis]" } } }, "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Domain]", "terseLabel": "Class of Financing Receivable [Domain]" } } }, "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r297", "r298", "r299", "r300" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Foreign exchange\u00a0(gains) losses\u00a0on investments" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FundsHeldUnderReinsuranceAgreementsLiability": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of funds held as security for payments to be received under reinsurance contracts.", "label": "Funds Held under Reinsurance Agreements, Liability", "verboseLabel": "Funds withheld" } } }, "localname": "FundsHeldUnderReinsuranceAgreementsLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r47", "r60", "r166" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "totalLabel": "Net gain (loss) on investment transactions" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnRestructuringOfDebt": { "auth_ref": [ "r216" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete.", "label": "Gains (Losses) on Restructuring of Debt", "terseLabel": "Gains on restructuring of debt" } } }, "localname": "GainsLossesOnRestructuringOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r46" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r41" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and Administrative Expense" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralLiabilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of business insurance which provides insurance coverage for a wide variety of liability exposures including, but not limited to, contractual liability, product liability and personal injury liability.", "label": "General Liability [Member]", "terseLabel": "General Liability" } } }, "localname": "GeneralLiabilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralPartnerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Party to a partnership business who has unlimited liability.", "label": "General Partner [Member]", "terseLabel": "General Partner" } } }, "localname": "GeneralPartnerMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HealthInsuranceProductLineMember": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Product line consisting of insurance against loss by illness or injury.", "label": "Health Insurance Product Line [Member]", "terseLabel": "Accident & Health", "verboseLabel": "Health" } } }, "localname": "HealthInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncentiveFeeExpense": { "auth_ref": [ "r326" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for incentive rights held by the managing member or general partner, of limited liability company (LLC) or limited partnership (LP).", "label": "Incentive Fee Expense", "terseLabel": "Performance allocation" } } }, "localname": "IncentiveFeeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossAttributableToParent": { "auth_ref": [ "r45" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "Income (Loss) Attributable to Parent, before Tax", "totalLabel": "Income (loss) before income tax" } } }, "localname": "IncomeLossAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r38", "r60", "r128", "r169", "r361", "r392" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedTerseLabel": "Loss (income) from investment accounted for under the equity method", "verboseLabel": "Income (loss) from equity method investments" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r200" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r70", "r94", "r95", "r129", "r274", "r283", "r284", "r397" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax (expense) benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r35", "r66", "r272", "r273", "r275", "r276", "r277", "r278", "r467" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Taxation" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r64" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income tax paid in cash" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers.", "label": "Increase (Decrease) in Deferred Policy Acquisition Costs", "negatedLabel": "Deferred acquisition costs" } } }, "localname": "IncreaseDecreaseInDeferredPolicyAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due to Related Parties", "terseLabel": "Change in due to related party investment fund" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The change in funds held under reinsurance agreements or treaty (contract between the reinsurer and the ceding entity stipulating the manner in which insurance written on various risks is to be shared).", "label": "Increase (Decrease) in Funds Held under Reinsurance Agreements", "negatedLabel": "Funds withheld" } } }, "localname": "IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.", "label": "Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve", "terseLabel": "Loss and loss adjustment expense reserves" } } }, "localname": "IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInNotesReceivables": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period of the amounts due from borrowers for outstanding secured or unsecured loans evidenced by a note.", "label": "Increase (Decrease) in Notes Receivables", "negatedTerseLabel": "Notes receivable collected (issued)" } } }, "localname": "IncreaseDecreaseInNotesReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Net change in" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets, excluding depreciation" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPremiumsReceivable": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The change in the premium receivable balance on the balance sheet.", "label": "Increase (Decrease) in Premiums Receivable", "negatedLabel": "Reinsurance balances receivable" } } }, "localname": "IncreaseDecreaseInPremiumsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The change in prepaid reinsurance premiums recorded on the balance sheet, which is needed to adjust net income to arrive at net cash flows provided by or used in operations.", "label": "Increase (Decrease) in Prepaid Reinsurance Premiums", "negatedLabel": "Unearned premiums ceded" } } }, "localname": "IncreaseDecreaseInPrepaidReinsurancePremiums", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReinsurancePayables": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due to other insurance companies when the reporting entity has assumed a portion of the cedant's insurance risk which has resulted in insurance losses.", "label": "Increase (Decrease) in Reinsurance Payables", "terseLabel": "Reinsurance balances payable" } } }, "localname": "IncreaseDecreaseInReinsurancePayables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReinsuranceRecoverable": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types.", "label": "Increase (Decrease) in Reinsurance Recoverable", "negatedLabel": "Loss and loss adjustment expenses recoverable" } } }, "localname": "IncreaseDecreaseInReinsuranceRecoverable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInUnearnedPremiums": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.", "label": "Increase (Decrease) in Unearned Premiums", "terseLabel": "Unearned premium reserves" } } }, "localname": "IncreaseDecreaseInUnearnedPremiums", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInUnearnedPremiumsNet": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_PremiumsEarnedNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of decrease (increase) in unearned premiums.", "label": "(Increase) Decrease in Unearned Premiums, Net", "terseLabel": "Change in net unearned premium reserves" } } }, "localname": "IncreaseDecreaseInUnearnedPremiumsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InsuranceLossReservesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Insurance Loss Reserves [Abstract]", "terseLabel": "Insurance Loss Reserves [Abstract]" } } }, "localname": "InsuranceLossReservesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InterestAndDividendIncomeOperating": { "auth_ref": [ "r364" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 2.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.", "label": "Interest and Dividend Income, Operating", "totalLabel": "Total Investment income" } } }, "localname": "InterestAndDividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDividendIncomeOperatingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Interest and Dividend Income, Operating [Abstract]", "terseLabel": "Investment income" } } }, "localname": "InterestAndDividendIncomeOperatingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r36", "r127", "r309", "r312", "r368" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 }, "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 1.0, "parentTag": "glre_InterestAndNoninterestExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.", "label": "Interest Income and Interest Expense Disclosure [Table Text Block]", "terseLabel": "Schedule of Interest Income and Interest Expense" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r365" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "totalLabel": "Deposit interest income/(expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOperating": { "auth_ref": [ "r44" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 1.0, "parentTag": "us-gaap_InterestAndDividendIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.", "label": "Interest Income, Operating", "terseLabel": "Interest income" } } }, "localname": "InterestIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r53", "r56", "r64" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid in cash" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r3", "r4", "r24" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestReceivable": { "auth_ref": [ "r29" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.", "label": "Interest Receivable", "terseLabel": "Accrued interest" } } }, "localname": "InterestReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentHoldingsOtherThanSecuritiesTextBlock": { "auth_ref": [ "r461" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the investment holdings which are represented by other than securities (for example, commodities). The investment holdings, other than securities investments table lists the long positions of non-security investments held by entity.", "label": "Investment Holdings, Other than Securities [Table Text Block]", "terseLabel": "Other Investments" } } }, "localname": "InvestmentHoldingsOtherThanSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r462", "r463", "r464", "r465" ], "lang": { "en-US": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r462", "r463", "r464", "r465" ], "lang": { "en-US": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Investments": { "auth_ref": [ "r389" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments", "totalLabel": "Total investments" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investments [Abstract]", "verboseLabel": "Investments" } } }, "localname": "InvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsByConsolidatedAndNonconsolidatedEntitiesAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by investments by consolidated and nonconsolidated entities. Includes, but is not limited to, variable interest entity (VIE) for which reporting entity is or is not primary beneficiary.", "label": "Investments by Consolidated and Nonconsolidated Entities [Axis]", "terseLabel": "Investments by Consolidated and Nonconsolidated Entities [Axis]" } } }, "localname": "InvestmentsByConsolidatedAndNonconsolidatedEntitiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsByConsolidatedAndNonconsolidatedEntitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investments by consolidated and nonconsolidated entities. Includes, but is not limited to, variable interest entity (VIE) for which reporting entity is or is not primary beneficiary.", "label": "Investments by Consolidated and Nonconsolidated Entities [Domain]", "terseLabel": "Investments by Consolidated and Nonconsolidated Entities [Domain]" } } }, "localname": "InvestmentsByConsolidatedAndNonconsolidatedEntitiesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r292" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Investments, at fair value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r20" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Investments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Investment in related party investment fund", "verboseLabel": "GLRE Limited Partners\u2019 share of Net Assets" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r320" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 1.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r320" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r320" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r320" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r320" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r320" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2020" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r316" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Term of contract" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Amount of letters of credit issued" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r23", "r69", "r136", "r172", "r286", "r287", "r288", "r296" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r18", "r69", "r172", "r296", "r357", "r385" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r292" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 2.0, "parentTag": "glre_NetAssetsFairValueDisclosure", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "negatedTotalLabel": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r410", "r413" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.", "label": "Liability for Claims and Claims Adjustment Expense", "periodEndLabel": "Gross balance at September 30", "periodStartLabel": "Gross balance at January 1", "totalLabel": "Total" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Liability for Claims and Claims Adjustment Expense [Line Items]", "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability": { "auth_ref": [ "r410", "r413" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to casualty insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date.", "label": "Liability for Claims and Claims Adjustment Expense, Property Casualty Liability", "verboseLabel": "Loss and loss adjustment expense reserves" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.", "label": "Liability for Claims and Claims Adjustment Expense [Table]", "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": { "auth_ref": [ "r432" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.", "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]", "terseLabel": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES" } } }, "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "auth_ref": [ "r412" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": 1.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "negatedTerseLabel": "Current year" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "auth_ref": [ "r412" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": 2.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "negatedTerseLabel": "Prior years" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency gain (loss) which decreases (increases) the cost of settling unpaid claims after deduction of reinsurance recoveries. Includes, but is not limited to, claims which have been incurred but not reported.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency revaluation" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": { "auth_ref": [ "r431" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount", "terseLabel": "IBNR" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "auth_ref": [ "r411" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "totalLabel": "Total incurred" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": { "auth_ref": [ "r376", "r410", "r413" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net", "periodEndLabel": "Net balance at September 30", "periodStartLabel": "Net balance at January 1" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "Amount, after effects of reinsurance, of increase (decrease) in the liability for unpaid claims and claims adjustment expense.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease)", "terseLabel": "Net loss reserve on prior contracts increase (decrease)" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Costs of settling insured claims and costs incurred in the claims settlement process for the specified year specifically for claims that have already been submitted to the insurance company for reimbursement.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount", "terseLabel": "Case reserves" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r22", "r73" ], "lang": { "en-US": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityIncreaseAccruedInterest": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase for accrued, but unpaid interest on the credit facility for the period.", "label": "Line of Credit Facility, Increase, Accrued Interest", "terseLabel": "Line of credit facility increase accrued interest" } } }, "localname": "LineOfCreditFacilityIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r22" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum Facility Limit" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r22", "r73" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LoansAndLeasesReceivableNonaccrualLoanAndLeaseStatusPolicy": { "auth_ref": [ "r66", "r159" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for when a loan ceases to accrue interest or other revenue because the borrower is in financial difficulty. May also describe the treatment of previously earned but uncollected interest income on loans in nonaccrual status, how cash received from borrowers is recorded on loans that are in nonaccrual status, and the policy for resuming accrual of interest. Also includes the policy for charging off uncollectible loans and trade receivables, and the policy for determining past-due or delinquency status (i.e. whether past-due status is based on how recently payments have been received or on contractual terms).", "label": "Loans and Leases Receivable, Nonaccrual Loan and Lease Status, Policy [Policy Text Block]", "terseLabel": "Notes Receivable" } } }, "localname": "LoansAndLeasesReceivableNonaccrualLoanAndLeaseStatusPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r9", "r213", "r356", "r382" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 2.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByMaturityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Long-term Debt, Fiscal Year Maturity [Abstract]", "terseLabel": "Interest and convertible note payable" } } }, "localname": "LongTermDebtByMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r75", "r209" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r75", "r209" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 5.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r75", "r209" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 6.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r75", "r209" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 2.0, "parentTag": "us-gaap_ContractualObligationDueInSecondYear", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r75" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "terseLabel": "2020" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r26" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r26", "r210" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r326" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 2.0, "parentTag": "glre_InterestAndNoninterestExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management Fee Expense", "negatedLabel": "Management fee", "terseLabel": "Management fee" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r55" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r55" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r55", "r58", "r61" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r33", "r34", "r39", "r61", "r69", "r82", "r87", "r88", "r89", "r90", "r94", "r95", "r101", "r130", "r134", "r138", "r141", "r144", "r172", "r296", "r362", "r393" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentIncome": { "auth_ref": [ "r394" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Net Investment Income", "totalLabel": "Net investment income (loss)" } } }, "localname": "NetInvestmentIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r81", "r82", "r83", "r84", "r85", "r86", "r89", "r108", "r176", "r177", "r178", "r179", "r180", "r181", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r279", "r280", "r281", "r282", "r337", "r338", "r339", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430" ], "lang": { "en-US": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r13", "r154", "r189" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, after Allowance for Credit Loss", "terseLabel": "Notes receivable (net of allowance for expected credit losses of $1,000)", "verboseLabel": "Note" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r122" ], "lang": { "en-US": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r317", "r321" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Operating lease obligations" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r315" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease, liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r314" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease, ROU asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasedAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Leased Assets [Line Items]", "terseLabel": "Operating Leased Assets [Line Items]" } } }, "localname": "OperatingLeasedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r290" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION AND BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/ORGANIZATIONANDBASISOFPRESENTATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r6", "r353", "r378" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "verboseLabel": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInsuranceProductLineMember": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Contract providing insurance coverage, classified as other.", "label": "Insurance, Other [Member]", "terseLabel": "Other Specialty" } } }, "localname": "OtherInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInvestments": { "auth_ref": [ "r20", "r388" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Investments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investments classified as other.", "label": "Other Investments", "terseLabel": "Other investments" } } }, "localname": "OtherInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r359" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other Liabilities", "verboseLabel": "Other liabilities" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of other liabilities.", "label": "Other Liabilities, Fair Value Disclosure", "negatedLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "auth_ref": [ "r57", "r412" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "negatedTotalLabel": "Total paid" } } }, "localname": "PaymentsForLossesAndLossAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r52" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Repurchase of Class A ordinary shares" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r50" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedTerseLabel": "Contributions to related party investment fund" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInterestInJointVenture": { "auth_ref": [ "r50" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.", "label": "Payments to Acquire Interest in Joint Venture", "negatedLabel": "Non-controlling interest contribution into (withdrawal from) related party joint venture, net" } } }, "localname": "PaymentsToAcquireInterestInJointVenture", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment": { "auth_ref": [ "r51" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).", "label": "Payments to Acquire Trading Securities Held-for-investment", "negatedTerseLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireTradingSecuritiesHeldforinvestment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForLetterOfCreditFacilities": { "auth_ref": [ "r335" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The carrying amount as of the date of the latest financial statement presented of securities which are owned but transferred to serve as collateral for letter of credit arrangements, and for which the transferee does not have the right by contract or custom to sell or re-pledge them to an unrelated party.", "label": "Pledged Financial Instruments, Not Separately Reported, Securities for Letter of Credit Facilities", "terseLabel": "Total equity securities, restricted cash, and cash and cash equivalents fair value pledged as security against the letters of credit" } } }, "localname": "PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForLetterOfCreditFacilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": { "auth_ref": [ "r373", "r399" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.", "label": "Policyholder Benefits and Claims Incurred, Net", "terseLabel": "Net loss and loss adjustment expenses incurred" } } }, "localname": "PolicyholderBenefitsAndClaimsIncurredNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred share capital, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred share capital, authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred share capital, issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r11" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsAndOtherReceivablesNet": { "auth_ref": [ "r390" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.", "label": "Premiums and Other Receivables, Net", "terseLabel": "Reinsurance balances receivable (net of allowance for expected credit losses of $89)" } } }, "localname": "PremiumsAndOtherReceivablesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsEarnedNet": { "auth_ref": [ "r360", "r391", "r402", "r440" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.", "label": "Premiums Earned, Net", "totalLabel": "Net premiums earned" } } }, "localname": "PremiumsEarnedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsWrittenNet": { "auth_ref": [ "r435", "r438" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_PremiumsEarnedNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums written.", "label": "Premiums Written, Net", "totalLabel": "Net premiums written" } } }, "localname": "PremiumsWrittenNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidReinsurancePremiums": { "auth_ref": [ "r409", "r445" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The unexpired portion of premiums ceded on policies in force as of the balance sheet date.", "label": "Prepaid Reinsurance Premiums", "verboseLabel": "Unearned premiums ceded" } } }, "localname": "PrepaidReinsurancePremiums", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromCollectionOfLoansReceivable": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.", "label": "Proceeds from Collection of Loans Receivable", "terseLabel": "Receivable collection amount" } } }, "localname": "ProceedsFromCollectionOfLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "auth_ref": [ "r49", "r54" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.", "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "terseLabel": "Proceeds from redemptions from related party investment fund" } } }, "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalMalpracticeLiabilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business insurance coverage for professionals, such as doctors, lawyers, insurance agents, accountants, real estate agents, veterinarians, and others. This liability coverage insures losses for claims arising from mistakes and errors or omissions in the course of professional activities.", "label": "Professional Malpractice Liability Insurance [Member]", "terseLabel": "Professional Liability" } } }, "localname": "ProfessionalMalpracticeLiabilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Contract providing insurance coverage to policyholder on commercial property against property-related loss. Includes, but is not limited to, damage, theft, or legal liability for personal injury.", "label": "Property and Casualty, Commercial Insurance [Member]", "terseLabel": "Commercial" } } }, "localname": "PropertyAndCasualtyCommercialInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyAndCasualtyPersonalInsuranceProductLineMember": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Contract providing insurance coverage to individual against property-related loss. Includes, but is not limited to, damage, theft, or legal liability for personal injury.", "label": "Property and Casualty, Personal Insurance [Member]", "terseLabel": "Personal" } } }, "localname": "PropertyAndCasualtyPersonalInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyInsuranceProductLineMember": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Contract providing insurance coverage against damage to or theft of property.", "label": "Property Insurance [Member]", "terseLabel": "Total Property" } } }, "localname": "PropertyInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r42", "r184" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Current expected credit losses recognized on notes receivable and reinsurance assets" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForLoanLeaseAndOtherLosses": { "auth_ref": [ "r59", "r157", "r366" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.", "label": "Provision for Loan, Lease, and Other Losses", "negatedTerseLabel": "Charge offs" } } }, "localname": "ProvisionForLoanLeaseAndOtherLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAllowanceForCreditLossesonNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r398" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 2.0, "parentTag": "us-gaap_GainLossOnInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "terseLabel": "Net realized gain (loss)" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceAccountingPolicy": { "auth_ref": [ "r66", "r373", "r374", "r441", "r442" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.", "label": "Reinsurance Accounting Policy [Policy Text Block]", "terseLabel": "Reinsurance Assets" } } }, "localname": "ReinsuranceAccountingPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReinsuranceCostsAndRecoveriesNet": { "auth_ref": [ "r373" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of recovery (expense) related to provision for policy benefits and costs incurred for policies assumed and ceded.", "label": "Policyholder Benefits and Claims Incurred, Assumed and Ceded", "terseLabel": "Loss and loss expenses recovered and recoverable" } } }, "localname": "ReinsuranceCostsAndRecoveriesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Reinsurance Disclosures [Abstract]", "terseLabel": "Reinsurance Disclosures [Abstract]" } } }, "localname": "ReinsuranceDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReinsurancePayable": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements.", "label": "Reinsurance Payable", "verboseLabel": "Reinsurance balances payable" } } }, "localname": "ReinsurancePayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": { "auth_ref": [ "r375", "r408", "r410", "r413" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.", "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments", "terseLabel": "Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47)", "verboseLabel": "Add: Losses recoverable" } } }, "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverables": { "auth_ref": [ "r375", "r386", "r407" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.", "label": "Reinsurance Recoverables, Including Reinsurance Premium Paid", "negatedLabel": "Less: Losses recoverable", "verboseLabel": "Loss and loss adjustment expenses recoverable" } } }, "localname": "ReinsuranceRecoverables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails", "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverablesAllowance": { "auth_ref": [ "r182", "r183", "r185" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on reinsurance recoverable.", "label": "Reinsurance Recoverable, Allowance for Credit Loss", "terseLabel": "Reinsurance balances receivable, allowance", "verboseLabel": "Provision for uncollectible losses recoverable" } } }, "localname": "ReinsuranceRecoverablesAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/RETROCESSIONDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceTextBlock": { "auth_ref": [ "r447" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.", "label": "Reinsurance [Text Block]", "verboseLabel": "RETROCESSION" } } }, "localname": "ReinsuranceTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSION" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r234", "r324", "r325" ], "lang": { "en-US": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r234", "r324", "r325", "r328" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r234" ], "lang": { "en-US": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r324" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Investor relations monthly fee" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r234", "r324", "r328", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r322", "r323", "r325", "r329", "r330" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r5", "r62", "r65", "r352", "r383" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashFlowSupplementalCashEquivalentsReconciliationDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Restricted cash and cash equivalents" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashFlowSupplementalCashEquivalentsReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r105" ], "lang": { "en-US": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Participating securities\u00a0excluded from calculation of loss per share", "verboseLabel": "Employee and Director Restricted Shares" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r15", "r229", "r267", "r384", "r425", "r430" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained earnings (deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r77", "r78", "r80", "r83", "r92", "r95", "r179", "r264", "r265", "r266", "r281", "r282", "r421", "r423" ], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained earnings (deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r149" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Gross Premiums Written by Geographic Area of Risks Insured" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r44", "r449" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "negatedLabel": "Loss (income) from investments in related party investment fund", "netLabel": "GLRE Limited Partners\u2019 share of net income (loss)", "terseLabel": "Income (loss) from investment in related party investment fund [net of related party expenses of $703 and $1,981, (three and nine months ended September 30, 2019: $1,325 and $9,888, respectively)]", "verboseLabel": "GLRE Limited Partners\u2019 share of net income (loss)" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r37", "r69", "r125", "r126", "r133", "r139", "r140", "r146", "r147", "r151", "r172", "r296", "r369" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "totalLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r319", "r321" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Non-cash addition of right-of-use asset" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": { "auth_ref": [ "r98", "r99", "r102", "r104", "r109" ], "lang": { "en-US": { "role": { "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.", "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]", "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]" } } }, "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r146" ], "lang": { "en-US": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Gross Premiums Written by Geographic Area of Risks Insured [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGeographicInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r0", "r69", "r171", "r172", "r296" ], "lang": { "en-US": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.", "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense" } } }, "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "auth_ref": [ "r22", "r73" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Schedule of Line of Credit Facilities [Table Text Block]", "terseLabel": "Letters of Credit Facilities" } } }, "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Operating Leased Assets [Table]", "terseLabel": "Schedule of Operating Leased Assets [Table]" } } }, "localname": "ScheduleOfOperatingLeasedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESScheduleofCommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r71", "r326", "r328" ], "lang": { "en-US": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r5", "r65", "r352", "r383" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Restrictions on Cash and Cash Equivalents" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r130", "r131", "r137", "r198" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r130", "r131", "r137", "r198" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Gross Premiums Written by Line of Business" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r240", "r259" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r27", "r67", "r111", "r112", "r218", "r220", "r221", "r223", "r224", "r225", "r226", "r227", "r228", "r229" ], "lang": { "en-US": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r10", "r11", "r12", "r219", "r220", "r221", "r223", "r224", "r225", "r226", "r227", "r228", "r229" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Schedule of Stock by Class" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSScheduleofOtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).", "label": "Schedule of Weighted Average Number of Shares [Table Text Block]", "terseLabel": "Schedule of Weighted Average Number of Shares" } } }, "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r121", "r123", "r124", "r130", "r132", "r138", "r142", "r143", "r144", "r145", "r146", "r150", "r151", "r152" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "SEGMENT REPORTING" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTING" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "verboseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r241" ], "lang": { "en-US": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r247" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited (in shares)", "terseLabel": "Shares forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r251" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r249" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Number of RSUs issued to employees (in shares)", "verboseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r249" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)", "verboseLabel": "Fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r248" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Balance at September 30, 2020 (in shares)", "periodStartLabel": "Balance at December 31, 2019 (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of non-vested restricted \u00a0shares", "verboseLabel": "Number of non-vested RSUs" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r248" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Balance at September 30, 2020 (in dollars per share)", "periodStartLabel": "Balance at December 31, 2019 (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted \u00a0average grant date fair value", "verboseLabel": "Weighted \u00a0average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r253" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Fair value of options vested in period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r242" ], "lang": { "en-US": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r259" ], "lang": { "en-US": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Number of shares available for grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Number of options granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r252" ], "lang": { "en-US": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r245", "r259" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "terseLabel": "Options outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r244" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "terseLabel": "Exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r237", "r243" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedSharesDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number", "terseLabel": "Number of shares with accelerated vesting" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r254" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "terseLabel": "Vested number of shares (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r318", "r321" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r10", "r11", "r12", "r67", "r69", "r98", "r99", "r100", "r102", "r104", "r111", "r112", "r113", "r172", "r222", "r296" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/CoverPage", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r28", "r77", "r78", "r80", "r83", "r92", "r95", "r110", "r179", "r222", "r229", "r264", "r265", "r266", "r281", "r282", "r302", "r303", "r304", "r305", "r306", "r307", "r421", "r422", "r423" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r77", "r78", "r80", "r110", "r336" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited": { "auth_ref": [ "r258" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-based Payment Arrangement, Forfeited", "terseLabel": "Shares forfeited" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r222", "r229" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issue of ordinary shares, net of forfeitures (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": { "auth_ref": [ "r11", "r12", "r222", "r229" ], "lang": { "en-US": { "role": { "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited", "terseLabel": "Number of restricted shares forfeited (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r222", "r229" ], "lang": { "en-US": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Shares issued (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r11", "r12", "r222", "r229", "r246" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Number of stock options exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r11", "r12", "r229", "r239", "r252" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Issue of Class A ordinary shares, net of forfeitures" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased", "terseLabel": "Stock repurchase program, remaining number of shares to be repurchased (in shares)" } } }, "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r11", "r12", "r222", "r229" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedLabel": "Repurchase of ordinary shares (in shares)", "terseLabel": "Repurchase of ordinary shares (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALScheduleofVotingOrdinarySharesIssuedAndOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r11", "r12", "r222", "r229" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedTerseLabel": "Repurchase of Class A ordinary shares" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r12", "r16", "r17", "r69", "r165", "r172", "r296" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r68", "r229", "r230" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "SHARE CAPITAL" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITAL" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r308", "r332" ], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r308", "r332" ], "lang": { "en-US": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r308", "r332" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r308", "r332" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r331", "r334" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SUBSEQUENTEVENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplementary information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r411" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.", "label": "Current Year Claims and Claims Adjustment Expense", "terseLabel": "Current year" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r411" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.", "label": "Prior Year Claims and Claims Adjustment Expense", "terseLabel": "Prior years", "verboseLabel": "Prior years adjustment increase (decrease)" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESChangeinOutstandingLossandLossAdjustmentExpenseReserveForHealthClaimsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r82", "r83", "r84", "r85", "r176", "r177", "r178", "r179", "r180", "r181", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r279", "r280", "r281", "r282", "r337", "r338", "r339", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430" ], "lang": { "en-US": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [ "r21" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "terseLabel": "Unamortized debt issuance expense" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnearnedPremiums": { "auth_ref": [ "r380" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.", "label": "Unearned Premiums", "verboseLabel": "Unearned premium reserves" } } }, "localname": "UnearnedPremiums", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r60" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails": { "order": 1.0, "parentTag": "us-gaap_GainLossOnInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "terseLabel": "Net change in unrealized appreciation (depreciation)" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedIncomeStatementsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r114", "r115", "r116", "r117", "r118", "r119", "r120" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "terseLabel": "Variable Interest Entity, Not Primary Beneficiary" } } }, "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r289" ], "lang": { "en-US": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r97", "r104" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average shares outstanding - diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average number of ordinary shares used in the determination of earnings and loss per share" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r96", "r104" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average shares outstanding - basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESEarningsPerShareReconciliationDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b,d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953659-111524" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5066-111524" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5111-111524" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953401-111524" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27405-111563" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=75018788&loc=d3e30768-111565" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r174": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL82887624-210437" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921833-210448" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921842-210448" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922352-210448" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922355-210448" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=99383045&loc=d3e9351-108337" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=99397363&loc=d3e9420-108338" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r203": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r205": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121548805&loc=d3e10037-110241" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121596127&loc=d3e12803-110250" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6402221&loc=d3e15743-112638" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5708775-113959" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r330": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r334": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(c))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.1-5)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.11)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.2)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6480726&loc=d3e6691-158385" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(13)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(6))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(7))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f,g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(7)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.5)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.5,6,7)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121638524&loc=SL117422543-158416" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121638524&loc=SL117422543-158416" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121638166&loc=d3e11522-158419" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21409-158489" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "340", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6485982&loc=d3e22818-158507" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(cc)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "9C", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884803&loc=SL65671395-207642" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "40", "Subparagraph": "(SAB TOPIC 5.W)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907" }, "r432": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/subtopic&trid=2560295" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "605", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=84167274&loc=d3e27175-158546" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(a)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(b)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(b)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(b)(3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "605", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "605", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487483&loc=d3e32239-158577" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121640538&loc=d3e32546-158582" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r447": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "944", "URI": "http://asc.fasb.org/topic&trid=2303980" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.20)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r478": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r479": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r480": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r481": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r482": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r483": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r484": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r485": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03" }, "r486": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r487": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r488": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r489": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" } }, "version": "2.1" } ZIP 73 0001385613-20-000083-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001385613-20-000083-xbrl.zip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�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ဤ:*[D?3FP7O]X#)381 M?,\6ZK,1C/.[\L=@C(G^J\GS+S"H90[S&Q)"\AR%KKVN"MV0SC*Z%!V+OE@% M5H*#+E]0.YFEZZ$<-@*RC:)&3:3?WKQX M^^GCQ=L_GK][^^G5VS]?O'W^ZL56%?KK'M=/ 7EGP O%XS)K#!*S+_2['#'Z M9)0/GB0ZF3]<1I^2?POC,4P'WW&'A@F;/+ZY-M8O:$$O/!5AG."";ATMZW!C MZ1VB-)B%5&GM7GCPHMT,49(!.6_/QY@'TY>0Z-R:R. M.; HC&$B)RZ]B#'I)DV0UJ+:*>!S.\QFX=D#G%QFGYQ"ZYA$*W<]G4QAF ?#SQ=? M:VSKTM-&$VB1D2%@&%D/F45PF>5@M %0N<0FJ?R/ 3L'9C110@/'^_T5YL^8 M7PZ&,$P#N+K7D_;M:/H1OP&=KGA%3N>WT;CV><)T/9[1^^5H?+NX)

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end